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 Ascending placentitis is a significant cause of abortions, stillbirths, and perinatal loss in 
horses. A technique for laparoscopic-guided catheterization of the allantoic space was developed 
and utilized in an experimental model of streptococcal infective pre-term delivery in pony mares. 
Mares received either 1 x 10
7
 CFU live S. zooepidemicus (n=3), 5.1 x 10
8
 CFU live S. 
zooepidemicus (n=1), 1 x 10
7
 heat-killed S. zooepidemicus (n=3), 1 mL sterile PBS (n=3).  Sham 
control mares did not receive a transcervical inoculation (n=3). One mare not instrumented with 
an allantoic catheter received 5.1 x 10
8
 CFU live S. zooepidemicus. Mares with spontaneous 
abortion had significantly increased CTUP compared to mares in which delivery was induced. 
There was not a significant effect of infection within the allantoic space on CTUP. Intrauterine 
infection increased the expression of IL-1β, IL-18, IL-15, and IFN-γ in a site-dependant manner.  
Spontaneous abortion also increased the expression of IL-1β, IL-18, IFN-γ, and iNOS in a site 
dependant manner. Soluble TNF-α was detected in only a few samples of fetal fluids. The 
concentrations of PGE2 and PGF2α in fetal fluids were increased within 24 h of delivery in mares 
with spontaneous abortion or intrauterine infection. Increased cortisol concentrations were 
observed in fetal fluid in some mares with infection or with histologic inflammation of the 
chorioallantois. None of the fetal fluids from mares induced to deliver or without inflammation 
of the chorioallantois had increased cortisol concentrations. This data suggests that the equine 
fetal adrenal gland less than 295 d may be capable of response to stimuli. Based on these 
findings, the following sequence of events leading from intrauterine infection to infective pre-
term delivery is proposed. Following infection of the chorioallantois, IL-1β, IL-18, IL-15, and 
IFN-γ are upregulated in a site-dependant manner. IL-1β causes increased PGHS-2 (COX-2) 
expression, resulting in increased PGE2 and PGF2α production, and ultimately labor.  IL-1β may 
xiii 
 
also accelerate fetal hypothalamic-pituitary-adrenal axis (HPAA) activation, thereby promoting 
precocious in utero fetal maturation. The eventual outcome of pre-term labor, i.e., neonatal 





INTRODUCTION AND REVIEW OF THE LITERATURE 
1.1 Overview of Placentitis 
 Placentitis has been reported to be responsible for 9.8 [1], 19.4 [2], 24.7 [3], and 33.5%  
[4] of abortions, stillbirths, and perinatal loss in horses. Bacterial infections were responsible for 
53%  of these losses; Streptococcus equi subsp. zooepidemicus, hereafter referred to as S. 
zooepidemicus, was isolated in 28% of these cases [3]. Other bacteria frequently identified were 
Escherichia coli, Leptospira spp., gram-positive filamentous rod (subsequently named as 
Crosiella equi), Pseudomonas spp., S. equisimilis, Enterobacter spp., Klebsiella spp., α-
hemolytic streptococci, Staphylococcus spp., and Actinobacillus spp. [3]. The discrepancy in the 
reported incidences of placentitis lies in a considerably higher occurrence of umbilical cord 
problems (38.8%) in the survey population [1], compared to 4.5% [4] and 3.4% [3] in other 
populations. The localization of placentitis to the cervical star was present in 95% of cases, 
supporting the argument that ascension of aerobic bacteria through the vagina and cervix is the 
most frequent route of infection [5]. Clinically, mares may have a vaginal discharge, show udder 
development, prenatally lactate, and deliver a premature or dead foal. Empirical treatment for 
placentitis includes progestins to maintain uterine quiescence, broad-spectrum antibiotics to 
eliminate bacterial infection, and anti-inflammatory agents to prevent prostaglandin synthesis. 
Although these agents should address the basic problems of infection-induced prostaglandin 
synthesis that leads to uterine contractions and fetal expulsion, the efficacy of these regimes is 
often poor [6]. There are two major areas where the basic knowledge of the pathophysiology of 
equine placentitis is lacking: (1) the endocrinological events associated with loss of myometrial 
quiescence and (2) the temporal relationship between the inflammatory cascade, increases in 
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prostaglandin synthesis and release, and activation of the fetal hypothalamic-pituitary-adrenal 
axis. 
1.2 The Equine Placenta 
 The equine placenta is characterized as diffuse, chorioallantoic,  epitheliochorial, villous 
(microcotyledonary), and adeciduate [7].  Although there does not appear to be a relationship 
between the structural anatomy of the placenta and its steriodogenic activities, a brief review of 
the equine placenta is useful to the topic of placentitis. 
1.2.1 Embryonic Events 
 The equine embryo enters the uterus on day 6 as a morula or early blastocyst. At this 
stage the outer covering is the zona pellucida, which thins and sheds around day 8 [8,9]. The 
equine embryonic capsule begins to form within the first days of intrauterine life and ruptures or 
retracts by day 21; its precise function is still unclear (review [10]). Ginther provides a most 
precise description of the development of the extraembryonic membranes in the mare [11].  At 
day 9 the blastocyst has a single layer of trophoblast (ectoderm) cells forming the blastocoele,  
and a single layer of endodermal cells, arising from the inner cell mass, beginning to encircle the 
blastocoele (the eventual yolk sac).  The exact day on which formation of the bilaminar yolk sac 
is complete is unknown, but probably is around day 11 [11]. Invasion of a mesodermal layer 
(originating from the embryonic disc) between the trophoblast and the endoderm begins on day 
14, gradually encroaching towards the mesometrial pole.  Blood islands within this mesodermal 
layer form, enlarge, coalesce, and eventually connect with channels within the embryo proper 
(vitelline-embryo circulation).  At the leading edge of the mesoderm, a prominent vein begins to 
develop (sinus terminalis).  The three-layered yolk-sac wall (ectoderm, mesoderm, and 
endoderm) that extends from the embryo and the sinus terminalis is the trilaminar 
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omphalopleure. The bilaminar omphalopleure is the remaining two-layer wall of the yolk sac.  
As the trilaminar omphalopleure continues to expand, the bilaminar omphalopleure contracts to 
the pole opposite the embryo proper, and later becomes the site of umbilical cord attachment to 
the fetus. Just after the mesodermal layer begins its invasion between the ectoderm and 
endoderm, amniotic folds begin to form, folding beneath the embryonic disc, and eventual fusing 
to form the amniotic sac. At the margins of the amniotic folds an exocoelom forms within the 
mesodermal layer, the outer layer of which becomes the chorion (ectoderm and mesoderm). 
Following fixation on day 16, the embryonic disc assumes an antimesometrial orientation 
leaving the yolk sac mesometrial. The transition from a yolk sac to an allantoic sac begins with 
the emergence of the allantois from the primitive hind gut on day 21, which forms a cup beneath 
the amnion (within the exocoelom)  and embryo proper by day 25, and continues to expand as 
the yolk sac regresses through day 40. As the allantois expands it fuses with the chorion to 
become the chorioallantois (or allantochorion) [11]. A unique feature of the equine placenta is 
the endometrial cups, which develop from trophoblast cells from the chorionic girdle (area of 
chorion between the developing allantoic sac and the regressing yolk sac) invading into the 
endometrium ([12], review [13]). 
1.2.2 Attachment and Microcotyledon Formation 
 The process of attachment of the chorioallantois to the endometrium is an extremely 
prolonged process compared to other domestic animals. Although one might consider the 
invasion of the trophoblastic cells of the chorionic girdle equivalent to placental attachment, such 
attachment is temporary and ends when invasion is complete (day 36 to 38) [14]. 
Microcotyledons develop from primary villi, whose first appearance has been reported to range 
from day 40 to 61 [15,16]. Interdigitation of the microvilli and the maternal epithelium begins at 
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this stage, and by day 100, the microvilli have branched and fused with adjacent villi, thereby 
forming a microcotyledon [16]. 
1.2.3 Umbilical Vasculature 
  The equine umbilical cord is comprised of allantoic and amniotic segments. The 
allantoic segment is lined with endoderm contiguous with the allantoic membrane, and is 
composed of two major arteries. One artery supplies the gravid horn and cranial uterine body and 
the other artery supplies the non-gravid horn and the remainder of the uterine body. At the 
periphery, umbilical veins tend to parallel the umbilical arteries, until converging into two 
umbilical veins, which converge into a single umbilical vein while still within the allantoic 
segment of the umbilical cord. The amniotic segment of the umbilical cord is comprised of two 
umbilical arteries, one umbilical vein, and the urachus (―allantoic duct‖), and the regressed yolk 
sac stalk. An ossified remnant of the yolk sac is commonly identified at delivery of the fetal 
membranes [17,18].  Umbilical veins carry oxygenated blood (―arterial‖) from the placenta to the 
fetus, while umbilical arteries return the poorer oxygenated blood (―venous‖) from fetus back to 
the placenta. 
1.3 Myometrium 
 Since loss of myometrial quiescence and the initiation of labor is a key event in 
pregnancy loss due to placentitis, understanding myometrial function is crucial to elucidating the 
mechanisms involved with pre-term labor and identifying potential targets for interventional 
strategies. Investigations on the ultrastructure, biochemistry, and signaling events of equine 
myometrium are scarce. The following discussion is based on findings from myometrial function 




1.3.1 Cellular and Intracellular Organization  
Myometrium is classified as unitary smooth muscle, also known as syncytial or visceral 
smooth muscle, meaning that a large mass of muscle fibers contract simultaneously as a single 
unit. Due to the aggregation of muscle fibers into bundles and the adherence of cell membranes 
at multiple points, contractile force generated in one muscle bundle is transmitted to adjacent 
bundles. The presence of gap junctions further contributes to the coordinated contraction of 
muscle fibers. In the majority of species, including the horse, myometrial fibers are organized 
into two layers, each with distinct phenotypic and biochemical properties that are maintained in 
vitro [19]. Myometrial cells are typically spindle-shaped. Their size (300 to 600 µm in length by 
5 to 10 µm in diameter) and number vary with the degree of uterine distension and stage of 
pregnancy [20]. The outer longitudinal muscle layer shortens the length of the uterine horns 
during contraction, and the inner circular muscle layer, compresses the diameter of the horns 
during contraction. Differences in response to contraction-stimulating agents exist. Circular 
muscle from mid-gestational pregnant, rat myometrium spontaneously contracted upon exposure 
to norepinephrine; while longitudinal muscle did not. The circular muscle layer’s  response to 
catecholamines was inhibited by isoproterenol, and declined with approaching parturition  
[20,21]. Differences in in vitro spontaneous contractility due to stage of estrous cycle and 
myometrial layer were recently described in equine myometrium [22].  The frequency of 
contractions was increased in estrous circular muscle compared to longitudinal muscle, while 
area under the curve and time occupied by contractions were greater for longitudinal muscle 
during diestrus. These findings lead to the hypothesis that circular muscle contractions during 
estrus are crucial to uterine clearance mechanisms and that longitudinal contractions during 
diestrus are key to embryo mobility prior to day 16 [22]. In contrast, no spontaneous contractility 
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of either muscle layer was observed in myometrium collected from mares under general 
anesthesia during pregnancy [23], or from mares 18 h following insemination [24] , presumably 
due to either anesthetic agents or the presence of propranolol in the Krebs solution used to bathe 
the muscle strips. Under these experimental conditions [24] the length-tension relationships of 
the two layers did not differ and the response to contractile agonists were similar. Clearly, 
differences in the experimental design of these two studies make direct comparisons difficult, but 
it is likely that differences in contractile properties exist between circular and longitudinal equine 
myometrium.  
1.3.2 Innervation   
 Postganglionic sympathetic fibers in the mare arise from the caudal mesenteric ganglion 
and plexus, and travel to the uterus via the hypogastric nerves and pelvic plexus. 
Parasympathetic innervation comes via the pelvic nerves from the sacral area [25]. The density 
of nerve fibers (noradrenaline, dopamine, and acetylcholine) of sheep myometrium decreases 
during pregnancy from day 15 through day 105 of gestation [20].  A similar pattern was seen 
with human myometrium, where 30% of nerve varicosities (―synapses‖) from nonpregnant, 
nonparous women were classified as adrenergic,  53% as cholinergic, and 17% as indeterminate, 
while nerve varicosities were only rarely observed at term [26].  Bae et al. [27] described the 
immunohistochemical distribution of adrenergic and peptidergic nerve fibers in the uterus and 
cervix of cycling mares. Nerves immunoreactive for the catecholamine-synthesizing enzymes 
tyrosine hydroxylase (TH) and dopamine β-hydroxylase (DβH) were present in all regions of the 
uterus, with very large numbers of fibers identified in both the longitudinal and circular layers of 
the myometrium. Stage of the estrous cycle had no difference on the intensity of staining or 
distribution of TH and DβH within the uterus. Immunoreactive staining for the peptidergic 
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nerves containing the neuropeptides neuropeptide Y (NPY), vasoactive intestinal polypeptide 
(VIP), calcitonin gene-related peptide (CGRP), and substance P (SP) were also examined. 
Moderate numbers of NPY-IR fibers were present in the myometrium. Only very small numbers 
of VIP-IR and CGRP-IR fibers were present, while no fibers with staining for SP were 
identified.  The adrenergic and peptidergic innervation of the pregnant uterus was not 
investigated, but presumably a similar reduction in nerve varicosities reported in other species 
occurs in the mare. If there is a functional consequence of this reduction and whether alterations 
in innervation occur with infective processes of the uterus and placenta are unknown. An 
alternative explanation is that the number of nerve varicosities is unchanged during gestation, but 
as hypertrophy and hyperplasia of the myometrium increases with advancing pregnancy, the 
relative number of nerve varicosities per myometrial cell declines. 
1.3.3 Contractile Proteins and Cytoskeleton 
 The contractile apparatus of myometrium is composed of thin, thick, and intermediate 
filaments, dense bodies, and ion channels. 
Thin actin filaments – Monomeric actin (globular or G-actin; 42.5 kDa) is polymerized into 
filamentous structures (F-actin), which in turn organize into a double-alpha helix to form the thin 
actin filaments (60 Å diameter) of myometrium. Several proteins (tropomyosin, caldesmon, and 
calponin) are also associated with the alpha helical coil. Three main actin isoforms (α, β, and γ) 
have been shown to be expressed in myometrium. Alpha-actin is invariant throughout pregnancy 
in the mouse and rat [28,29],  but γ-actin localization changes significantly during gestation from 
predominant staining in the longitudinal layer to intense staining in the circular layer, suggesting 




Intermediate filaments and microtubules – Intermediate fibrils (100 Å diameter, intermediate 
filaments)  and microtubular networks (25 Å) are composed of desmin, a member of the 
vimentin-like superfamily, and are thought to provide cytoskeletal support and help regulate cell 
shape by connecting cytoplasmic dense bodies with plasmalemmal dense plaques [30]. 
Intermediate fibers may play a role in the cellular transmission of active and passive force, as 
demonstrated by a significant reduction in the active force per cross-sectional area in smooth 
muscle (urinary bladder and vas deferens) in a transgenic desmin null mouse model [31]. Their 
functional role in myometrium is unknown, although intermediate filaments were identified in 
gene clusters  activated at term mouse myometrium (compared to the murine genome [32]), and 
in those mediating microtubule polymerization and microtubule-based movement in late 
pregnant (96% gestation) guinea pig myometrium (compared to the human genome [33]). 
Dense Bodies – Dense bodies (so named because of a high affinity for electron-dense 
substances) are located within the cytoplasm and at the plasmalemma (1.2 µm long, up to 0.3 µm 
wide) and are referred to as ―dense bands‖ or ―plaques‖. They are composed of α-actin and are 
the site of attachment for thin actin filaments and intermediate filaments, and have been 
suggested to function as a primary link between the contractile apparatus and the cytoskeleton 
[34]. Some putative myometrial dense plaque proteins (α5 integrin, focal adhesion kinase, 
paxillin, heat shock protein (hsp) 27, and extracellular signal-related (ERK) kinase 2) are 
upregulated in rat myometrium at term [35-38]. 
Myosin-containing (thick) filaments – A thick filament subunit is composed of two heavy chains 
and four light chains. Each heavy chain (MHC, 220 kDa) has a globular head domain and an α-
helical coiled-coil rod domain. The two rod domains are in parallel arrangement and coil around 
one another into a left-handed super helix, leaving the globular heads at one end of the rod. A 
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regulatory light chain (MLC20, 20 kDa) and an essential light chain (MLC17, 17 kDa) are 
associated with each globular head of a MHC. Although the exact organization of myosin 
filaments is the subject of debate, multiple subunits (hexameric groups of two MHCs and four 
MLCs) are associated in an anti-parallel fashion, with the globular heads exposed at opposite 
poles for interaction with thin actin filaments [39]. A single myosin filament (150 Å diameter) is 
located equidistant between two dense bodies and overlaps the many actin filaments emanating 
from dense bodies [30].  Myosin filaments also possess sidepolar cross-bridges, which hinge in 
opposite directions on opposing sides of the myosin filament for attachment to actin filaments. 
The cycling (time from attachment, to release, and subsequent reattachment) of cross-bridges is 
extremely slow compared to skeletal muscle, but the length of attachment is much longer. This 
translates into a greater force of contraction at reduced energy expenditure [40].  An additional 
feature of smooth muscle is the ―latch‖ mechanism, whereby full force of contraction is 
maintained with only minimal excitatory signal needed compared to that required for initiation of 
contraction [41]. 
Ion channels – Fast and voltage-gated sodium channels, calcium channels, and potassium 
channels have been described in myometrial cell membranes. During pregnancy the Na
+
 ion is 
the main determinant of the resting membrane potential, which in turn establishes the degree of 
membrane polarization. An increase in the Na
+
 current densities was observed approaching term 
gestation [42], and a Na
+
 gradient was important for the regulation of myometrial contraction 
[43]. L-type voltage-dependent Ca
2+
 channels (nifedipine-sensitive) are thought to be responsible 
for oxytocin (OT)- and prostaglandin F2α (PGF2α)-induced contractions and increases in 
intracellular calcium concentration in pregnant myometrium [44,45]. While L-type Ca
2+
 channels 
may be involved with agonist stimulated myometrial contraction, there is no evidence that these 
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channels are upregulated in term myometrium.  Blockade of T-type Ca
2+
 channels by mibefradil 
indicates that this channel may also be important for OT-induced contractions [46].  
1.3.4 Myometrial Contraction 







 ions bind with the calcium binding protein calmodulin 
(CAM, 17-kDa) resulting in a conformational change in CAM, allowing Ca-CAM to interact 
with myosin light chain kinase (MLCK, 130-160 kDa). The MLCK phosphorylates  Ser19 of 
MLC20 (regulatory chain), increasing the actin-activated Mg-ATPase activity of myosin, and its 
interaction (initiation of a cross-bridge cycle) with actin [40,47]. (See Figure 1.1) Substances 
(―contractile agents‖, ―uterotonins‖,  ―uterotonic agonists‖) which increase [Ca
2+
]i, either by 
entry through receptor-mediated Ca
2+
 channels or release from intracellular stores will increase 
MLCK activity leading to contraction.  
 The principle agonists of myometrial contraction are oxytocin and prostaglandins (PGF2α 
and PGE2), which exert their effects through specific receptors on the cell membrane. Other 
agents such as endothelin-1, bradykinin, platelet-activating factor, and cholinergic agents 
increase MLC20 phosphorylation either by increasing [Ca
2+
]i or decreasing cAMP activity [20].  
The role of corticotrophin releasing hormone (CRH) as an indirect uterine stimulant in primates 
has received considerable attention. It is produced by the placenta (syncytiotrophoblast and 
intermediate trophoblasts) in response to cortisol, IL-1β, PGE2, and OT, and it stimulates 
increased prostaglandin H synthase-2 (PGHS-2),  PGE2, and PGF2α  production by the placenta 
(review [48]). CRH production has not been documented in other species, and was shown to 
have extremely limited ability to cross the rat placenta from the maternal circulation  [49]. 







Figure 1.1 Biosynthetic pathways involved with smooth muscle contraction. Adapted from Challis et al. 
(2000) [48]. Abbreviations: oxytocin receptor (OT-R), AA (arachidonic acid), prostaglandin E2 (PGE), 
prostaglandin F2α, (PGF), sarcoplasmic reticulum (SR), cyclic adenosine monophosphate (cAMP), 
adenosine triphosphate (ATP), myosin light chain (MLC), and myosin light chain kinase (MLCK). 
 
[50], or by reduction of MLCK activity. Reduction of [Ca
2+
]i reduces MLCK activity by 
dissociation of calcium from CA-CAM.   
1.3.5 Stimulatory Agents 
1.3.5.1 Oxytocin 
Oxytocin is a nonapeptide (OT; 1007 Da; sequence: Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-
GlyNH2) synthesized by the supraoptic and paraventricular nuclei of the hypothalamus, and is 
stored bound to neurophysin 1 within dense-core vesicles of the posterior lobe of the pituitary 
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gland. The principle physiologic actions of OT are involved with contractions of the 
myometrium, epididymis, vas deferens, and myoepithelial cells within the mammary gland. OT 
causes direct stimulation of myometrium by increasing intracellular Ca
2+
 concentrations and 
MLC20 [51]. Indirect myometrial stimulation also occurs through increased prostaglandin release 
from the deciduas [52,53].  
The oxytocin receptor (OTR) is coupled to several G proteins [54] and is dramatically 
increased near parturition [48], as demonstrated by a four-fold increase in in vitro myometrial 
sensitivity to OT and a ten-fold increase in OT-receptors in the 24 h preceding parturition in the 
rabbit [53]. Interestingly, oxytocin may not be essential to labor, as evidenced by failure of OT 
antagonists to prevent labor in rats [55] and the normal initiation of parturition in OT-deficient 
mice [56]. While OT is undoubtedly involved with normal parturition, these studies suggest that 
labor can occur in the absence of signaling through the OTR. The in vitro resting tension, 
contraction amplitude, and contraction frequency of equine myometrium displayed a dose-
dependent response to OT, although at higher doses of OT, the amplitude and frequency began to 
decline. There was no effect of gestational age or presence of progestagens (progesterone, 5α-
DHP, ββ-diol, βα-diol, or 20α-5P; see Table 1 for nomenclature) either prior to addition of OT or 
at the time of OT addition on the response to OT [23]. Although it was concluded that 
progestagens are ineffective at controlling agonist stimulated myometrial contraction in vitro, the 
myometrial preparation was not separated by layer, possibly masking significant effects.  
1.3.5.2 Prostaglandins 
 Prostaglandins are 20-carbon unsaturated fatty acid enzymatic derivatives of membrane 
phospholipids containing a 5-carbon ring. Prostaglandins are mediators of a wide variety of 
physiologic processes including platelet aggregation, renal function, bronchial reactivity, 
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vascular reactivity, and maintenance of gastrointestinal mucosal integrity, to name a few. 
Prostaglandins also have many key roles in reproduction including ovulation, gamete transport, 
implantation, luteolysis, ejaculation, cervical dilation, and myometrial contraction. 
1.3.5.3 Prostaglandin Synthesis 
 Isoforms of phospholipase A2 catalyze the release of unesterified arachidonic acid from 
membrane phospholipids and are broadly categorized into cytosolic phospholipases (30-110 
kDa, with no catalytic requirement for Ca
2+
) and secretory phospholipases (13-18 kDa, which 
require millimolar Ca
2+
 concentrations  for catalysis) [57]. Type-IV cytosolic phospholipase A2 
(cPLA2-IV) is increased at term compared to pre-term in guinea pig cervix [58], human amnion 
[59], human myometrium [60], and in ovine endometrium [61]. In sheep and women there is no 
change in myometrial cPLA2 during gestation and labor [60,61]. Type-IIA secretory PLA2 
(sPLA2-IIA) has been shown to either have no change [60] or to be increased in lower uterine 
segment of human myometrium near term and in labor [62].  
Prostaglandin H Synthase – Arachidonic acid is metabolized to prostaglandin H2 (PGH2) by 
prostaglandin H synthase 1 (PGHS-1, 70-71 kDa), also known as cyclooxygenase-1 (COX-1), 
which is a constitutively expressed enzyme. Prostaglandin H synthase-2 (PGHS-2, 72-24 kDa), 
also known as cyclooxygenase-2 (COX-2), can be induced by hormones, cytokines, growth 
factors, tumor promoters, and bacterial endotoxin. PGHSs catalyze both bis-oxygenase 
conversion of arachidonic acid to PGG2 and the peroxidase conversion of PGG2 to PGH2 
(review, [63-65]).   
 PGHS-1 and PGHS-2 expression was localized to human amniotic epithelium and 
mesoderm [66,67] , while the chorion leave was found to either express both PGHS-1 and 
PGHS-2 [67,68] or only  PGHS-1 [66]. In most studies, the expression  of PGHS-2 has been 
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shown to increase with labor [66,69] and the activity of PGHS-2 (measured as the ability of the 
microsomal fraction of chorionic tissue to convert arachidonate to PGE2) was significantly 
greater in chorion from term spontaneous labor patients compared to chorion from term prior to 
labor patients [69]. A gestational age dependent increase in PGHS activity was observed after 35 
to 37 weeks of human pregnancy (term < 41 weeks), and was highly correlated with PGHS-2 
mRNA levels, but not PGHS-1 mRNA levels [68]. Similar to human fetal membranes, PGHS-1 
and PGHS-2 mRNA were expressed in cotyledonary tissues from ewes at 40 d to term; and while 
no change in the relative abundance of PGHS-1 was observed during this period, the relative 
abundance of PGHS-2 mRNA increased sevenfold between 40 to 85 d and 140 to 145 d. No 
significant change in PGHS-2 was observed between ewes not in labor at 140 to 145 d and ewes 
in labor [70]. To more critically evaluate the changes occurring near term, the changes in PGHS-
2 expression and production were compared in ewes not in labor (140 to 145 d), in early labor 
(143 to 149 d), and in active labor (145 to 149 d) in relationship to fetal PGE2, maternal PGFM 
(PGF2α metabolite), and PG receptor subtype expression. Although an observed trend of 
increasing PGHS-2 mRNA was non-significant, there was a significant increase in PGHS-2 
protein in myometrium from ewes in labor compared to ewes not in labor. Fetal PGE2 increases 
followed the pattern of increased placental PGHS-2 mRNA (progressive increase towards labor), 
while maternal PGFM did not increase significantly until the onset of labor. No change in PGE2 
or PGF2α receptor subtype with respect to onset of spontaneous labor was identified [71]. Taken 
together these studies confirm an increase in PGHS-2 in fetal and maternal tissues from women 




 Specific synthases and isomerases convert PGH2 to the primary prostaglandins.  Both 
cytosolic and membrane-bound PGE synthases (cPGES, mPGES) have been described. 
Prostaglandin E Synthase – Cytosolic-PGES is the glutathione (GSH)-dependent terminal 
enzyme in the PGHS-1-mediated biosynthesis of PGE2, and is identical to p23, a hsp90-
associated protein [72]. Membrane-bound PGES (mPGES, also referred to as microsomal PGES) 
is also GHS-dependant; and two isoforms (mPGES-1 and mPGES-2) have been identified [30]. 
Microsomal-PGES-1 is coupled to a PGHS-2-mediated pathway leading to the production of 
PGE2 and its expression is increased with lipopolysaccharide (LPS), IL-1β, and TNF-α [73,74].  
Microsomal-PGES-2 was initially isolated from bovine heart, is constitutively expressed, is not 
homologous with the PGHS S-transferase family, and is thought to be coupled with PGHS-1. All 
three isoforms have been detected in human myometrium [75,76], with no change in the 
expression of cPGES in lower uterine segment (LUS) with labor, but an increased expression of 
mPGES-2 in LUS with labor [76]. Similar to women in labor, upregulation of myometrial and 
fetal membrane mPGES, but not cPGES, was seen following LPS-induced labor. There was no 
difference in time to delivery between wild-type mice and mPGES-1 (-/-) mice, most likely due 
to upregulation of mPGES-2 in mPGES-1 knockout mice [77]. No changes in relationship to 
spontaneous or dexamethazone-induced labor were seen in PGES in sheep, and PGES actually 
declined in endometrium, myometrium, cervix, amnion, and placentome, compared to 
gestational-age matched controls  [78,79]. The reasons for the differences seen between women 
and sheep are not entirely clear, but location of sampling and selection of primers are 
possibilities. A single site of the mid-section ovine uterus was sampled (horn not specified, but 
presumably gravid), so potential differences in expression of PGES at different sites within the 
myometrium are possible.  The designs for oligonucleotide primers for PGES used in the study 
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were based on the previously reported bovine sequence for inducible PGES (membrane-
associated), for which the homology with cPGES in that species has not been reported [80]. 
Another possibility is that upregulation of PGES is not coupled with PGHS-2 in ovine 
gestational tissues as was shown with IL-1β treatment of human trophoblast cells [81]. Bovine 
endometrium and myometrium (day 16 of diestrus) have been shown to possess PGES (Western 
blot and immunohistochemistry), and although the antibovine-PGES was generated from a 
primer sequence based on human mPGES, the in vivo activity was more similar to that described 
for cPGES, since interferon-τ (IFNτ; the embryonic signal for maternal recognition of pregnancy 
in this species) caused no change in PGES or PGHS-1 expression, while PGHS-2 was 
upregulated [82]. It should also be noted that confusion in the literature exists over the 
designation of the three isoforms. Soorana et al., [75] suggested that PGES-1 investigated was 
cytosolic, when in fact, according to the Genbank reference number, it was membrane-
associated. 
Prostaglandin F Synthase – Prostaglandin F2α is produced by one of three pathways (review, 
[83]). (See Figure 1.2) 
 (1) PGE 9-ketoreductase (9-KPR, 36,000 kDa), present in cytosolic fractions, converts 
PGE2 to PGF2α in the presence of NADH/NADPH in a reversible fashion, and has been isolated 
from human [84] and bovine [85] term placentas, and bovine endometrial epithelial cells [86]. 
Very little has been reported on the roles of 9-KPR in reproductive tissues. Increased 9-KPR 
activity was seen with retained bovine fetal membranes, whether pre-term or term, with higher 
activity in caruncular tissue than cotyledonary tissue [87]. Down-regulation and activity of 9-
KPR due to IFNτ has been observed in bovine endometrium [86], which suggests 9-KPR has a 





Figure 1.2 Pathways of PGF synthesis. Adapted from Watanabe (2002) [83]. 
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activity of 9-KPR due to diethylamine NONOate (NOC-18, a nitric oxide donor), and increased 
activity due to aminoguanidine (an iNOS inhibitor) was seen in term human chorioamnion [88].  
Further investigations are needed to determine if 9-KPR is increased in fetal and uterine tissues 
at term compared to pre-term, and whether in vitro incubation of endometrial epithelial cells with 
TNF-α or IL-1 causes increases in 9-KPR activity.  
 (2) PGD 11-ketoreductase (36,666 kDa) converts PGD2 to 9α-, 11β-PGF2α (ll epi-
PGF2α), requires NADPH as a cofactor, and has been isolated predominately in lung and liver 
[83]. PGD 11-ketoreductase was designated by Watanabe [83] as PGFSI (lung isozyme) and 
PGFSII (liver isozyme). PGFS (isozyme not specified) was detected in cycling and pregnant gilt 
myometrium; and although OT increased the in vitro production of PGF2α, there was no 
detectable change in the amount of PGFS [89].  
 (3) PGH 9-, 11-endoperoxide reductase converts PGH2 to PGF2α, also in the presence of 
NADH or NADPH. Two PG endoperoxidases have been reported. The first was a 16,500 kDa 
glutathione- (GSH) dependent microsomal enzyme isolated from sheep seminal vesicles that did 
not utilize PGD2 in the production of PGF2α [90]. The second was a 33,000 kDa, cytosolic PG 
endoperoxidase isolated from Trypanosoma bruci, and although it was designated PGFS, it is 
considered distinct from mammalian PGFSs [91]. 
 The effect of cytokines on prostaglandin production is well documented in a variety of 
tissues. Interleukin-1β (IL-1β) has been shown to increase prostaglandin production by cultured 
human amnion cells  [92,93] and myometrial cells [94]; and while the administration of an IL-1β 
receptor antagonist prevented IL-β-induced labor in mice [95] it was unable to prevent delivery 
in endotoxin-induced pre-term labor [96]. The observed response to direct stimulation with IL-6 
has been less consistent, varying from causing an increase in cPLA2 expression by myometrial 
cells [75], to having no significant effect on PGE2 production by human myoctyes [94]. 
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1.3.5.4 Prostaglandin Metabolism 
The enzyme 15-hydroxy prostaglandin dehydrogenase (PGDH) metabolizes the primary 
prostaglandins to biologically inactive metabolites [97], and due to its localization to trophoblast 
cells of the chorion, has been hypothesized to act as a barrier preventing the access of primary 
prostaglandins to the endometrium and myometrium [48].  PGDH is upregulated by progesterone 
(P4), synthetic progestagens, and interleukin-10 (IL-10), and is down-regulated by 
glucocorticoids (endogenous or exogenous), IL-1β, tumor necrosis factor α (TNF-α), and CRH 
(review, [48]). A relative deficiency of PGDH activity was identified in a subset of human 
patients with idiopathic pre-term delivery [98]. The site of PGDH localization is somewhat 
different in the mare; PGDH was localized to maternal epithelium and interstitial cells in the 
microcotyledons of the equine placenta between 150 and 280 d, and to the maternal epithelium, 
maternal interstitium, and trophoblast cells by day 300 [99]. Altered expression or activity of 
PGDH due to infection in equine tissues, although not documented, would contribute to 
increased concentrations of PGF2α and PGE2 available to the myometrium. 
1.3.6 Electromyographic Studies 
 The pattern of myoelectrical activity preceding parturition varies among species. In sheep 
during the second half of gestation, bursts of EMG activity occurred at 54.7 minute intervals and 
lasted for an average of 6.7 min. The frequency of activity increased in the 24 h preceding 
parturition, but the duration of bursts decreased [100]. Similar to sheep, no diurnal pattern of 
EMG activity was seen with goats [101], pigs [102], and cows [103,104].  In primates, a diurnal 
pattern of EMG activity was observed with a greater percentage of activity occurring during 
night and early morning hours [105-107]. Two patterns of activity have been described in 
primates. Contractures are approximately 5 minutes in duration and occur 2 to 6 times per hour. 
Contractions are 1 minute in duration, but occur up to 30 times per hour and with a greater force 
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of contraction than contractures. The switch from contractures to contractions occurs 
spontaneously at term, usually at the onset of darkness, over a variable number of days preceding 
labor [107]. The pattern of EMG activity in the mare is most similar to that of the primate, in that 
a diurnal pattern of activity exists with spontaneous parturition [108,109].  Interestingly in both 
the mare [108] and the goat [101], a period of quiescence (2 to 4 h and 8 to 12 h, respectively) 
was seen immediately prior to delivery.  Relaxin was suggested as the cause of this phenomenon, 
possibly due to its ability to increase cAMP, leading to a lowering of [Ca
2+
]i and a reduction in 
MLCK in myometrial cells.  An increase in myoelectrical activity at night (spike bursts) was not 
seen in mares with experimentally induced placentitis [109], suggesting that pathways leading to 
spontaneous labor are altered with infection. 
1.4 Gestational and Peripartal Endocrinology of the Mare (Control of Labor) 
1.4.1 Maternal Progestagens 
Progestagens are C-21 steroid hormones that are responsible for maintaining uterine 
myometrial quiescence during pregnancy. The biosynthetic pathway for their production is 
illustrated in Figure 1.3. Species such as the cow, rabbit, pig, dog, rat, and goat are dependent on 
P4 from the corpus luteum for pregnancy maintenance, although placental contribution of 
progesterone during late gestation has been demonstrated in the cow and rat (review, [110-112]). 
In ewes, placental secretion of progesterone is sufficient to maintain pregnancy during the last 
two-thirds of pregnancy since ovariectomy after day 50 does not result in abortion [113]. 
Progesterone concentrations decline in all of these species approaching the end of gestation, with 
a precipitous drop immediately prepartum [111]. Primates are similar to sheep in that the 
placenta is the major source of progesterone during the last half of gestation. Serum P4 in 




Figure 1.3 Biosynthetic pathways of progestagens in the pregnant mare. Adapted from Chavette et al. (1995) [114]. 
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ethamoxytriphetol (MER-25) from day 130 to term (180 d)  caused a 50% reduction of serum P4 
in intact animals, while producing an 80% reduction in luteectomized animals, indicating that the 
placenta is the predominant source of P4 [115].    
 What is interesting is the concept that progesterone withdrawal, at least at the level of the 
maternal circulation, is not a prerequisite in the control of labor in primates [116]. Progesterone 
concentrations were measured in maternal and fetal blood, and in amniotic fluid, in long-term 
catheterized rhesus macaques from animals receiving epostane, an inhibitor of the enzyme 3β-
hydroxysteroid dehydrogenase (3β-HSD) which converts pregnenolone (P5) to P4, alone or P4 
implants prior to the administration of epostane. Epostane alone caused a 75% reduction in 
maternal P4 within 24 h and produced delivery within 48 h. Progesterone supplementation 
prevented alterations in maternal and fetal progesterone concentrations and uterine activity 
during the administration of epostane, but upon removal of the P4 implant, delivery occurred 
within 48 h. A third group of animals received P4 implants on day 146 to 148 of gestation (term 
gestation 167 d). These animals had markedly elevated maternal P4, yet delivered spontaneously 
at term. Post-partum P4 concentrations in this group were 8.13 + 0.84 ng/mL, falling to 0.81 + 
0.13 ng/mL after implant removal [117]. Clearly, there are signaling events leading to labor that 
can override the effect of P4 on myometrial quiescence.    
In the mare, ovarian progesterone is responsible for maintenance of myometrial 
quiescence for roughly the first third of gestation; metabolites of progesterone produced by the 
fetoplacental unit assume this role thereafter. Holtan et al., [118]  ovariectomized pony mares at 
different stages of pregnancy and revealed the following pattern: pregnancies less than 50 d 
resulted in abortion in all mares, 9 of 20 mares between 50 and 70 d aborted, and all mares over 
140 d maintained pregnancy to term.  The fetal gonad was subsequently hypothesized as a source 
of progestagens; however, this is not the case as was demonstrated by the failure of  fetal 
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gonadectomy between 197 to 253 d of gestation to cause a reduction in maternal progestagens 
[119]. Progestagen profiles of the mare during late gestation have been studied extensively, with 
variable results depending on the type of assay used. Using an assay with a detection limit of 4 
ng/mL, Short [120] found no measurable progesterone in jugular vein samples in mares from 120 
to 310 d of gestation, but was able to measure progesterone in cord blood (3.8 to 6.3 ng/mL) of 
fetuses at parturition. Other early studies using competitive protein-binding assay or 
radioimmunoassay (RIA) found rising concentrations of progestagens (immunoreactivity with 
progesterone) during late pregnancy with maximums of 20 [121], 12.8 [122], and 10 ng/mL 
[123] on the day preceding foaling. Although a precipitous decline in progestagens began just 
prior to foaling, the progestagen concentration at the time of parturition was 11.3 [122] and 5 
ng/mL [123], and was 3.3 ng/mL for progesterone [122]. This pattern is distinctly different from 
that observed in the aforementioned domestic animals.  
In order to identify and quantify specific progestagens, Holtan et al., [124] used gas 
chromatography-mass spectrometry (GC/MS) to evaluate samples from maternal blood samples 
in normal (n=10) and abnormal (n=4) pregnancies, and from fetal and maternal blood samples in 
chronically catheterized animals or during general anesthesia (n=11). The systematic names of 
the progestagens are listed in Table 1. Progesterone, 5α-DHP, and 3β-5P had parallel increases 
during early pregnancy; but after day 200 P4 was undetectable in most mares, while 5α-DHP and 
3β-5P remained elevated to term. Other pregnanes were detectable after 60 d of gestation; 20α-
5P and βα-diol were higher than all other pregnanes from day 170 to term. During the last 30 d 
of gestation 20α-5P increased 4- to 6-fold, reaching a maximum concentration (656.4 + 210.7 




Table 1.2 Systematic names and abbreviations of progestagens. 
 












foaling a decrease in 20α-5P and βα-diol occurred, and by 24 h post-partum all pregnanes were 
undetectable. Pregnenolone, P5ββ, 3β-5P, and ββ-diol were significantly higher in the fetal artery 
than all other vessels (fetal or maternal). The predominant steroid in the fetal vein was 5α-DHP, 
and its concentration was higher than that of the fetal artery. Progesterone was higher in the fetal 
vein than fetal artery, and was detectable in only 3 of 19 maternal venous samples and no 
maternal artery samples. The concentration of 20α-5P was higher in the maternal vein than the 
maternal artery and was only detected in 1 of 8 fetal artery samples. Venous plasma samples 
from four mares with abnormal pregnancies were also evaluated by GC/MS and RIA-P4. A 
transient increase in 20α-5P and RIA-P4 was detected following endoscopically-induced 
placental separation in one mare; this mare went on to carry to term with a progestagen pattern 
similar to that of normal pregnancies. A mare with vaginal discharge that delivered with dystocia 
had increases in 20α-5P and RIA-P4 from 30 d until 4 d prior to delivery. An EHV-1 infected 
mare delivered a dead fetus at 320 d having a profile that was a gradual decline in 20α-5P and 
RIA-P4 during the week preceding the abortion.  A mare with premature udder development 
delivered a premature foal at 294 d with a pattern of declining 20α-5P and RIA-P4 in the 20 d 
preceding delivery. It was suggested [124] that abnormal pregnancies are associated with a 
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pattern of decreasing progestagens; however, this conclusion is based on a small sample size 
with a single observation from a specific type of abnormal pregnancy.  
 The possible site of 5α-DHP production in pregnant horse and pony mares during the last 
six weeks of gestation was investigated using a specific ELISA for this progestagen metabolite 
[125] . Samples were also obtained from four pooled samples collected at 20 to 30 minute 
intervals from a maternal artery and uterine vein, and umbilical artery and vein from a pregnant 
mare under general anesthesia at 254, 280, 284, or 300 d of gestation. At the end of the 
anesthetic period, the fetus, placenta, and endometrium were collected to evaluate the ability of 
each tissue to convert [
3
H P5] and [
14
C P4] to various progestagens as measured by thin-layer 
chromatography (values were expressed as the mean + SEM percentages of added radioactivity 
found in TLC). There was no significant difference in the 5α-DHP concentration between pony 
and horse mares prior to 30 d prepartum, and both groups had increases during the last month 
which peaked at 3 d prepartum; however, during the last 30 d, the concentration of 5α-DHP in 
thoroughbred mares was higher than in pony mares at the majority of sampling points. Umbilical 
and venous plasma concentrations of 5α-DHP were higher than those of the umbilical and 
uterine artery. Chorioallantoic membranes surgically collected from day 254 to 300 were able to 
convert P5 to P4 (47.5 + 9.0%), 5α-DHP (2.6 + 1.2%), and 20α-DHP + 20β-DHP (4.1 + 1.7%), 
and to convert P4 to 20α- and 20β-DHP (7.7 + 2.0%), and to 5α-DHP (2.9 + 1.2%). The 
endometrium was able to convert P5 to P4 (11.0 + 3.0%) and 5α-DHP (7.8 + 2.4%); but the P4 
production was lower than that of chorioallantois, while the 5α-DHP production was higher than 
that of chorioallantois. There was negligible production of 5α-DHP from P5 or P4 by fetal tissues.  
Based on the venous-arterial (V-A) differences and the conversion of P5 and P4 to 5α-DHP by 
fetal membranes, it was concluded that maternal 5α-DHP is derived from endometrial 
metabolism of P5 and/or P4. Unfortunately, these conclusions are based on samples from a single 
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mare at each gestational age evaluated, and were obtained at the end of an anesthetic period of at 
least two hours duration. 
 Ousey et al., [126] catheterized the fetal aorta and vena cava, umbilical vein, uterine vein, 
and maternal aorta at three stages of gestation [180 to 220 d (n=5), 260 to 280 d (n=3),  and > 
300 d (n=4)] to measure umbilical and uterine plasma flows and progestagen concentrations 
(GC/MS). Antipyrine steady-state diffusion techniques were used to determine the uterine and 
umbilical flow rates, and were converted to plasma flow rates based on maternal and fetal 
hematocrits. Using Fick’s principle (the rate of diffusion is proportional to the difference in 
concentration), uteroplacental uptake (UPU) and output (UPO) of the progestagens P5, P5ββ, P4, 
3β-5P, 5α-DHP, ββ-diol, βα-diol, and 20α-5P were calculated. The following equations were 
used to calculate the uptake or output by the uterus or placenta: 
UPUumbilical circulation =  Flowumbilical x [Afetal – Vumbilical] plasma 
 
UPO umbilical circulation = Flowumbilical x [Vumbilical – Afetal] plasma 
 
UPUuterine circulation = Flowuterine x [Amaternal – Vuterine] plasma 
 
UPO uterine circulation = Flowuterine x [Vuterine – Amaternal] plasma 
 
where [A – V ] = arterial – venous,  or [V – A] =  venous – arterial plasma concentration 
difference across the respective circulations. Significant uteroplacental uptakes from the 
umbilical circulation of P5, P5ββ, 3β-5P, ββ-diol, and βα-diol; and significant uteroplacental 
outputs of 5α-DHP to the umbilical circulation during the second half of gestation were detected. 
Uteroplacental output of P4 and 20α-5P to the umbilical circulation was also detected after 260 d 
gestation. There was no significant uteroplacental uptake from the maternal circulation of any of 
the progestagens. Significant uteroplacental outputs of 5α-DHP, βα-diol, and 20α-5P to the 
maternal circulation were found in all groups, with significantly higher concentrations of 20α-5P 
and βα-diol in pregnancies >300 d compared to pregnancies 180 to 220 d. There was a 5- to 10-
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fold increase in the net output of 20α-5P (predominately to the mother) after 300 d, which most 
likely accounts for the increase in total progestagens seen near term in previous studies [121-
124,127]. Based on the net uteroplacental uptakes and outputs, the main precursors for 5α-DHP 
and 20α-5P appeared to be P5 and 3β-5P. The rate of uptake of these two progestagens increased 
5-fold between mid and late gestation. It was concluded that the source of fetal P5 and 3β-5P 
during the last half of gestation is difficult to explain, since fetal gonadectomy fails to reduce 
maternal progestagens [118] and fetal adrenal activity of P450scc was not detected until near term 
[114], although P450scc has been localized to the fetal adrenal during late gestation [128]. 
Although the full complement of enzymes involved in progestagen biosynthesis have not been 
identified in uteroplacental tissues, the equine term placenta has been shown to possess 3β-
hydroxysteroid dehydrogenase (3β-HSD, Figure 1.3) activity [129]. 
 If the assumption that the fetoplacental unit is the source of progestagens during the last 
half of pregnancy in the mare is correct, then processes that adversely affect the health of the 
fetus or placenta would be expected to affect progestagen production and peripheral maternal 
concentrations. Following induced placental separation between 228 and 262 d of gestation, 
jugular venous progestagen concentrations (RIA-P4) were increased (defined as a value 2 s.d. 
outside of the mean established for that individual prior to induced separation) in 4 of 7 pony 
mares within 4-11 d of the procedure [127]. Increases were not seen until 42 d after the 
procedure in a fifth mare. Five of the placentas were available for examination; 4 of which had 
gross placental pathology. Three of the four placentas with pathology were from mares with 
increased progestagen concentrations. Four mares delivered live foals (3 induced deliveries) with 
a mean gestational age of 323 d. The three aborting mares delivered between 9 and 28 d (1 
induced delivery) after the procedure. Placental histopathology was not performed. Repetitive 
embolization (112 to 128 d of gestation, term 144 to 151 d) of the uterine arterial circulation in 
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chronically catheterized pregnant ewes produced a significant increase in fetal arterial cortisol, 
with labor occurring during or immediately after embolization in 66% of ewes. Maternal 
progesterone exhibited an extremely variable pattern; however, when the output of progesterone 
was compared, there was a statistically significant increase in progesterone concentrations in 
embolized ewes compared to control ewes [130].  Similarly, comparison of plasma progestagen 
concentrations (RIA-P4) from 25 abnormal equine pregnancies (n=25; criteria: RIA-P4 > 10 
ng/mL and < 308 d of gestation) to a group of control pregnancies  revealed that 16 had 
increased progestagens, 24 had abnormal placentas, and 18 live foals were produced, of which 
11 were abnormal based on postnatal behavior [127]. Unfortunately, only gross examination was 
used to determine placental abnormalities, and the types of placental pathology varied from 
avillous, edema at pole (although not defined by the authors, this is presumably cervical), twins, 
or necrotic; and more than one classification was present in many instances.  
Subsequently Ousey et al., [131] used GC/MS and RIA-P4 to evaluate plasma 
progestagens from normal and abnormal pregnancies with the aim of identifying specific 
progestagens present and their ontogenic profile in 14 mares with concurrent premature 
pregnancy termination. Mares with placentitis (n=7) had elevated (> 99.8% CI) concentrations of 
P5ββ, ββ-diol, βα-diol, and 20α-5P compared to control mares. Compromised pregnancies due to 
non-inflammatory placental lesions (avillous placenta, placental edema) or maternal causes 
(colic, uterine rupture, laminitis, uterine torsion, and premature udder development) displayed a 
mixed profile of progestagen concentrations (elevated, normal, or decreased); however, each 
type of pathology was represented by only a single mare. A similar finding of reduced 
progestagens following medical or surgical disease has previously been reported [132,133]. It 
was speculated [131] that placentitis causes fetal stress and precocious fetal adrenal maturation, 
which results in an overproduction of P5, and that diseased uteroplacental tissues retain their 
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capacity to metabolize P5 to 5α-DHP, βα-diol, and 2α-5P leading  to increased circulating 
concentrations of these metabolites  An alternative explanation suggested was that fetal 
production and metabolism are altered as well, not only leading to increased P5 output, but 
increased fetal hepatic conversion of P5 to reduced 5α-pregnanes. Placentally derived CRH has 
been shown to be increased in women with pre-term delivery [134,135], and is believed to be 
involved with fetal hypothalamic-pituitary-adrenal axis (HPAA) activation during pre-term 
delivery. Localization of CRH in the equine placenta has not yet been described, but if present 
would provide greater insight to the endocrinologic pathways leading to HPA activation and pre-
term delivery due to placentitis. 
 An experimental model of induced placentitis in the mare measured maternal plasma 
progestin profiles (RIA-P4; cross reactivities were 5α-DHP: 10%, 3α-5P: 0.25%, 20α-5P: 0.25%) 
before and after transcervical inoculation of S. zooepidemicus [136]. The endpoint used for 
statistical analysis was defined as a >50% change in progestin from a baseline sample within a 
mare. Placentitis was confirmed by gross and histopathologic evaluation of the placenta. The 
following patterns were observed: a decrease in 7 of 15, an increase in 6 of 15, and no change in 
2 of 15 inoculated mares. Mares that aborted < 7 d from inoculation exhibited a decrease in 
progestins, while those aborting > 7 d following inoculation exhibited an increase in progestins. 
As a diagnostic tool, a change in progestin concentration had a sensitivity and specificity of 87% 
and 100% respectively, and the positive and negative predictive value (defined as the proportion 
of mares testing positive that were truly affected or testing negative that were truly unaffected) 
were 100% and 78% respectively. The inconsistent pattern of change in inoculated mares was 
thought to result from instrumentation with myometrial electrodes and allantoic catheters in 11 
of the 15 inoculated mares. Data that were not described were the days from inoculation to 
abortion for each mare and the days from inoculation to detected change in progestin profile.  
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1.4.2 Fetal Maturation 
In most species, activation of the hypothalamic-pituitary-adrenal axis (HPAA) is a key 
event in the control of labor at term. In sheep the increase in fetal cortisol during the last 2 weeks 
of gestation causes a decline in the placental production of progesterone and an increase in 
estrogen production (Figure 1.4) [137,138]. Labor can either be delayed by hypophysectomy 
[139] or adrenalectomy [140], or accelerated by fetal ACTH administration [141]. The fetal pig 
also has a gradual increase in cortisol during the last 2 weeks, but the final surge is of a shorter 
duration than that of the fetal lamb [142,143]. In contrast, the cortisol in the fetal horse only rises 
just before birth (Figure 1.5) [142,144]. HPAA activation in primates is characterized by 
increased fetal cortisol, dehydroepiandrosterone sulfate, estrone, and progesterone only a few 
days prior to term vaginal delivery [116]. Similar to sheep, administration of glucocorticoids 
does promote fetal maturation, and is commonly given to affect pulmonary surfactant secretion 
[145,146] .  Activation of the HPAA has also been shown to be a key event in pre-term delivery 
due to intrauterine infection in women. Patients with intrauterine infection and pre-term delivery, 
as defined by recovery of a microbial pathogen from amniotic fluid or an amniotic interleukin-6 
(IL-6) concentration > 2 ng/mL, had significantly higher amniotic fluid concentrations of 





Figure 1.4 Relationship between fetal cortisol and maternal progesterone, estrogen, and 






Figure 1.5 Prenatal changes in plasma cortisol in fetal sheep, pig, and horse in late gestation, 




infection [147]. It was suggested that placental CRH is responsible for HPAA activation; 
however, elevated CRH has only been demonstrated in women in whom pre-term birth is not due 
to intrauterine infection [135].  
 
Elevation of equine fetal cortisol was seen during the final 4 to 5 [148] or the final 9 d 
[144] of gestation. Levels for cortisol rose from 3.1 + 1.0 to 13.4 + 3.7 ng/mL, while significant 
increases in ACTH were not seen until the last 2 d of gestation (159 + 21 to 246 + 42 pg/mL) 
[144]. Fetuses less than 295 d of gestation failed to release cortisol in response to administration 
of  intravenous ACTH1-24 (the partially degraded product of ACTH having only amino acids 1-24 
but maintaining all effects of the total molecule), those > 304 d showed small but significant 
releases in cortisol, while those > 313 d of gestation showed the greatest release of cortisol, 
demonstrating that the equine fetal adrenal responsiveness to exogenous ACTH does not develop 
until extremely late in gestation [148]. Based on the observed adrenal response in fetuses > 304 
d, the investigators then compared the effects of intramuscular intrafetal ACTH1-24 (n=16) 
administration daily for 3 d with saline administration (n=7), and whether induction of 
parturition 2 to 4 d after ACTH1-24 administration was associated with a positive neonatal 
outcome (n=4) compared to spontaneous delivery. Five mares aborted immediately following the 
last ACTH1-24 injection. Administration of ACTH1-24 shortened gestation significantly in 
spontaneous delivery mares (312 to 314 vs. 327 to 333) and postnatal adaptive and endocrine 
patterns were normal; however, in pregnancies induced to deliver (306 to 308 d) 1 fetus died, and 
5 of the remaining 6 foals required supportive care, and had lower plasma cortisol and elevated 
progestagens which failed to decline with the first 24 h of life [149] . Given the number of 
abortions and postnatal complications associated with intrafetal injections, the effect of 
maternally administered depot ACTH1-24 (1 mg vs. 4 to 5 mg) at 300, 301, and 302 d on fetal 
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maturation was examined. Earlier parturition was significantly correlated with high dose ACTH 
given to mares mated late in the season (after July 1), compared to those mated early, although 
the strength of the correlation was not strong (r
2 
= 0.5). Maternal plasma cortisol and progestagen 
concentrations were elevated following ACTH1-24 administration, and this effect was greater and 
of a longer duration with high dose ACTH1-24 [150]. It is apparent from these studies that not 
only does HPAA maturation occur only at the end of gestation, but that manipulations in an 
attempt to accelerate fetal maturation precociously are frequently complicated with a negative 
neonatal outcome. Effective interventional strategies to advance fetal maturation would be of 
great benefit in many instances of both reproductive and nonreproductive compromised 
pregnancies. 
1.5 Immunologic Aspects of Infective Pre-term Delivery 
1.5.1 Immunologic Aspects of the Non-pregnant Equine Uterus 
 The equine uterus is a mucous membrane; therefore, the predominant immunologic 
response to disease is characteristic of innate immunity. This is an obvious advantage when 
breeding on successive cycles to the same stallion, where a strong adaptive response would 
likely preclude establishment of pregnancy. Likewise, vigorous adaptive immunity would be 
disadvantageous during pregnancy, i.e., the fetus as an allograft [151]. From a historical 
perspective, much of the early work on defining immune parameters of the uterus and the cause 
of susceptibility to endometritis in mares focused primarily on the innate response to infection, 
namely opsonins in uterine secretions and the function of uterine-derived neutrophils. Once 
physical or mechanical clearance was determined to be an extremely important factor in the 
resolution of uterine infection [152-155], research emphasis shifted away from further 
investigation of the uterus as a mucosal immune system. In the meantime, the field of 
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immunology has expanded exponentially, and compared to other species, there are many basic 
aspects of equine uterine mucosal immunity that remain to be elucidated. Cells involved with 
adaptive immunity have been identified in endometria and the presence of mucociliary currents 
has been proposed; however, their role in diseases of the uterus is not yet clear. 
1.5.1.1 Role of Immunoglobulins in Uterine defense Mechanisms 
 Immunoglobulin A [156-161], secretory IgA [159,160], IgG [157-159,161,162], IgG(T) 
[157-159], IgGa [156], IgGb [156], IgGc [156], and IgM [157,158] have been demonstrated in 
luminal secretions from mares resistant and susceptible to endometritis. Secretory IgA (11s peak) 
comprises a mean of 60% of the total IgA present in uterine secretions [161]. The former (and 
current) designations for the sub-isotypes of IgG are as follows: IgGa (IgG1, IgG2), IgG(T) (IgG3, 
IgG5), IgGb (IgG4), and IgGc (IgG6, IgG7) [163]. Demonstration of secretory IgA and higher Ig to 
albumin ratios in uterine secretions compared to those in serum supports the classification of the 
equine uterus as a local secretory immune system [161]. Transudation of Ig and active transport 
may also be a significant source of intraluminal Ig [160].  The relative contributions of active 
transport from serum versus local Ig production is largely unknown, but in vitro endometrial 
production of specific IgG, IgM, and IgA has been reported [164].  
 Results of studies on immunoglobulins in luminal secretions and immunohistology of the 
equine endometrium pose some interesting questions.  First, that antigen processing in the equine 
uterus is variable.  Intrauterine inoculation with S. zooepidemicus results in a local titer increase 
with no concurrent increase in systemic titer.  Inoculation with Taylorella equigenitalis or dinitro-
phenylated human serum albumin results in both local and systemic titer increases in antibody 
[165,166]. Despite no overall change in the peripheral titer, differences in the bactericidal activity of 
blood is seen following intrauterine inoculation with S. zooepidemicus; this activity is not only 
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strain specific, but also is comprised of heat-stabile and heat-labile components [167-169].  
Antigen-processing and dendritic cell function in the equine uterus has not been studied. Second, 
since in general mares susceptible to endometritis have similar or higher levels of free Ig in the 
uterus, the common inference is that a dysfunction in the humoral response to intrauterine infection 
does not contribute significantly to increased susceptibility to endometritis. The suggestions that 
IgGT [164] or IgA [170]  may interfere with effective opsonization by specific antibody warrants 
further study.  Investigation of bacterial proteins, such as immunoglobulin-binding proteins [171], 
which can reduce both antibody-mediated complement fixation and opsonization,  would lead to a 
better understanding of the humoral response to intrauterine infection and its role in susceptibility to 
infection. Indeed, immunoglobulin-binding proteins have been identified in uterine secretions, and 
deplete hemolytic complement activity in vitro [172]. 
1.5.1.2 Chemotactic Properties of Uterine Secretions 
 The chemotactic activity of uterine fluid is influenced by ovarian hormones.  Fluid collected 
during estrus possessed similar chemotactic activity to the activated serum control, but was 
significantly greater than that of diestrous uterine fluid [173].  Uterine washes from estrogen-
supplemented ovariectomized mares prior to inoculation with S. zooepidemicus stimulated random 
migration of neutrophils under agarose, while those from control or progesterone-supplemented 
mares inhibited chemokinetic activity [174]. Infection [175], spermatozoa-induced complement 
activation [176], and susceptibility [177,178] appears to increase chemoattractants in uterine 
secretions, and susceptibility increases the chemotactic activity  irrespective of stage of cycle or 
presence of uterine infection [177]. This pattern was thought to reflect the increased chemotactic 
activity present in uterine secretions from mares with active endometritis observed by Blue et al. 
[175]. Chemoattractants are composed of both heat-labile [176,179] and heat stabile [179] 
components, and are dose dependent [179]. This finding is specific to chemoattractants released by 
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the endometrium since S. zooepidemicus  itself does not to possess chemotactic activity [180].   
1.5.1.3 Opsonins in Uterine Secretions 
 Interest in characterization of opsonins in uterine luminal secretions began with the clinical 
response seen with the use of intrauterine plasma infusion in mares susceptible to endometritis 
[181].  The conclusion was that susceptibility to uterine infection may be due in part to deficiency 
either in quality or quantity of opsonins in uterine secretions [181]. In vitro, the addition of serum to 
uterine washings resulted in a significant increase in opsonization and phagocytosis by peripheral 
neutrophils, and this activity was reduced by complement depletion  [182]. 
 Non-infected estrous fluid promoted greater phagocytosis than diestrous fluid [183], and the 
opsonic activity of susceptible mares was either increased [177,184] or decreased [178] compared to 
that of resistant mares.  The interaction between ovarian hormone status and susceptibility on 
opsonins is complex with opsonic activity being reported as greater in resistant mares during 
diestrus and greater in susceptible mares during estrus  [184], while culture supernatant of 
endometria from mares treated with progesterone was less effective at bacterial opsonization than 
supernatant from control mares or those treated with estrogen [185].  The contribution of 
complement as an opsonin has also been controversial. In one study, opsonic activity was not 
reduced by heat inactivation, and the major opsonin was associated with IgG [184]. However, when 
standardized for protein content, both complement and specific IgG were found to be important 
opsonins in uterine washes from reproductively normal non-cycling mares [186]. An interesting 
observation of declining IgG concentration in susceptible mares by 36 h of infection [162] raises the 
question of whether decreased production or secretion, or increased consumption of IgG is involved 
with persistence of endometritis. 
1.5.1.4 Complement in Uterine Secretions 
 Examination of complement components and hemolytic activity has yielded conflicting 
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results. Antigenic C3 and breakdown products of C3 were identified,  yet no hemolytic complement 
(functional) activity was measured in uterine secretions [182], possibly due to the species of target 
red blood cells. Hemolytic complement activity using porcine red blood cells was significantly 
greater in uterine flushings from susceptible mares compared to resistant mares, although individual 
variability was high and stage of cycle was variable [177]. Lastly, immunoactive C3 was not 
significantly different between resistant and susceptible mares, although at 36 h after bacterial 
challenge immunoactive C3 was greater in resistant mares [162]. 
1.5.1.5 Antibacterial Activity of Uterine Secretions 
 Although it has been reported that cell-free uterine flushes from mares in mid-diestrus 
possesses antibacterial activity [173], other investigators failed to demonstrate inherent antibacterial 
activity of uterine fluid from noncycling mares [186] or from E2- or P4-supplemented 
ovariectomized mares [187]. The discrepancy in the results from these studies may lie in potential 
qualitative and quantitative differences between the uterine secretions from cycling and noncycling 
mares. Recently lactoferrin, an antimicrobial and immunomodulator member of the transferrin gene 
family which is expressed by epithelial cells and neutrophil granules, has been identified in the 
equine endometrium [188]. Lactoferrin’s antibacterial property lies within its ability to sequester 
free iron, thereby inhibiting bacterial growth. Lactoferrin expression was upregulated during early 
estrus, protein staining was uninfluenced by cycle and was most intense in the glandular epithelium, 
and expression of lactoferrin was only increased in mares with delayed physical clearance during 
early estrus [188], which might represent a response to inflammation. While intriguing from a 
perspective of host-pathogen interactions, unless diminished response in lactoferrin expression and 
production were observed in susceptible mares, reduced lactoferrin activity is unlikely to be 
responsible for increased susceptibility to infection. 
1.5.1.6 Modulators of Uterine Contractility 
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 In cycling [189], and E2- or P4-supplemented ovariectomized mares [190,191], uterine 
luminal immunoreactive PGF, PGE2 and leukotriene B4 (LTB4) dramatically increase following an 
inflammatory insult. Progesterone-supplemented, or P4-supplemented followed by E2-supplemented 
ovariectomized mares had higher concentrations of immunoreactive PGF and PGE2, than those 
receiving E2 alone [191]. Resistant mares have greater release of PGF2α in response to antigenic 
stimulation (insemination) or oxytocin administration than do mares susceptible to persistent 
endometritis [192]. Since LTB4 and PGE2 cause dose-related chemokinesis of peripheral 
neutrophils, PGF2 and LTB4 increase bactericidal activity, and LTB4 increases phagocytosis [193], 
their presence is unlikely to play a role in persistence of endometritis by adversely affecting 
neutrophil function. To the contrary, it has been suggested that increased eicosanoids in susceptible 
mares may contribute to enhanced phagocytic function [178]. 
 Nitric oxide (NO), a bactericidal agent produced by macrophages and neutrophils following 
ingestion of microorganisms [194], can cause myometrial relaxation [195]. Nitric oxide 
concentration was higher in uterine secretions from mares susceptible to delayed clearance than in 
resistant mares [196]. Whether this is due to upregulation of NO-synthase or due to accumulation of 
inflammatory byproducts in susceptible mares was not determined, but it was speculated that NO 
accumulation may contribute to undesirable uterine relaxation following an antigenic challenge 
[196]. 
1.5.1.7 Functional Properties of Neutrophils 
 Uterine neutrophils from susceptible mares have been reported to have either reduced 
[197,198] or equal [178] chemokinetic function compared to resistant mares. Similarly, decreased 
[177,199] or increased [178,200] phagocytic function of uterine-derived neutrophils from 
susceptible mares has been reported. Clearly there is an interaction between stage of estrous cycle 
and category of mare and both may have a profound effect on the functional capacity of uterine 
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neutrophils. It is doubtful that some level of compromised uterine neutrophil function exists in the 
susceptible mare; the more likely explanation for findings to date is the effect of experimental 
design, specifically method of uterine neutrophil recruitment, stage of cycle, and differences in 
bacterial strain on in-vitro neutrophil function. Indeed, when a chemokine (recombinant human 
interleukin-8) was used to recruit neutrophils into the uterus not only was there no difference in 
phagocytic capacity of uterine neutrophils between normal mares and those with degenerative 
changes, but the capacity of uterine neutrophils from mares with degenerative uterine changes to 
generate reactive oxygen species was enhanced relative to peripheral neutrophils or uterine 
neutrophils from normal mares [201]. Diminished cellular clearance occurs most likely secondary to 
persistence of infection and continued bacterial growth, which exceeds the capability of normal 
phagocytic function. 
1.5.1.8 Evidence of an Adaptive Immune Response in the Uterus 
 The endometrium of the mare is inhabited by T lymphocytes [202-206]. Genitally normal 
mares had greater numbers of CD4+ lymphocytes (TH cell; ―helper T cell‖) and CD8+ cells (TC cell; 
―cytotoxic/suppressor cell‖) in the stratum compactum than in the stratum spongiosum [204]; the 
density of cells was either increased during the estrus [203] or found to be independent of cycle 
stage [204], was not influenced by age [206], and greater numbers of CD4+ and CD8+ cells were 
present in the uterine body than in the uterine horns [206].  Following insemination [205] or in the 
presence of endometritis [204] the number of CD4+ [204,205] and CD8+ cells [204] increased; the 
number of CD4+ cells doubled in lymphoid aggregates, and the number of CD8+ cells in the 
luminal and glandular epithelium increased [204] suggesting that an adaptive response is initiated 
following antigenic stimulation of the endometrium. 
 Exogenous antigens, such as those of S. zooepidemicus, are processed through an endocytic 
pathway and are presented on the surface of the membrane of cells which express class II Major 
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Histocompatability Molecules (MHC) [207]. Presentation of class II MHC to CD4+ TH cells is 
restricted to ―professional‖ antigen presenting cells (APCs), namely dendritic cells, macropages, 
and B cells. ―Nonprofessional‖ APCs, such as certain epithelial cells, fibroblasts, and vascular 
endothelial cells, can present antigen in the context of class II MHC, but fail to deliver a 
costimulatory signal and present antigen for brief periods during a sustained inflammatory response. 
Cells in the equine endometrium expressing MHC class II staining include macrophages, 
monocytes, dendritic cells, lymphocytes, vascular endothelium, and uterine luminal epithelium 
[202]. Expression of MHC II was greater in genitally normal mares in estrus than in diestrus; the 
distribution was predominantly beneath the luminal epithelium, with occasional foci in the stratum 
compactum and rarely in the stratum spongiosum [204]. This pattern is consistent with antigen 
presentation. There was no difference in expression between infected and noninfected mares [204], 
which is similar to findings from murine models of intestinal Salmonellosis where little change 
from the steady state numbers of dendritic cells is seen with infection [208]. 
1.5.1.9 Cytokine Expression in Response to Infection and Insemination 
 It has been suggested that increased endometrial expression of the pro-inflammatory 
cytokines IL-1β, IL-6, TNF-α, and IL-8 during estrus, increased IL-1β, TNF-α, and IL-8 during 
diestrus,  and decreased expression of the anti-inflammatory cytokine IL-10 during estrus 
contributes to susceptibility to endometritis [209,210], although non-infected susceptible mares 
were not examined in these studies. This pattern would be predicted to occur with chronic-active 
inflammation; however, re-examination of mares susceptible to endometritis prior to initiation of an 
inflammatory insult would be useful to understand the potential roles of these cytokines during 
persistent endometritis. If elevated IL-8 expression and diminished IL-10 expression in susceptible 
mares in the absence of infection or inflammation exists, a potential factor in susceptibility to 
endometritis may be explained. These studies are a first step towards investigating the cytokine 
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signaling involved with endometritis, and clearly further study is needed in this area. 
1.5.1.10 Mucociliary Clearance in the Mare  
 It has been recently suggested that mucociliary clearance may play an important role in the 
clearance of infections and that disruption of mucociliary currents in the susceptible mare leads to 
persistence of infection [211]. While mucus-producing cells and ciliated cells beneath a mucus 
blanket suggests a functional mucociliary apparatus in the equine uterus [212], in vitro 
documentation of ciliary movement is lacking [211]. Mucus production and secretion is increased 
during estrus [212] and inflammation [212,213], and the optical density of the mucus is increased in 
mares with delayed clearance [212]. The biological significance of alterations in the mucous blanket 
is unknown. The effects of fluid accumulations [214], intrauterine therapy [215], and uterine 
pathogens [214,216,217] on mucociliary clearance are deserving of future research, as is whether or 
not there is a primary defect in the mucociliary apparatus in mares susceptible to endometritis. 
1.5.2 Animal Models for Infective Pre-term Delivery 
 The pre-term delivery (PTD) rate for human infants in 2005 was 12.7% [218], a rate that 
is on the rise, despite considerable efforts and progress towards defining the pathogenesis of pre-
term births and advancing treatment strategies. Infection has been reported to be responsible for 
up to 10 to 50% of pre-term deliveries, with higher rates being seen in underdeveloped countries 
[219,220].  Intrauterine infection resulting from ascension of bacteria through the cervix with 
invasion of the chorioamnion and 41eciduas (maternal endometrium at the site of placental 
attachment) is a significant cause of pre-term delivery in women as it is in the mare [221,222]. A 
wide variety of animal models have been described to investigate the mechanisms of PTDs; but 
direct comparisons between models are hampered by differences in species used, the agents used 
to initiate PTD, and the route of inoculation or administration.  
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 In most species studied, an increase in pro-inflammatory cytokines has been observed in 
fetal fluids in response to inflammation or infection [223-229]. Non-infectious models for pre-
term delivery typically use lipopolysaccharide (LPS) administered into the maternal circulation 
[230], the maternal peritoneal space [231,232], or the uterus [233] to cause pregnancy loss. 
Intraamniotic, but not maternal, administration of LPS to sheep at approximately 80% gestation 
resulted in increases in amniotic and fetal IL-6 (immunoreactive) concentrations but no 
premature labor despite increased uterine activity, though there was a considerable degree of 
variability and the samples size were small [228]. Intraamniotic inoculation of group B 
streptococci in instrumented (fetal artery and vein, amniotic pressure catheter, myometrial EMG 
electrodes, maternal artery and vein) rhesus macaques at 77% gestation produced increased the  
bioactivity of  TNF-α in amniotic fluid, and increased immunoreactive concentrations of  IL-1β, 
and IL-6 as early as 9 h following inoculation. PGE2 and PGF2α concentrations paralleled the 
increases in cytokines, and uterine contractility occurred within 28 h. The peak concentrations of  
PGE2, compared to control, were 16,046 pg/mL vs. 2,765 pg/mL (p < 0.05), and was 5,547 vs. 
708 pg/mL for PGF2α (p < 0.05) [224].  
 While intraamniotic inoculation may provide a greater uniformity of response due to 
precise deposition of the inflammatory agent, it does not reproduce what happens during the 
course of natural infection, namely ascension through the cervical canal. Other models have 
attempted to mimic natural infection by intracervical inoculation.  Intracervical inoculation of 
rabbit does at 70% gestation with E. coli also produced increased bioactivity of TNF-α, and 
increased immunoreactive concentrations of IL-1β, and IL-6, and PGE2 and PGF2α in amniotic 
fluid as early as 4 h after inoculation [223]. Similarly, intracervical deposition of either LPS or E. 
coli in wild-type or IL-1β -/- mice produced increases in amniotic immunoreactive TNF-α, IL-β, 
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and IL-6 and premature delivery in 92% (E. coli) to 100% (LPS) of mice. Although decreased 
cytokine was observed in IL-1β -/- mice, pregnancy loss was the same [226]. 
 One of the proposed mechanisms of infection-induced pre-term delivery is that pro-
inflammatory cytokines (IL-1, IL-6, TNF-α) from the deciduas and cortisol from the mother 
cause activation of the fetal hypothalamic-pituitary-adrenal axis, causing elevation of fetal 
cortisol [48]. Increased fetal cortisol, either at term or in response to pro-inflammatory cytokines, 
decreases levels of PGDH, an enzyme responsible for inactivation of PGE2 and PGF2 , leading to 
increased PGE2 and PGF2  and subsequent myometrial contractions. Pro-inflammatory cytokines 
also increase the activity of another key enzyme, prostaglandin H2 synthase (PGHS-2), which 
increases prostaglandin synthesis. The decrease in PGDH and increase in PGHS-2 lead to 
increased PGE2 and PGF2  synthesis, myometrial contractions and premature labor (See Figure 
1.6)  [227,234-236]. 
1.5.3 A Model of Ascending Placentitis in the Mare 
 One model examining the relationship between inflammatory cytokines and ascending 





 CFU of S. zooepidemicus in mares between 283 and 291 d of gestation. 
Groups consisted of mares instrumented with allantoic catheters 10 to 16 d prior to inoculation  
(n=4), non-instrumented inoculated mares (n=4), and non-inoculated control mares (n=4). 
Allantoic fluid samples were obtained from the catheter (if patent) or by allantocentesis from 
inoculated mares at  pre-inoculation, 3 to 4 d post-inoculation, 6 to 10 d post-inoculation, and a 
sample within 48 h of delivery. Mares in the control group were sampled at 280, 288 to 290, 296 
to 303 d, and within 48 h of delivery.  Allanotic fluid was analyzed for TNF-α (cytolytic assay), 





Figure 1.6 Role of progesterone and cytokines in regulating prostaglandin synthesis during 
pregnancy. From Challis et al., (2000) [48]. 
 
Placental tissue was collected for histopathology and mRNA expression of IL-1, IL-6, and IL-8. 
No differences were detected in the concentrations of soluble TNF-α, IL-1 and IL-6 between 
groups over time (means and standard deviations were not reported). Placental IL-6 and IL-8 
mRNA was higher at the cervical star and IL-6 mRNA was higher in the placental body of 
inoculated mares compared to control mares (tissues not matched for gestational age).  Based on 
the mRNA data it was hypothesized that bacterial infection causes increased expression of 
proinflammatory cytokines leading to the release of PGE2 and PGF2α into the allantoic fluid 
resulting in premature labor.  
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 The failure to demonstrate an increase in the concentrations of pro-inflammatory 
cytokines in equine fetal fluids following bacterial infection differs from results from rabbits, 
monkeys, women, sheep, and mice [223-226,228,238]. There may be several explanations for 
this difference. In the study using mares [237], the number of days from inoculation to abortion 
ranged from 4 to 27, and the clinical and histologic characterization of the placentitis varied from 
acute to chronic, thus the experimental group was heterogeneous. This variation may have 
resulted from individual differences in response to the strain of S. zooepidemicus used [168], the 
variable dose of the inoculum, and difficulty in standardizing the site of inoculation within the 
cervical canal. Failure to detect soluble cytokines in the allantoic fluid may have been due to 
sampling intervals which were too infrequent to detect changes in cytokine concentrations. 
Amniotic levels of TNF-α, IL-1α, and IL-1β were elevated within 4 h of transcervical inoculation 
of pregnant rabbits with E. coli [223]. In pregnant ewes, the concentration of IL-6 in amniotic 
fluid peaked between 4 to 6 h following administration of LPS and had begun to decrease by 24 
h [228], making it conceivable that changes in cytokine levels were missed in the equine study. 
Other potential sources of variability were the presence of allantoic catheters in some, but not all, 
of the mares; and repeated ultrasound-guided allantocentesis to obtain fluid from mares without 
catheters or those with non-patent catheters. Biochemical characterization [239,240] of fetal fluid 
was not performed, therefore the potential confounding effect of amniotic fluid contamination on 
analytes cannot be assessed. 
1.6 Conclusions and Proposed Studies 
The need still remains for a dependable method for collection of allantoic fluid that would permit 
reliable and frequent sampling within the first 24 h after transcervical inoculation. The temporal 
relationship between elevations in allantoic cytokines and prostaglandins is quite important. If the 
synthesis of PGF2α and PGE2
 
is driven by cytokines in concert with fetal cortisol, as has been suggested 
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in a model of ascending placentitis [48], then treatment strategies that fail to interrupt the inflammatory 
cascade and reduce fetal stress may be ineffective in delaying the onset of labor. In other species, 
activation of the fetal HPAA axis is likely a key event in placentitis-induced pre-term pregnancy loss 
[147]. However, this may not be the case for the horse, since the fetal HPA only matures near the end of 
gestation [126,241]. Therefore, it would be useful to delineate a noninfectious-inflammatory model from 
an infectious-inflammatory model. Inflammation of the chorioallantois will be induced by inoculation 
with live bacteria or heat-killed bacteria. Heat-killed S. zooepidemicus has been used both in vivo in an 
endometritis model in the mare [172] and in vitro in phagocytosis assays for equine neutrophils 
[184,200]. By comparing the inoculation with heat-killed S. zooepidemicus to the inoculation with live 
S. zooepidemicus, we may be able to separate the effects of a transient inflammatory response and 
resultant prostaglandin synthesis from the effects of placental, and possibly fetal, infection. We 
hypothesize that both types of inocula will induce an acute placentitis, that heat-killed S. zooepidemicus 
will produce a less variable pattern of inflammatory mediators than that produced by live S. 
zooepidemicus, and that live S. zooepidemicus will lead to pre-term delivery in all mares. Because the 
inflammatory insult initiated by heat-killed S. zooepidemicus would occur as a single event without 
continual replication and propagation of the inflammatory cascade as would occur with live S. 
zooepidemicus, it is unlikely to lead to pre-term delivery in all mares.  
In the mare, ovarian progesterone is responsible for maintenance of myometrial quiescence for 
roughly the first third of gestation; metabolites of progesterone produced by the fetoplacental unit 
assume this role thereafter [241]. The fetus synthesizes pregnenolone, which is the precursor for a wide 
variety of progestagens. Two progestagens, 5α-pregnane-3,20-dione (5α-DHP) and 20α-hydroxy-5α-
pregnan-3-one (20α-5P), are excreted into the umbilical and uterine circulation and are believed to be 
the most biologically important progestagens for preventing uterine contractions [126]. Changes 
observed in progestagen profiles during late pregnancy appear to depend on the nature of the stress and 
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the maturity of the fetal HPAA. Stress of the equine fetus due to infection-induced placentitis has been 
shown to result in two patterns of progestagen profiles: acute placentitis was associated with no change 
in total progestagens, whereas chronic placentitis was associated with elevations in maternal total 
progestagens [136]. In contrast, maternal progestagens tend to remain stable and then decline prior to 
abortion in cases of severe maternal stress without direct involvement of the fetus, such as colic or 
uterine torsion [133]. What is not clear from previous studies is why supplementation with synthetic 
progestins (altrenogest) in cases of placentitis is not always successful in preventing uterine 
contractions. Although maternal progestagens appear to provide some measure of placental health, what 
is needed is a measure of synthesis of pregnenolone from the fetus. Fetal output of pregnenolone and 
progestagens are typically measured in studies involving fetal umbilical vasculature, uterine vasculature, 
and maternal catheterization [126]. No attempts have been made to measure either cortisol or 
progestagens in allantoic fluid; therefore we propose to analyze allantoic samples serially to examine 
possible effects of placentitis on fetal synthesis of cortisol.  
This is the first reported attempt to use laparoscopy rather than laparotomy for allantoic catheter 
placement in the mare [242]. Avoiding general anesthesia and laparotomy in a late gestation mare, with 
all the attendant problems of pre-operative fasting, intra-operative hypotension, post-operative ileus, and 
potentially increased concentrations of fetal cortisol due to maternal fasting, justify attempting the use of 
laparoscopy as a less invasive alternative to instrumentation of pregnant mares. We will test the 
hypothesis that TNF-α, IL-1 and IL-6, which increase in response to inflammation of the chorioallantois, 
are temporally related to increases in allantoic cortisol, PGF2α
 
and PGE2, leading to myometrial 
contractions and premature foal delivery. Inflammation of the chorioallantois will be induced by 





LAPAROSCOPIC PLACEMENT OF AN INDWELLING ALLANTOIC 
CATHETER IN THE MARE: DEVELOPMENT OF THE TECHNIQUE 
 
2.1 Introduction 
 Catheterization of fetal vasculature, maternal vasculature, and the allantoic and amniotic 
compartments has been used to study normal physiology and pathologic conditions of pregnancy 
in many species for several decades. Undoubtedly the knowledge gained has been invaluable; 
however, the invasiveness of the described surgical procedures are tremendous, leading to fetal 
demise, potential alteration of endocrine function of the dam and fetus, and limited ability to re-
instrument the dam in future pregnancies. The mare has proven to be extremely problematic for 
these studies, especially with regards to allantoic catheterization. A recently reported model of 
placentitis in the mare showed increased expression of pro-inflammatory cytokines in the 
chorioallantois of mares transcervically inoculated with Streptococcus equi subsp. zooepidemicus 
compared to control mares, while no differences were detected in activities of soluble cytokines 
from both groups of mares [237]. In women, rhesus monkeys, rabbits, and mice increased 
concentrations or activity of soluble pro-inflammatory cytokines in amniotic or allantoic fluid are 
observed as a result of natural or experimental infection of the placenta [224-226,243] . The 
reason for this discrepancy between the mare and other species is not clear. It was felt that a non-
invasive method of catheterizing the allantoic space of the mare was needed. The objective of 
this study was to develop a technique for laparoscopic placement of an allantoic catheter in the 
standing mare. Obstacles and concerns included side of placement, catheter design, bacterial 




2.2 Material and Methods 
2.2.1 Experimental Animals 
 Twenty-nine adult pony mares and one horse mare of various ages were used in this 
study over a four-year period (2003 to 2007). Mares were maintained on pasture and 
supplemented with hay and a pelleted ration during the winter to maintain good body condition. 
All procedures were in accordance with Louisiana State University’s Institutional Animal Care 
and Use Committee’s guidelines for the humane treatment of research animals. The horse mare 
was artificially inseminated with a horse stallion, and the pony mares were pasture-bred with one 
of four different adult pony stallions. Two weeks after introduction of the stallions, mares were 
examined for pregnancy by transrectal ultrasonography every 7 to 14 d to determine gestational 
age of the early embryo. Ovulation dates were extrapolated from this information to provide 
ovulation dates that would be accurate within 2 to 3 d [11]. Laparoscopic procedures were 
performed between 234 and 285 d of gestation.  
2.2.2 Allantoic Catheter Placement 
 Allantoic catheters were placed in sedated standing animals under local anesthesia using 
laparoscopic visualization. Mares were not fasted prior to surgery. Either immediately, or 24 h 
preceding surgery and again immediately prior to surgery, the hair of the left or right flank was 
clipped and the skin scrubbed with a povidone-iodine cleanser. Mares were sedated with 0.05 
mg/kg detomidine iv and 0.1 mg/kg butorphanol iv, and then restrained in stocks. After regional 
anesthesia with 2% lidocaine (approximately 60 mL), the left or right flank was aseptically 
prepared prior to insertion of the laparoscopy cannulas (See Figure 2.1). From 2005 to 2007, 
following a stab incision through the skin,  a 14 ga Veress needle (VS150000, VersaStep
TM
, 




Figure 2.1 Laparoscopic portal placements for catheterization of the allantoic space in the 
standing mare. 
 
expandable sleeve (VS101500, VeraStep
TM
, United States Surgical, Tyco Healthcare Group, 
Norwalk, CT) was used to allow bladeless entry into the peritoneal space. A 12-mm cannula and 
dilator (VS101512P, VeraStep
TM
, United States Surgical, Tyco Healthcare Group, Norwalk, CT) 
were inserted into the expandable sleeve, and pneumoperitoneum was created with CO2 
insufflation. Intraperitoneal pressure was maintained between 10 and 14 mm Hg. This step was 
repeated for each portal site. After identifying the gravid uterus, one of three types of catheter 
designs was introduced either through a cannula or along a rigid guide to the uterine wall. With a 
quick thrust, the catheter was introduced into the allantoic space. The dead space of the catheter 
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and attached access port system, if present, was measured for each individual. The skin incisions 
were sutured with 2-0 nylon suture in either a cruciate or a Ford-interlocking pattern (depending 
on incisional length) and a sterile adherent dressing with a triple-antibiotic ointment (Bacitracin-
Neomycin-Polymyxin B, Clay-Park Labs, Inc., Bronx, NY) was applied.  
Post-operatively, physical examinations were performed twice daily for one week to 
monitor body temperature, vaginal discharge, and pain, heat or swelling at the cannula entry 
sites. Fluid from the catheter was collected, centrifuged at 2,000 x g for 15 min and stored at 4°C 
until analyzed for creatinine, chloride, sodium, and calcium concentrations to confirm that it was 
of allantoic origin [239,240]. All samples were analyzed within 12 h of collection. In two mares, 
a multi-frequency rigid laparoscopic transducer (UST-5526L-7.5, Aloka, Inc. Wallingford, CT), 
a multi-frequency flexible laparoscopic transducer (UST-5536-7.5, Aloka, Inc. Wallingford, 
CT), or a 6.5-MHz transvaginal transducer (Medison, Universal Medical Systems, Inc., Bedford 
Hills, NY)  was introduced through a separate portal site to evaluate the usefulness of 
laparoscopic ultrasonography in locating a suitable site for catheter insertion. Fluid samples were 
obtained at surgery, 4, 8, 12, 16, 20, 24, 28, 36, 42, and 50 h post-operatively, and then daily 
until fetal delivery. Biochemical and cytologic analysis of each sample verified the nature of the 
fluid as allantoic, amniotic, peritoneal, or an admixture of allantoic and amniotic fluid. 
2.2.3 Catheter Design 
 Three custom-designed and one commercially available catheter were evaluated. The first 
catheter design was a 3-Fr, 75-cm, polypropylene, balloon-tipped catheter; placed by a 10-ga 
split-steel introducer (Figure 2.2A). The second catheter was a 3-Fr, 75-cm, polypropylene, 
through-the needle (12 ga) catheter with a collapsible disk at the terminal end and a moveable 




Figure 2.2 Schematic drawings for custom-designed catheters for catheterization of the allantoic 
space in the standing mare. A) A balloon-tipped catheter; placed by a 10-ga split-steel introducer. 
B) A through-the needle catheter with a collapsible disk at the terminal end and a moveable disk 
designed to anchor the catheter to the serosal surface of the uterus. 
 
catheter design was a polypropylene, over-the needle, (10 ga) catheter with a bonded flange for 
anchoring the system to the serosal surface of the uterine wall. The fourth catheter design was a 
commercially available, over-the-needle, 7.5 Fr, 25-cm, polyurethane catheter, with a locking 
pigtail (Ultrathane
®
 Suprapubic Catheter, Cook Urological, Spencer, IN) designed for 
percutaneous placement of a loop catheter in the renal pelvis for nephrostomy drainage (Figure 
2.3A). Figure 2.3B depicts the placement of the locking pigtail within the allantoic space. 
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A)       B)     
  
Figure 2.3 A) A commercially available over-the-needle, 7.5 Fr, 25-cm, polyurethane catheter, 
with a locking pigtail (Ultrathane
®
 Suprapubic Catheter, Cook Urological, Spencer, IN) used for 
catheterization of the allantoic space in the standing mare. B) Schematic drawing of catheter 
placement within the allantoic space. 
 
2.2.4 Modifications to Reduce Microbial Tracking along the Catheter System 
2.2.4.1 Subcutaneous Access Port 
 For 13 of 17 of the catheterizations, a subcutaneous access port (PMIDA-SIL-C70 
Custom, Instech Solomon, Plymouth Meeting, PA) was incorporated in the collection system. 
Attached to the port was a 12-inch section of silicone tubing ending in a locking male luer. After 
catheterization of the allantoic cavity, a 4-cm vertical incision was made 4 to 5 cm dorsal and 3 
to 4 cm anterior to the exit wound of the allantoic catheter. A subcutaneous pouch under the 
anterior margin of the port incision was formed by blunt dissection. The access port was placed 
in this pouch. After bluntly dissecting a tunnel from the catheter incision to the port incision, the 
tubing of the port was connected to the catheter, and both incisions were closed with 2-0 nylon 
suture in a Ford-interlocking pattern (Figure 2.4). 
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Figure 2.4 Placement of a subcutaneous access port in mares with an indwelling allantoic 
catheter.  
 
2.2.4.2 Indwelling Huber Needle 
 Non-coring needles (Huber needles, Instech Solomon, Plymouth Meeting, PA) were used 
to obtain samples from the access ports. Straight single-use 22 ga x 3/4‖ Huber needles were 
used for sample acquisition in seven mares. For ten mares, a 22 ga x 5/8‖ right angle Huber 
needle with a 6-inch PVC tubing and female luer was inserted into the subcutaneous access port, 
and a sterile adherent bandage applied. Bandages and needles were changed every 72 h. 
2.3 Results 
2.3.1 Side of Approach 
 A total of 48 laparoscopic procedures were performed; eight during 2004, 30 during 
2005, eight during 2006, and two during 2007. The first procedure was on a mare at 234 d of 
gestation and a left flank approach was utilized. The left uterine horn was adequately visualized; 
however, later in gestation (>260 d), the left uterine horn was totally obscured by small intestines 
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or small colon (n=2). For the remaining procedures, mares were between 260 and 285 d of 
gestation, and a right flank approach provided adequate visualization of the right uterine horn in 
all but two instances. In both of these cases fat, in addition to loops of small intestine, obscured 
visualization of the uterus. 
2.3.2 Catheter Design 
 None of the custom-designed catheters could either be inserted into or retained within the 
allantoic space. The through-the-needle catheter with a terminal collapsible disk was too bulky to 
allow advancement of the catheter through the introducing trocar. Although the balloon-tipped 
catheter could be successfully inserted into the allantoic space, the balloon size was inadequate 
to retain the catheter within the allantoic cavity. The catheter material of the over-the-needle 
design created too much tissue drag, and prohibited advancement of the catheter through the 
uterine wall. The nephrostomy catheter proved to be an acceptable design, creating minimal 
tissue drag during insertion and having good retention of the locking pigtail. It was important 
however, that the tension on the pull tie was sufficient to create the maximal degree of loop 
fixation to retain the catheter. Failure to do so resulted in three catheters pulling out of the uterine 
wall. The peritoneal location of the catheter was determined by biochemical and cytologic 
evaluation of the sample. (See Table 2.1) Subsequent to identifying the appropriate catheter 
design, 17 catheters were successfully placed into the allantoic space (2005 to 2006). Two of the 
three catheters that pulled out were successfully replaced during a second laparoscopy; the third 
mare was not re-catheterized. 
2.3.3 Catheter Patency 
 The number of days indwelling, patent, and number of potential and missing samples is 
summarized in Table 2.2. In 2004, four mares were successfully catheterized during the eight 
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All Fluid Categories Allantoic Fluid Admixed Fluid Peritoneal Fluid 
Mare Date Creat. Chloride Calicum Sodium Creat. Chloride Creat Chloride Creat Chloride 
25 sham 1/26/2005 39.8 36 26.5 112 39.8 36 
    25 
 
1/27/2005 27 84 18 130 
  
27 84 
  25 
 
1/28/2005 27 93 21.7 127 
  
27 93 
  25 
 
1/29/2005 25 102 18.5 129 
  
25 102 
  25 
 
1/30/2005 25 102 17.6 122 
  
25 102 
  25 
 
1/31/2005 23 109 16.4 120 
  
23 109 
  25 
 
2/14/2005 20.8 99 25.4 105 
      762 sham 5/30/2005 72 39 22.2 74.5 72 39 
    762 
 
5/31/2005 74 36 23.1 71 74 36 
    762 
 
6/1/2005 79 34 23.1 69 79 34 
    762 
 
6/2/2005 79 34 22.3 63 79 34 
    762 
 
6/3/2005 80 36 21.8 63 80 36 
    762 
 
6/4/2005 83 38 22.5 61 83 38 
    762 
 
6/5/2005 86 38 21.9 58 86 38 
    762 
 
6/6/2005 87 37 20.3 57 87 37 
    762 
 
6/7/2005 91 36 22.5 54 91 36 
    847 sham 3/21/2005 97.9 22 39.8 50 97.9 22 
    847 
 
3/22/2005 101.8 19 41 47 101.8 19 
    847 
 
3/23/2005 87 35 37 65 87 35 
    847 
 
3/24/2005 83 46 34.7 73 83 46 
    847 
 
3/25/2005 56 24 20.8 108 56 24 
    847 
 
3/26/2005 90 48 34 74 90 48 
    847 
 
3/29/2005 141 13 50.1 51 141 13 
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All Fluid Categories Allantoic Fluid Admixed Fluid Peritoneal Fluid 
Mare Date Creat. Chloride Calicum Sodium Creat. Chloride Creat Chloride Creat Chloride 
790 PBS 2/22/2005 53 66 149 24 53 66 
    790 
 
2/24/2005 48 67 137.5 31 48 67 
    790 
 
2/25/2005 1 107 9.9 138 
    
1 107 
781 PBS 3/23/2005 27.4 57 13 116 27.4 57 
    781 
 
3/24/2005 53 21 24.1 107 53 21 
    781 
 
3/25/2005 88 48 33.6 75 88 48 
    781 
 
3/26/2005 57 22 22.2 113 57 22 
    22 PBS 6/14/2005 49.9 23.7 9.6 116 49.9 23.7 
    22 
 
6/15/2005 48.2 36.3 10.8 118 48.2 36.3 
    22 
 
6/16/2005 49.2 41 10.8 122 49.2 41 
    22 
 
6/17/2005 50.3 45 10.9 122 50.3 45 
    22 
 
6/18/2005 53 50 12.1 123 53 50 
    22 
 
6/19/2005 51 52 11.2 118 51 52 
    22 
 
6/20/2005 53 54 13.3 116 53 54 
    22 
 
6/21/2005 55 57 15.6 115 55 57 
    22 
 
6/22/2005 54 59 19.3 110 54 59 
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All Fluid Categories Allantoic Fluid Admixed Fluid Peritoneal Fluid 
Mare Date Creat. Chloride Calicum Sodium Creat. Chloride Creat Chloride Creat Chloride 
682 killed 3/4/2005 58 13 37.1 92 58 13 




3/5/2005 1.5 110 9 142 




3/6/2005 1.1 108 9.7 142 




3/24/2005 82 64 12.4 114 82 64 




3/25/2005 82 61 11.7 109 82 61 




3/26/2005 84 59 12.1 107 84 59 




3/27/2005 77 64 12.2 111 77 64 




3/28/2005 88 62 12.8 109 88 62 




3/30/2005 86 65 13.3 109 86 65 




3/31/2005 89 63 13.3 107 89 63 




4/1/2005 101 57 13.1 105 101 57 




4/2/2005 82 71 12.5 112 82 71 




4/3/2005 53 82 13.8 127 53 82 
   
 











































































































All Fluid Categories Allantoic Fluid Admixed Fluid Peritoneal Fluid 
Mare Date Creat. Chloride Calicum Sodium Creat. Chloride Creat Chloride Creat Chloride 
20 live-low 2/28/2005 18.5 58 5.95 137 
  
18.5 58 
  20 
 
3/1/2005 12 84 7.3 144 
  
12 84 
  20 
 
3/2/2005 11 80 11.3 141 
  
11 80 
  20 
 
3/3/2005 11 72 9.4 131 
  
11 72 
  20 
 
3/4/2005 11.9 63 6.7 132 
  
11.9 63 
  20 
 
3/5/2005 14.8 53 8 125 
  
14.8 53 
  12 live-low 3/28/2005 57 7 48.6 84 57 7 
    12 
 
3/30/2005 52 23 30.5 95 52 23 
    12 
 
3/31/2005 48 36 31.7 105 48 36 
    12 
 
4/1/2005 51 38 32.4 106 51 38 
    12 
 
4/2/2005 54 36 31.1 107 54 36 
    12 
 
4/3/2005 57 34 30.9 106 57 34 
    12 
 
4/4/2005 57 32 31.6 104 57 32 
    12 
 
4/5/2005 58 30 32.8 103 58 30 
    12 
 
4/6/2005 60 28 28.3 103 60 28 
    12 
 
4/7/2005 61 26 39.7 102 61 26 
    12 
 
4/8/2005 63 24 36.3 105 63 24 
    12 
 
4/14/2005 79 14 31.6 97 79 14 
    24SG live-low 7/5/2005 43 26 41.7 98 
  
43 26 
  24SG 
 
7/6/2005 24 101 15.4 123 
  
24 101 
  24SG 
 
7/7/2005 25 109 13.9 126 
  
25 109 
  24SG 
 
7/8/2005 24 111 12.6 126 
  
24 111 
  24SG 
 
7/9/2005 26 114 11.1 129 
  
26 114 
  24SG 
 
7/10/2005 23 114 10 129 
  
23 114 
  24SG 
 
7/11/2005 21 118 10.4 130 
  
21 118 
  24SG 
 
7/12/2005 20 120 10.4 130 
  
20 120 
  24SG 
 
7/13/2005 20 122 10.8 128 
  
20 122 
  24SG 
 










All Fluid Categories Allantoic Fluid Admixed Fluid Peritoneal Fluid 
Mare Date Creat. Chloride Calicum Sodium Creat. Chloride Creat Chloride Creat Chloride 
23 live - high 8/25/2006 54 19 30.7 130 54 19 
    23 
 
8/26/2006 58 20 32 129 58 20 
    23 
 
8/27/2006 60 17 33.7 129 60 17 
    23 
 
8/28/2006 65 14 36.3 130 65 14 
    23 
 
8/29/2006 67 15 36.8 129 67 15 
    23 
 
8/30/2006 66 17 37.3 127 66 17 
    23 
 
8/31/2006 65 20 38.1 128 65 20 
    23 
 
9/2/2006 66 30 34.3 127 66 30 
    23 
 
9/6/2006 61 31 32.2 126 61 31 
    
             

























62 36 24 99 1.1 108 
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Table 2.2 Summary results of allantoic catheterization for 2005 to 2006. Number of days indwelling, days patent, potential samples, 
missing samples, for 13 mares laparoscopically catheterized between 260 and 285 days of gestation. 
 






Group A Single Huber sampling; spontaneous abortion 
25 19 19 13 0  
790 7 2 13 4  
20 10 5 18 5  
Group B Indwelling Huber sampling; spontaneous abortion 
682 10 10 12 0  
847 12 8 20 6  
781 3 3 11 0  
Group C
 
 Indwelling Huber sampling; spontaneous abortion; flank preparation 24 h pre-operatively 
12 17 16 24 1  
416 5 5 13 0  
23 11 8 19 3  
Group D Indwelling Huber sampling; induced delivery day 8; flank preparation 24 h pre-operatively 
24SG 8 8 16 0  
12SG 8 8 16 0  
762 8 8 16 0  
22SG 8 8 16 0  
Mean 9.7 8.3 15.9 1.4  
SEM 1.22 1.3 1.0 0.6  
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procedures; however, biochemical confirmation of the fluid was only performed in three mares 
due to limited funding resources. Catheters were patent for an average of 5.6 d, with a range of 
five to six d. In 2005, 12 mares were successfully catheterized during 30 procedures. In 2006, 
two mares were successfully catheterized during eight procedures. Fluid samples were obtained 
at surgery, 4, 8, 12, 16, 20, 24, 28, 36, 42, and 50 h post-operatively, and then daily until fetal 
delivery. Biochemical and cytological analysis of each sample verified the nature of the fluid as 
allantoic, amniotic, an admixture of allantoic and amniotic fluid, or peritoneal. (See Table 2.1) 
For all mares in 2005 and 2006, catheters were indwelling and patent for 9.7 + 1.2 d  and 8.3 + 
1.3 d, respectively (mean + SEM). Of a potential 207 samples for all mares, there were only 19 
sample times for which no fluid sample was obtained.  For four of the last five mares 
instrumented, samples were acquired from all mares at each of the specified time points. (See 
Table 2.2) The majority of the samples were easily withdrawn using a 6- or 12-mL syringe. On 
occasion, fluid recovery was not immediate, presumably due to fetal position. In these instances, 
ballottement of the fetus resulted in sufficient fetal movement to allow sample retrieval. 
2.3.4 Control of Bacterial Contamination 
 Tracking of skin microflora along the catheter system and into the allantoic cavity was a 
significant problem. During the pilot study of 2004, the catheter exited the body wall through the 
portal site created during laparoscopy. Because of the extreme caudal flank location of this portal 
site, maintaining a bandage over the exit wound was difficult. Contamination of the allantoic 
space usually occurred within 5 d of catheterization. The first day of bacterial contamination and 
cytologic inflammation, and the histologic description of the catheter site for mares catheterized 
in 2005 and 2006 are summarized in Table 2.3. During 2005, utilization of the subcutaneous 
access port and single-use Huber needles (three mares) for sampling delayed, but did not 
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Table 2.3 Summary results of allantoic catheterization for 2005 and 2006. Culture, cytology, and biochemical characterization of fetal 





Pulled out at 40 h, not re-catheterized 
2
Pulled out at 24 h, re-catheterized 10 d after first surgery 
3











Characterization   
Histologic description of catheter site 
Group A Single Huber sampling; spontaneous abortion  
25 none Day 9 Admix Cystic allantoic dysplasia; microcotyledonary atrophy; no 
 inflammation 
790 none Day 2 Allantoic
1
 Vascular thrombi, transmural infarction; coccoid bacteria 
20 >Day 5 NA Admix Severe diffuse placental necrosis; marked squamous metaplasia; 
diffuse allantoic fibrosis; allantoic vascular thrombosis 
Group B Indwelling Huber sampling; spontaneous abortion  
682 Day 10 Day 10 Allantoic
2
 Focal subacute placentitis with bacterial cocci 
847 Day 4 Day 8 Allantoic Focal bacterial placentitis 
781 Day 3 Day 3 Allantoic Not identified at necropsy 
Group C
 
 Indwelling Huber sampling; spontaneous abortion; flank preparation 24 h pre-operatively  
12 Day 17 Day 17 Allantoic Chronic focal necrotizing placentitis 
416 None None Admix Not identified at necropsy 
23 None
3
 Day 6  Allantoic Placentitis at cervical star extended cranially to the catheter site  
Group D Indwelling Huber sampling; induced delivery day 8; flank preparation 24 h pre-operatively  
24SG None None Admix Focal fibrosis; edema; no inflammation 
12SG None None Admix Not identified at necropsy 
762 None None Allantoic Chronic focal reactive placental changes; no significant 
inflammation; edema 
22SG None None Allantoic Not identified at necropsy                                           
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 eliminate, tracking along the catheter. This was evidenced by either focal placentitis at the 
catheter site or positive bacteriologic culture of the allantoic fluid. Bacterial tracking along the 
catheter system was associated with inflammatory changes of the chorioallantois at the catheter 
exit site (Figure 2.5A), while absence of bacterial tracking was typically evidenced by fibrotic 
changes (Figure 2.5B). Additionally, patient discomfort was considerable with single-use 
needles. Indwelling Huber needles (three mares), significantly improved patient comfort and 
ease of sample procurement, but did not significantly reduce tracking. Clipping and cleansing the 
flank with povidone-iodine scrub 24 h prior to laparoscopy resulted in no bacterial tracking in six 
of seven mares. The allantoic fluid of the seventh mare remained culture negative for 16 of the 
17 d that the catheter was indwelling.  
2.3.5 Location of Allantoic Space 
 In 2005, a sufficiently deep pocket of allantoic fluid in the allantoic space could not be 
located during 13 laparoscopies, due to either fetal positioning, or close proximity of the 
amniotic membrane to the allantoic membrane. Additionally, fluid from five mares successfully 
catheterized at surgery showed evidence of an admixture of the allantoic and amniotic 
compartments by 24 h post-laparoscopy (Tables 2.1 and 2.3). Three transducers for laparoscopic 
ultrasound were evaluated in two mares. All three types of probe configurations allowed imaging 
of the allantoic cavity, amnion, and fetus. The rigid side-fire laparoscopic transducer necessitated 
placing the probe on the ventrad portion of the uterine horn, making catheter insertion adjacent to 
the beam extremely difficult. Because the transvaginal transducer produced an end-fire sector 
beam, images and triangulation of the catheter direction were possible; however, the diameter of 




Figure 2.5 Histologic changes of the chorioallantoic membrane at the catheter site in response to 
bacterial tracking along the catheter system. Chronic necrotizing placentitis associated with 
bacterial tracking (A), or focal fibrosis in the absence of bacterial tracking (B). 
 
transducer provided adequate visualization of allantoic fluid, amnion, and fetus, and could be 
introduced through a standard laparoscopic trocar or directly through the body wall (Figure 2.6). 
2.3.6 Complications Encountered and Future Fertility 
In 2006, the cecum of one mare was inadvertently punctured despite the use of the 
Veress-needle system for bladeless creation of a pneumoperitoneum. This mare was treated with 
flunixin meglumine, broad-spectrum antibiotics, intravenous fluids, and was withdrawn from the 
study. While peritonitis was successfully controlled, the mare subsequently developed 
irreversible hepatic lipidosis and was euthanized. All eight of the mares used in 2004, except for 
one, were successfully re-bred and were used again in 2005; this mare conceived in 2005 and 
foaled in 2006. Nine of the 12 mares catheterized in 2005 to 2006 were successfully rebred and 
foaled the following year; three mares were not rebred. Nine mares underwent unsuccessful 
attempts at catheterization in 2005; all foaled uneventfully at term, one was not rebred, and five 




Figure 2.6 Laparoscopic ultrasonographic image of the uterus, allantoic fluid, and fetus prior to 
placement of an allantoic catheter. 
 
pregnant was in low body condition score and suffered from summer-associated chronic 
obstructive pulmonary disease, the remaining two mares became pregnant in 2006. Four mares 
were used in 2006, three were successfully rebred and the fourth was euthanized as previously 
explained due to hepatic lipidosis. 
2.4 Discussion 
 These findings describe using laparoscopy to catheterize the allantoic space with a 
nephrostomy catheter in the pregnant mare. Subcutaneous access ports, indwelling Huber 
needles and pre-operative skin preparation reduced bacterial tracking along the catheter system 
to a minimum. Although these modifications were applied sequentially, the latter may have had 
the greatest impact on tracking. Prophylactic antibiotics could provide a further reduction in the 
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incidence of contamination. Because the development of this instrumentation technique was 
done in conjunction with a placentitis model, antibiotic administration was not employed. In 
2004 flunixin meglumine was administered perioperatively, but was not in 2005. Patient 
discomfort appeared to be minimal. Mares were alert upon return to the stall and resumed eating 
immediately. Only slight tenderness was noted along the incision sites, and mares tolerated the 
bandaging well. Despite no antibiotics or non-steroidal anti-inflammatory agents in 2005, no 
mares experienced a febrile episode post-operatively. The ability to repeatedly use this technique 
from year to year greatly improves the welfare and the economic aspects of gestational 
catheterization studies. Laparoscopic ultrasound produced a significant refinement in the 
procedure by localizing allantoic fluid. Retraction of the gastrointestinal tract by the laparoscopic 
transducer, as is done in human medicine, may allow for the use of a left-sided approach later in 
gestation and simplify the procedure from the right side especially when mares are obese. 
Ultrasound-guided laparoscopy can be successfully used to catheterize the allantoic space of the 
pregnant mare thereby providing a minimally invasive, reliable method of studying the 





AN EXPERIMENTAL MODEL OF INFECTIVE PRE-TERM DELIVERY 
IN THE MARE: RESPONSE TO INOCULATION 
 
3.1 Introduction 
Placentitis is responsible for approximately one-third of abortions and perinatal loss in 
horses [3]. The ascension of aerobic bacteria through the vagina and cervix is the most common 
cause of placentitis; Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) is the species 
most frequently isolated [5]. Clinically, mares may have a vaginal discharge, show udder 
development, prenatally lactate, and deliver a premature or dead foal. Mares suspected or 
diagnosed as having placentitis are treated empirically with progestins to maintain uterine 
quiescence, broad-spectrum antibiotics to eliminate bacterial infection, and anti-inflammatory 
agents to prevent prostaglandin synthesis. Although these agents should address the basic 
problems of infection-induced prostaglandin synthesis which leads to uterine contractions and 
fetal expulsion, the efficacy of these regimes is frequently poor [6]. In a controlled trial the best 
results in neonatal outcome were achieved when pentoxifylline was combined with trimethopim-
sulfamethoxazole and therapy was initiated very early in the course of infection [6,244] . There 
are two major areas where the basic knowledge of the pathophysiology of equine placentitis is 
lacking: (1) the temporal relationship between the inflammatory cascade and increases in 
prostaglandin synthesis and (2) the endocrinological events associated with loss of myometrial 
quiescence and activation of the fetal hypothalamic-pituitary-adrenal axis.  
To the investigators’ knowledge, only one study has examined the relationship between 
inflammatory cytokines and ascending placentitis in pregnant mares [237]. Induction of 
placentitis by intracervical inoculation of S. zooepidemicus increased mRNA expression of IL-6 
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in allantoic fluid, whereas no differences were detected in the activities of 
TNF-α, IL-1 and IL-6 in allantoic fluid between groups over time. The failure to demonstrate an 
increase in the activities of pro-inflammatory cytokines in equine fetal fluids following bacterial 
infection differs from the results from monkeys, rabbits, women and mice [223-226]. The 
reasons for this discrepancy between the mare and other species is not clear, but may have 
resulted from sampling intervals and the heterogenic response of experimental animals. This 
latter variation may have been due to individual differences in response to the strain of S. 
zooepidemicus used [168], and the dose and site of inoculation chosen for this study.  
The temporal relationship between elevations in allantoic cytokines and prostaglandins is 
quite important. If the synthesis of PGF2α and PGE2
 
is driven by cytokines in concert with fetal 
cortisol, as has been suggested in a model of ascending placentitis [48], then treatment strategies 
that fail to interrupt the inflammatory cascade and fetal stress may be ineffective in preventing 
pre-term labor. Therefore, it would be useful to delineate a noninfectious-inflammatory response 
from an infectious-inflammatory response. Inflammation of the chorioallantois was induced by 
inoculation with live bacteria or heat-killed bacteria. Heat-killed S. zooepidemicus has been used 
both in vivo in an endometritis model in the mare [172] and in vitro in phagocytosis assays for 
equine neutrophils [184,200]. By comparing the inoculation with heat-killed S. zooepidemicus to 
the inoculation with live S. zooepidemicus, the effects of the inflammatory cascade and resultant 
prostaglandin synthesis can be separated from the effects of placental, and possibly fetal, 
infection. We hypothesized that both types of inocula would induce an acute placentitis, that 
heat-killed S. zooepidemicus would produce a less variable pattern of inflammatory mediators 
than that produced by live S. zooepidemicus, and that live S. zooepidemicus would lead to pre-
term delivery in all mares. Because the inflammatory insult initiated by heat-killed S. 
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zooepidemicus would occur as a single event without continual replication (and thus propagation 
of the inflammatory cascade) as would occur with live S. zooepidemicus, it would be unlikely to 
lead to pre-term delivery in all mares.  
3.2 Material and methods 
3.2.1 Experimental Animals  
 Fourteen adult pony mares of various ages were used in this study over a 2-year period 
(2005-2006). Mares were maintained on pasture and supplemented with hay and a pelleted ration 
during the winter to maintain good body condition. All procedures were in accordance with 
Louisiana State University’s Institutional Animal Care and Use Committee’s guidelines for the 
humane treatment of research animals. Only mares with normal perineal conformation and no 
previous history of spontaneous abortion due to placentitis were included. The mares have been 
in the  herd for several years and accurate reproductive records were available for all individuals. 
Mares were pasture bred with one of four different adult pony stallions. Beginning two weeks 
after introduction of the stallions, mares were examined by transrectal ultrasonography for 
pregnancy every 7 to 14 d to determine gestational age of the early embryo. Ovulation dates 
were extrapolated from this information. This method provided ovulation dates that are accurate 
within 2 to 3 d [11]. Mares were grouped by age and by body condition score and randomly 
assigned to one of four treatment groups. Prior to the placement of allantoic catheters, fetal heart 
rate (FHR) was measured by transabdominal ultrasonography, and combined thickness of the 
uterus and placenta (CTUP) ventrad to the internal cervical os was measured by transrectal 
ultrasonography to avoid inclusion of any mares with pre-existing placentitis. To avoid inclusion 
of a mare with preexisting placentitis, any pregnancy with a  sustained FHR less than 60 bpm or 
greater than 120 bpm [245], or a CTUP greater than 7 mm [246] was excluded from the study. 
Pony mares were assigned to one of four treatment groups: low STREP, high STREP, KILLED 
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STREP, PBS CONTROL, and SHAM CONTROL groups. Procedures were performed between 
260 and 285 d of gestation.  
3.2.2 Inoculates 
3.2.2.1 Live Bacterial Inoculates  
 One colony of a S. zooepidemicus isolate from a clinical case of endometritis (provided 
by Dr. Robert Causey, University of Maine, Orono, ME) was used to inoculate 200 mL of Todd 
Hewitt broth and incubated at 37°C for 24 h. Following centrifugation, the pellet was 
resuspended in sterile PBS supplemented with 10% sterile glycerol to a concentration of 10 x 10
7 
CFU/mL, determined spectrophotometrically [200] and confirmed by serial dilution. Two-mL 
aliquots were frozen at -70°C until needed for inoculation. Upon thawing at 37°C for 2 min, 100 
μL were added to 900 μL of sterile PBS to provide an inoculum of 1 x 10
7
 
CFU (low STREP). A 
100-µL aliquot was streaked on blood agar and incubated at 37°C for 48 h to document purity 
and viability of the inoculum. This technique ensured consistency among inocula. Preparation of 
the high STREP was similar except the concentration of the aliquots was adjusted to 5.1 x 10
8
 
CFU/mL, and confirmed by serial dilution. Upon thawing at 37°C for 2 min, 1 mL provided an 
inoculum of 5.1 x 10
8
 CFU (high STREP). 
3.2.2.2 Heat-Killed Bacterial Inoculate  
 One colony of the same S. zooepidemicus isolate used for the live inoculate was used to 
inoculate 200 mL of Todd Hewitt broth and incubated at 37°C for 24 h. Following autoclaving 
and centrifugation, the pellet was resuspended in sterile PBS supplemented with 10% sterile 
glycerol to a concentration of 10 x 10
7
 CFU/mL, determined spectrophotometrically [200]. Two-
mL aliquots were frozen at -70°C until needed for inoculation. Upon thawing at 37°C for 2 min, 
100 μL was added to 900 μL of sterile PBS and used for inoculation (KILLED STREP). A 100-
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µl aliquot was streaked on blood agar and incubated at 37°C to document that no viable 
organisms were present. 
3.2.2.3 PBS Inoculate 
 The PBS CONTROL inoculate consisted of 990 μL of PBS and 10 μL of sterile glycerol. 
Two-mL aliquots were frozen at -70°C until needed for inoculation. Upon thawing at 37°C for 2 
min, one mL was used for inoculation. A 100-µl aliquot was streaked on blood agar and 
incubated at 37°C to document that no viable organisms were present. 
3.2.3 Procedures 
3.2.3.1 Allantoic Catheter Placement  
 Allantoic catheters were placed in 13 of the 14 sedated standing animals under local 
anesthesia using laparoscopic visualization as previously described (Chapter 2). The type of pre-
operative and post-operative approach to control bacterial tracking is listed in Table 3.1. The 
dead space of the catheter and attached port system was measured for each individual. Body wall 
portal sites were closed routinely and a sterile adherent dressing with an antibiotic ointment 
applied. Post-operatively, physical examinations were performed twice daily for one week to 
monitor body temperature, vaginal discharge, and pain, heat or swelling at the cannula entry 
sites. Each sample of fluid obtained via the catheter was analyzed for creatinine, chloride, and 
sodium concentrations to define the character of the fetal fluid [239,240]. (Table 2.1) 
3.2.3.2 Transcervical Inoculation  
 Transcervical inoculation was performed 4 to 6 h after placement of the allantoic 
catheters and was designated Time 0. In two instances inoculation was delayed one or four days 
due to cytologic evidence of intra-allantoic hemorrhage following the catheterization procedure. 
Mares were restrained in stocks and sedated with 0.05 mg/kg detomidine, iv. Following aseptic 
preparation of the perineum, a guarded culture instrument was used to obtain a culture of the 
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vaginal fornix and external os of the cervix. Obtaining a culture of the microflora of the vaginal 
fornix and external os at the time of  inoculation was useful in determining the source of 
contaminants (from the vagina at the time of inoculation or from the skin due to bacterial 
tracking along the catheter system) that might be isolated from the placenta, fetal fluids, or fetus. 
A sheathed sterile artificial insemination pipette (IUI Pipette with Inner Catheter, Minitube of 
America, Verona, WI; or Equi-Flex-EzeTM, Reproduction Resources, Walworth, WI) was 
introduced manually through the vagina. Once the pipette was positioned at the external os, the 
outer sheath was penetrated as the pipette entered the cervical canal. The examiner’s arm was 
withdrawn, and transrectal ultrasonography was used to monitor advancement of the pipette to 
the internal os, positioning it adjacent to the surface of the chorioallantois, where the inoculum 
was deposited. Inoculated mares received either 1 x 10
7
 
live S. zooepidemicus in 1 mL sterile 
phosphate-buffered saline (low STREP; n=3), 5.1 x 10
8
 live S. zooepidemicus in 1 mL (high 
STREP; n=2), 1 x 10
7
 
heat-killed S. zooepidemicus in 1 mL of PBS (KILLED STREP; n=3), or 1 
mL of PBS (PBS CONTROL; n=3). SHAM CONTROL mares (n=3) were sedated, restrained in 
the stocks, had the vaginal fornix and external os sampled for culture, but did not receive a 
transcervical inoculation. We were unable to instrument one of the high STREP mares with an 
allantoic catheter, but elected to inoculate the mare in order to provide tissue for expression 
analysis and histologic evaluation. 
3.2.3.3 Sample Collection and Patient Monitoring  
 Ultrasonography was performed daily following catheter placement to monitor the health 
of the fetoplacental unit. Fetal heart rate was evaluated daily with B/M-mode transabdominal 
ultrasonography using a 3.5 to 5.0-MHz sector-array transducer (SonoAce PICO, Medison Co., 
Ltd., Seoul, Korea). Transrectal evaluation of the combined uteroplacental thickness (CTUP) at 
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Table 3.1 Pre- and post-operative methods, type of delivery, and presence of inflammation at the 
catheter site from mares (n=14) in an experimental model of ascending placentitis. The allantoic 
space was catheterized laparoscopically between 265-280 days gestation: SHAM mares (n=3) 
received no transcervical procedure; PBS Control mares (n=3) received 1 mL sterile PBS 
transcervically; KILLED STREP (n=3) received 10
7
 heat-killed Streptococcus zooepidemicus 
transcervically; low STREP mares (n=3) received 10
7
 S. zooepidemicus transcervically; and high 
STREP mares (n=1) received 5.1 x 10
8




Group A: Single Huber sampling; spontaneous abortion 
2




 Indwelling Huber sampling; spontaneous abortion; flank preparation 24 h pre-
operatively 
4
Group D Indwelling Huber sampling; induced delivery day 8; flank preparation 24 h pre-
operatively 
5
Not identified at necropsy 
6
Placentitis extended from the cervical star region cranially to encompass the catheter site 







SHAM treatment group 
25 A
1
 induced 0   
847 B
2
 abortion 2+   
762 D
4
 induced 0   
PBS treatment group 
790 A abortion 1+   
781 B abortion NA
5
   
22SG D induced NA   
KILLED STREP 
682 B abortion 2+   
416 C
3
 abortion NA   
12SG D induced NA   
low STREP 
20 A abortion 2+   
12 C abortion 2+   
24SG D induced 0   
high STREP 
23 D abortion 3+
6
   
42 no catheter abortion NA   
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 the internal cervical os was examined daily using a 5.0 to 7.5-MHz linear-array scanner. Six mL 
of fetal fluid for soluble cytokine and prostaglandin concentration determination, were collected 
at 0, 4, 8, 12, 16, 20, 24, 32, 40, and 48 h, and then daily until delivery or induction of 
parturition. An additional 5 mL was collected at 24 h intervals for progestagen and cortisol 
analysis. Catheters were removed either immediately prior to induced delivery, or immediately 
after spontaneous delivery. 
Fetal fluid samples were collected and immediately placed on ice for transport to the 
laboratory. Prior to centrifugation, 1 mL was removed for culture, biochemical profile, and 
cytologic evaluation. The presence of neutrophils, with or without intracellular and extracellular 
bacteria, was defined as cytologic inflammation. The remainder of the sample was centrifuged at 
2,000 x g for 15 min at 4ºC, and the supernatant aliquoted into one-mL units. Samples for future 
analysis were stored at -70ºC. All samples were evaluated for the presence of bacteria by 
incubating 100 μL on a blood agar plate at 37ºC for 48 h. If bacteria were recovered, the 
Louisiana Veterinary Medical Diagnostic Laboratory identified all isolates using standard 
microbiological techniques. Any isolate determined to be S. zooepidemicus was characterized by 
pulsed-field gel electrophoresis. Maternal blood was collected into heparin once daily and 
plasma stored at -70ºC until assayed for future cortisol and progestagens determination. 
At delivery of the fetus, chorioallantoic tissue was collected from the region of the 
cervical star, any grossly abnormal areas, the catheter site (if identifiable), and from one normal 
area located at least 10 cm from any grossly abnormal areas. Tissue was also collected from the 
amnion, umbilical cord, fetal lung, and fetal liver. The gender of the fetus, crown rump length, 
and placental and fetal weights were recorded. Contents from the fetal lung and stomach were 
submitted for aerobic bacterial culture. All tissues were fixed in formalin, paraffin embedded, 
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stained using hematoxylin and eosin, and evaluated by a pathologist. From each site of the 
chorioallantois sampled for histopathology, three 0.2-g pieces of tissue were placed in 2 mL of 
RNA stabilization reagent (RNAlater, Qiagen Inc., Valencia, CA) and stored at -20
○
C for later 
analysis of cytokine expression. 
3.2.4 Induction of Parturition  
 Two mares from the SHAM CONTROL group, one mare from the PBS CONTROL 
group, one mare from the KILLED STREP group and one mare from the low STREP group were 
induced to deliver fetuses to provide gestational age-matched placental and fetal tissue, and 
control for the variability from inoculation to delivery. Parturition was induced by insertion of a 
1000-µg alprostadil suppository (MUSE, Vivus, Inc., Mountain View, CA) to achieve cervical 
dilation [247]. Two h after alprostadil administration, mares were treated with 5 mg of dinoprost 
tromethamine, im (Lutalyse, Pfizer, New York, NY) followed one hour later by oxytocin (10 IU, 
iv), repeated as needed until delivery. Any fetuses alive at delivery were humanely euthanized 
with an overdose of barbiturate (100 mg/kg, iv). 
3.2.5 Differentiation of Isolates by Pulsed-Field Gel Electrophoresis 
 Any streptococcal isolate determined to be S. zooepidemicus from chorioallantois, 
allantoic fluid, fetal stomach and lung contents was differentiated by pulsed-field gel 
electrophoresis to determine if it originated from the inoculum or from a contaminant source. 
Each isolate was grown on brain heart infusion agar overnight at 37°C. Cells were harvested, 
resuspended in a cell suspension buffer and the cell suspension added to a 1% agarose solution 
(SeaKem Gold Agarose, BioWhittaker Molecular Applications, Rockland ME) in TE buffer (10 
mM Tris-HCl, 1 mM EDTA, pH 8.0) at 55°C. The cell/agarose suspension was pipetted into 
disposable agarose gel plug molds, and allowed to solidify. Each plug was incubated in two 
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different cell wall lysis solutions: one containing lysozyme for 2 h, the second containing 
proteinase overnight. Following removal of the cell lysis solution each plug was washed twice in 
sterile reagent grade water, and then washed 4 times in TE buffer. Plugs were stored in fresh TE 
buffer at 4°C. For restriction endonuclease digestion, a 2-mm wide slice of each plug was placed 
in commercial buffer containing 40 units of Sma1 restriction endonuclease (New England 
Biolabs, Beverly, MA). Digestion took place over a 16-hour incubation period at 25°C and plugs 
were stored in TE buffer for up to 14 d at 4°C. 
In situ digested genomic DNA-containing plugs was adhered to gel comb teeth, using a 
drop of warm 1% agarose solution in 0.5 X TBE buffer (45 mM Tris-HCl, 45 mM borate, 1.0 
mM EDTA, pH 8.0). A 1 % agarose gel in 0.5 X TBE was poured around the comb and allowed 
to solidify. The comb was removed and the gel placed in a pulsed-field gel electrophoresis cell 
(Chef Dr-II, Bio-Rad Laboratories, Hercules, CA) with 0.5 X TBE as the running buffer. The 
running buffer was maintained at 14°C using an external cooling module (Chef Dr-II, Colling 
Module, Bio-Rad Laboratories, Hercules, CA). Following electrophoresis, the gel was stained 
with aqueous ethidium bromide solution and destained twice in distilled water. The gel was 
transilluminated with ultraviolet radiation (302 nm) and the image recorded digitally 
(ChemiImager 4400, Alpha Innotech Corp., San Leandro, CA). 
3.2.6 Statistical Analysis 
 Because of the small samples sizes within treatment group, effect of treatment group on 
the response to inoculation was not possible. The effect of infection (positive fetal fluid culture), 
type of delivery (spontaneous abortion or induced delivery), and fluid characterization (allantoic 
or admixture) on various parameters was compared by a Student’s t test, using a statistical 
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analysis software program (SAS 9.1, Cary, NC) with significance set at p<0.05, including 
Satterthwaite’s  and Cochran’s methods for sample populations with unequal variances. 
3.3 Results 
3.3.1 Response of the Fetoplacental Unit to Inoculation 
The individual daily CTUP measurements and FHRs are shown in Table 3.2, and Figures 3.1 and 
3.2. Small sample size precluded analysis of effect of treatment group on CTUP. Mares with 
spontaneous abortion had significantly increased (p=0.038) CTUP compared to mares in which 
delivery was induced (Figure 3.4A). There was not a significant effect of infection within the 
allantoic space on CTUP (p=0.11). Two mares (one SHAM CONTROL and one KILLED 
STREP mare) had significant edema of the chorioallantois, but no infection of fetal fluids and no 
histologic inflammation of the chorioallantois. One mare in the PBS CONTROL group had 
infected fetal fluids, minimal inflammatory changes of the chorioallantois, and aborted within 
four d of instrumentation; contamination of the allantoic fluid likely occurred at the time of 
laparoscopy. Removal of these three mares from analysis resulted in mares with allantoic 
infection having increased CTUP approaching significance (p=0.051; Figure 3.5B).  There was 
no significant effect of fluid characterization (allantoic or admixture) on CTUP (p=0.23; Figure 
3.6). There was no difference in FHR with infection or type of delivery. In only one instance (a 
mare in the high STREP group) was in utero fetal death documented during a daily exam. This 
mare aborted two hours following examination. Measurement of FHR was not possible in one 
mare in the KILLED STREP group (#416) due to excessive fetal motion. 
3.3.2 Microbiology and Cytology 
The results of microbiological and cytological evaluation of allantoic fluid samples from thirteen 
mares are presented in Table 3.3. Bacterial tracking along the catheter system was a 
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Table 3.2 Daily individual combined thickness of uterus and placenta (CTUP) and fetal heart 












     25 1/26/2005 0 120 4 
  25 1/27/2005 1 88 3.9 
  25 1/28/2005 2 124 4.3 
  25 1/29/2005 3 132 4 
  25 1/30/2005 4 132 4.2 
  25 1/31/2005 5 136 4.8 
  25 2/4/2005 9 113 4.4 
  25 2/14/2005 19 
   
induction 
       847 3/21/2005 0 88 4 4 
 847 3/22/2005 1 112 4.4 4,4 
 847 3/23/2005 2 120 4.2 4.2 
 847 3/24/2005 3 122 4 4 
 847 3/25/2005 4 110 5.8 5.8 
 847 3/26/2005 5 80 4.8 11 
 847 3/27/2005 6 
 
5.6 12 
 847 3/28/2005 7 100 5.68 8.5 
 847 3/29/2005 8 99 5.6 8.1 
 847 3/30/2005 9 128 5.5 14 
 847 3/31/2005 10 122 5.1 14 
 847 4/1/2005 11 130 7.1 25 
 847 4/2/2005 12 111 14.7 22.6 
 847 4/3/2005 13 
   
abortion 
       762 5/26/2005 0 118 5.5 
  762 5/26/2005 -D4 
    762 5/27/2005  -D3 
    762 5/30/2005 0 115 6.5 
  762 5/31/2005 1 99 7 
  762 6/1/2005 2 120 7 
  762 6/2/2005 3 106 10 
  762 6/3/2005 4 93 9 
  762 6/4/2005 5 106 9 
  762 6/5/2005 6 107 9.5 
  762 6/6/2005 7 111 9.5 















PBS Control Mares          
790 2/23/2005 0 102 5 
 
 
790 2/24/2005 1 114 4.9 
 
 
790 2/25/2005 2 113 4.3 
 
 
790 2/26/2005 3 89 4 
 
 





790 2/28/2005 5 ? ? 
 
 
790 3/2/2005 7 
   
abortion 
     
 
781 3/23/2005 0 107 4 
 
 
781 3/24/2005 1 99 5.4 
 
 
781 3/25/2005 2 92 5 
 
 
781 3/26/2005 3 73 5.9 
 
 
781 3/27/2005 4 
   
abortion 
      
 
22SG 6/14/2005 0 102 4.9 
 
 





22SG 6/16/2005 2 71 4 
 
 
22SG 6/17/2005 3 88 4.4 
 
 
22SG 6/18/2005 4 96 4.5 
 
 
22SG 6/19/2005 5 95 4.9 
 
 





22SG 6/21/2005 7 85 5.9 
 
 
22SG 6/22/2005 8 96 5.1 
 
induction 
















Killed STREP mares 
682 3/24/2005 0 118 4 6.5 
 682 3/25/2005 1 98 6.6 6.6 
 682 3/26/2005 2 89 6 6 
 682 3/27/2005 3 95 6.7 6.7 
 682 3/28/2005 4 97 6.4 6.4 
 682 3/29/2005 5 99 9.30 15.6 
 682 3/30/2005 6 102 6.1 14 
 682 3/31/2005 7 96 6 17 
 682 4/1/2005 8 98 6.8 15 
 682 4/2/2005 9 90 7.3 15.5 
 682 4/3/2005 10 96 7.2 12 
 682 4/4/2005 11 
   
abortion 
       416 3/30/2005 0 (active)* ? 4.5 
 416 3/31/2005 1 (active)* 4.5 10.2 
 416 4/1/2005 2 (active)* 4.4 10.4 
 416 4/2/2005 3 (active)* 6.3 15.4 
 416 4/3/2005 4 (active)* 6.1 15.8 
 
416 4/4/2005 5 
(no 
activity) 5.9 
  416 4/5/2005 6 
   
abortion 
       12SG 6/22/2005 0 
 
? 
  12SG 6/23/2005 1 126 5.6 
  12SG 6/24/2005 2 109 6.6 
  12SG 6/25/2005 3 119 5.7 
  12SG 6/26/2005 4 104 6 
  12SG 6/27/2005 5 110 6 
  12SG 6/28/2005 6 113 6 
  12SG 6/29/2005 7 99 6.1 
  12SG 6/30/2005 8 100 6.5   induction 
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low STREP mares           
20 2/28/2005 0 106 4.1 
  20 3/1/2005 1 97 4.9 
  20 3/2/2005 2 107 6.5 
  20 3/3/2005 3 82 6.6 
  20 3/4/2005 4 115 6.9 
  20 3/5/2005 5 123 5.5 
  20 3/6/2005 6 115 6.1 
  20 3/7/2008 7 
    20 3/8/2005 8 87 5.1 
  20 3/9/2005 9 62 11.1 
  20 3/10/2005 10 73 10.1 
  20 3/11/2005 11 
   
abortion 
       12 3/28/2005 0 91 5 5 
 12 3/29/2005 1 91 6.5 8.1 
 12 3/30/2005 2 
    12 3/31/2005 3 95 6.3 15 
 12 4/1/2005 4 97 6.2 18.1 
 12 4/2/2005 5 107 5.7 16.3 
 12 4/3/2005 6 107 5.5 9.7 
 12 4/4/2005 7 88 5.8 14.6 
 12 4/5/2005 8 
 
6.5 15.5 
 12 4/6/2005 9 91 4.5 11.1 
 12 4/7/2005 10 95 6.4 15.9 
 12 4/8/2005 11 
    12 4/9/2005 12 77 6 21.3 
 12 4/10/2005 13 95 5.6 12 
 12 4/11/2005 14 91 6.8 12 
 12 4/13/2005 16 88 6.3 16 
 12 4/14/2005 17 87 7.4 16 















low STREP Mares     
24SG 7/6/2005 0 106 5.3 
  24SG 7/7/2005 1 106 5.5 
  24SG 7/8/2005 2 111 5.7 
  24SG 7/9/2005 3 91 5 
  24SG 7/10/2005 4 104 5.9 
  24SG 7/11/2005 5 98 5.9 
  24SG 7/12/2005 6 87 6 
  24SG 7/13/2005 7 92 5.9 
  24SG 7/14/2005 8 84 ? 
 
induction 
       high STREP Mares 
     23 8/25/2006 0 78 4.5 
  23 8/26/2006 1 98 14.5 
  23 8/27/2006 2 78 17.5 
  23 8/28/2006 3 101 20.8 
  23 8/29/2006 4 76 24.7 
  23 8/30/2006 5 79 30.5 
  23 8/31/2006 6 79 26.9 
  23 9/1/2006 7 78 36.4 
  23 9/2/2006 8 72 48.9 
  23 9/3/2006 9 64 48.2 
  23 9/4/2006 10 91 54.8 











Figure 3.1 Ultrasonographic images from a mare following transcervical inoculation with 5.1 x 
10
8
 CFU/mL S. zooepidemicus. Inoculation is Day 0. Note the progressive widening of the 
combined thickness of the uterus and placenta (CTUP), separation of the chorioallantois from the 







Figure 3.2 Combined thickness of uterus and placenta (CTUP) from mares (n=13) in an 
experimental model of placentitis. The allantoic space was catheterized laparoscopically between 
265-280 days gestation. Day 0 was day of inoculation. SHAM mares (n=3) received no 
transcervical procedure; PBS Control mares (n=3) received 1 mL sterile PBS transcervically; 
KILLED STREP (n=3) received 1 x 10
7
 heat-killed Streptococcus zooepidemicus transcervically; 
low STREP mares (n=3) received 1 x 10
7
 S. zooepidemicus transcervically; and high STREP 
mares (n=1) received 5.1 x 10
8
 S. zooepidemicus transcervically. Measurements were performed 
with a 5 to 7.5-MHz linear transducer, and were obtained from the caudal uterine segment, 







Figure 3.3 Fetal heart rates (FHR) from mares (n=12) in an experimental model of placentitis. 
The allantoic space was catheterized laparoscopically between 265-280 days gestation. Day 0 
was day of inoculation. SHAM mares (n=3) received no transcervical procedure; PBS Control 
mares (n=3) received 1 mL sterile PBS transcervically; KILLED STREP (n=3) received 1 x 10
7
 
heat-killed Streptococcus zooepidemicus transcervically; low STREP mares (n=3) received 1 x 
10
7
 S. zooepidemicus transcervically; and high STREP mares (n=1) received 5.1 x 10
8
 S. 
zooepidemicus transcervically. Measurements were performed with a 5 to 7.5-MHz linear 





Figure 3.4 Relationship between type of delivery and the combined thickness of the uterus and 
placenta (CTUP) within 24 h of delivery in an experimental model of placentitis for mares with 
induced delivery (n=5) and mares with spontaneous abortion (n=7). CTUP was significantly 
greater (p=0.038) in mares with spontaneous abortion. 
 
 
considerable problem. Use of an indwelling Huber needle for sample collection and clipping and 
sterile preparation of the skin 24 h prior to laparoscopy were associated with a reduction in 
bacterial tracking. Comparing the bacterial isolates with the histologic inflammatory changes at 
both the cervical star and catheter site made it possible to determine the source of infection. 
Streptococcus zooepidemicus was not isolated from any fetal fluid or fetal samples from SHAM 
CONTROL, PBS CONTROL, or KILLED STREP mares; however, five of nine mares in these 
groups became infected with bacteria via the catheter system. Streptococcus zooepidemicus was 
recovered from only one of three mares in the low STREP; one mare had Staphylococcus spp, 
and the other mare had no growth. Evidence of inflammation preceded the recovery of bacteria 
in one instance, was on the same day of bacterial recovery in three instances, and in one instance 








Figure 3.5 Relationship between infection of the fetal fluids and the combined thickness of the 
uterus and placenta (CTUP) within 24 h of delivery in an experimental model of placentitis.  (A) 
No significant effect between infected mares  (n=6) and uninfected mares (n=6) on CTUP 
including all mares (p=0.11); (B) removal of mares #416, #762, #781 results in infection (n=5) 





Figure 3.6 Relationship between characterization of the fetal fluid and the combined thickness of 
the uterus and placenta in an experimental model of placentitis.  No significant effect of allantoic 
fluid (n=7) and admixed fluid (n=5) was observed (p=0.23). 
 
3.3.3 Histopathology  
 The results of histologic evaluation of the individual fetal membranes and fetal tissue 
from fourteen mares are presented in Appendix: Histopathology of placental and fetal tissue. 
3.3.3.1 Changes at the Cervical Star 
The predominant histologic change at the cervical star in mares in the SHAM 
CONTORL, PBS CONTROL, and KILLED STREP groups was of edema (four of nine mares); 
two of these mares spontaneously aborted, two had induced deliveries. Inflammatory changes at 
the cervical star in mares not receiving a live inoculum were classified as mild in one of the 
SHAM mares (#25) and two of the PBS mares (#790, #781), and none of the KILLED STREP 
mares. In mares receiving a live inoculum, chronic necrotizing placentitis of the cervical star was 
present in three of five mares (#20, #23, #42), with extensive cranial extension from the cervical 




Table 3.3 Cytologic findings and culture results of fetal fluid samples from mares (n=13) in an experimental model of placentitis. The 
allantoic space was catheterized laparoscopically between 265-280 days gestation. Day 0 was the day of inoculation. SHAM mares 
(n=3) received no transcervical procedure; PBS Control mares (n=3) received 1 mL sterile PBS transcervically; KILLED STREP 
(n=3) received 1 x 10
7
 heat-killed Streptococcus zooepidemicus transcervically; low STREP mares (n=3) received 1 x 10
7
 S. 
zooepidemicus transcervically; and high STREP mares (n=1) received 5.1 x 10
8
 S. zooepidemicus transcervically. 
  Day of   Inflammatory changes  
Mare 
ID 










Catheter site Bacterial isolate 
SHAM Control Mares 
25 Admix 9 None 19 induced 1+  0 No growth 
847 Allantoic 5 4 13 abortion 0 (necrosis) 2+ Staphylococcus aureus 
762 Allantoic None None 8 induced 0 (edema) 0 (edema) No growth 







 7 abortion 0 (edema) 1+ Corynebacterium spp. (fetus) 
781 Allantoic 3 3 4 abortion 1+ Not identified Staphylococcus spp. (coagulase +) 
22SG Allantoic None none 8 induced 0 (edema)  Not identified No growth
3
 
KILLED STREP Mares 
682 Allantoic 10 10 11 abortion 0 2+ Staphylococcus aureus 
416 Admix None None 6 abortion 0 (edema) Not identified No growth 










 11 abortion 2+ 2+ S. zooepidemicus
6
, R. equi 
12 Allantoic 17 17 18 abortion 0 (edema) 2+ Staphylococcus spp. 
24SG Admix None None 8 induced 0 (edema)  0 (edema) No growth 
High STREP Mares 






Pulled out at 40 h, not re-catheterized; positive cytology of peritoneal fluid. 
2
Pulled out at 24 h, re-catheterized 10 d after first surgery. 
3
S. zooepidemicus isolated from cervix prior to induction (not inoculum strain), allantoic fluid no growth. 
4
S. equisimilis isolated from cervix pre-induction, fetal lung, fetal stomach; E. coli isolated from fetal lung, fetal stomach. 
5
Inflammatory lesions from cervical star extended cranially to encompass the catheter site. 
6
S. zooepidemicus isolate identical to inoculum (confirmed by pulsed-field gel electrophoresis)
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 (#23). Because only S. zooepidemicus was recovered from the fetus and from fetal fluids in this 
mare, the change at the catheter site was presumed to be extension from an ascending placentitis. 
Edematous changes only were present in the remaining two low STREP mares (#12, #24SG). 
3.3.3.2 Changes at the Catheter Site 
 The catheter site was identified at necropsy in 9 of the 13 catheterized mares. 
Inflammatory changes at the catheter site were present in five of these mares and extended from 
the cervical star to encompass the catheter site one of the high STREP mares (#23). Excluding 
the mare with cranial extension of ascending placentitis, the affected area of the chorioallantois 
ranged from 7 cm
2
 to 75 cm
2
. The pattern varied from subacute placentitis to chronic necrotizing 
placentitis. Two mares had chronic reactive placental changes with no inflammation, three mares 
had edema, one mare had infarction with transmural necrosis, and one mare had focal fibrotic 
changes. The non-inflammatory changes were seen either singly or in combination with other 
non-inflammatory changes. 
3.3.3.3 Changes in the Umbilical Cord 
 Inflammation of the umbilical cord (funicitis) was present in 7 of the 14 mares (two 
SHAM CONTROL mares, three PBS CONTROL mares, one low STREP mare, and one high 
STREP mare), six of which had positive cultures of the fetus and fetal fluids, and three of which 
received a live inoculum (two low STREP and one high STREP). One of the PBS CONTROL 
mares had mild cord hemorrhage, and the remainder of the mares had no inflammatory changes. 
3.3.3.4 Fetal Pneumonia 
 In mares not receiving a live inoculum (SHAM CONTROL, PBS CONTROL, and 
KILLED STREP groups), fetal pneumonia was present in three of the nine fetuses, no changes 
were present in three fetuses, and one fetus had bacteria with minimal inflammation (PBS 
CONTROL group). In the five mares receiving a live inoculum, pneumonia was present in two 
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fetuses, autolysis with bacteria was present in two fetuses, and no changes were present in the 
remaining fetus. Four of the five fetuses with pneumonia had a positive culture of the fetal lungs 
and fetal fluids, one fetus (KILLED STREP group) had mild fibrinous pneumonia with negative 
cultures. Bacteria were present with either minimal inflammation once (PBS CONTROL) or 
with autolysis on two occasions (high STREP group); in all three instances positive cultures were 
obtained from both fetal lung and fetal fluids.  
3.4 Discussion 
 Initiation of placentitis was attempted by inoculation with either heat-killed or live S. 
zooepidemicus in pony mares instrumented with allantoic catheters between 260 and 285 d of 
gestation. Despite visualization of the pipette tip at the surface of the chorioallantois during 
inoculation, an ascending placentitis subsequent to a single inoculum with live S. zooepidemicus 
was only established in two of four animals.  No animals receiving heat-killed bacteria or sterile 
PBS developed an ascending placentitis due to the introduction of vaginal microflora.  Two 
possible reasons for a failure to establish infection of the chorioallantois are incomplete 
deposition of inocula and the dose of inoculum. In 2005, inoculations were performed with a 
double-lumen low-dose insemination pipette, in which seating of the inner catheter within the 
inner lumen is essential for complete delivery of the desired fluid. It is likely that failure to seat 
the two catheters tightly together allowed all or part of the inoculum to escape within the inner 
lumen of the outer catheter. In 2006, a single-lumen low-dose insemination pipette was used and 
an ascending placentitis was successfully induced in all mares receiving a live inoculum, with a 
consistent interval from inoculation to abortion. We considered the possibility that 1 x 10
7
 CFU 
of S. zooepidemicus was not sufficient to establish an infection. During the winter of 2005 to 
2006, three un-instrumented mares were inoculated with 1 x 10
10
 live S. zooepidemicus in a 2-
mL volume, using the single lumen catheter. All three mares aborted, one less than 48 h, one less 
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than 72 h, and one 7 d post-inoculation. Based on these findings, the dose of 5.1 x 10
8
 live S. 
zooepidemicus was chosen for further investigations. 
 We were unable to initiate an inflammatory response with heat-killed S. zooepidemicus. 
Whether this was due to the type of pipette used (all mares were inoculated in 2005) or that heat-
killed S. zooepidemicus produces negligible inflammation of the chorioallantois cannot be 
determined from this study. During the winter of 2005 to 2006 inoculation of a single un-
instrumented mare with 1 x 10
10
 heat-killed S. zooepidemicus produced a transient mild edema of 
the chorioallantois of less than 48 h of duration, but abortion failed to occur. This pregnancy 
continued without complication until delivery at term. Further development of a non-infectious 
inflammatory model may be useful in evaluating potential anti-inflammatory therapeutics for 
ascending placentitis. 
The presence of neutrophils in fetal fluids was associated with a positive bacterial culture, 
and was usually present on the first day of a positive culture. In instances where fetal fluid was 
available for evaluation within 24 h of abortion, abortion was preceded by a positive culture of 
fetal fluid by 24 h or less except for one of the SHAM CONTROL mares. Small sample sizes 
and bacterial tracking along the catheter system (Chapter 2) produced considerable confounding 
effects, making comparison among treatment groups not possible. Therefore the effects of 
infection of the fetal fluid, characterization of fetal fluid, and abortion on the CTUP were 
compared. Mares spontaneously aborting had significantly increased CTUP compared to mares 
in which delivery was induced; however, there was not a significant effect of the presence of 
infection on the CTUP. This later finding was somewhat surprising; however, three mares had 
measurements considerably different from the other mares within their respective category. One 
of the KILLED STREP mares and one of the SHAM CONTROL mares had significantly 
increased CTUPs and placental edema but did not have intrauterine infection or histologic 
94 
 
inflammation at the cervical star; both mares spontaneously aborted. Edema is associated with 
impending term delivery [248]. It is unknown what initiated labor in these mares.  One of the 
PBS CONTROL mares had intrauterine infection, but no histologic changes at the cervical star; 
based on the interval from catheter placement to abortion in this mare (less than 96 h), bacterial 
introduction presumably occurred at the time of surgery. When these mares were excluded from 
analysis, mares with infected fetal fluid tended to have an increased CTUP.  These findings are 
in agreement with experimentally induced streptococcal placentitis [249] and clinical 
observations of  mares with naturally occurring ascending placentitis [244]. Our findings also 
emphasize that increases in CTUP of the chorioallantois may signal impending abortion, but that 
the abortion is not necessarily due to in utero infection. Increased CTUP due to edema, but 
without concurrent separation of the chorioallantois from the endometrium and accumulation of 
exudate warrants careful monitoring, but antimicrobial therapy may not be indicated. 
 Chronic necrotizing placentitis was the most common histologic description in mares 
with an ascending infection of the chorioallantois; and, similar to a previous report [250], 
funicitis was associated with infection of the fetal fluids. A surprising finding was the 
inconsistent presence of fetal pneumonia in response to bacteria within the lung with in utero 
infection. While the interpretation by the pathologist was bacterial overgrowth presumed to be 
post-mortem contamination; this was not the case. In all of these instances, fetal fluids were 
culture positive prior to abortion; identical isolates were recovered from fetal fluid and fetal lung. 
Whether this finding represents a peracute fetal infection and death prior to the initiation of an 
inflammatory response, or the failure of the fetus to mount an immunologic response to infection 
is unknown. In two of the fetuses with bacteria and no pneumonia, there was no increase in fetal 
fluid cortisol (Chapter 6), so an incompetent immunologic response is possible.  
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 Clearly this study was hampered by small samples sizes and bacterial contamination due 
to bacterial tracking along the catheter system. Our original study design included sample sizes 
of six in each treatment group; however, we were forced to conclude the study with the animals 
presented herein. Although the intent was to produce a model of ascending placentitis in mares 
inoculated with S. zooepidemicus, comparison of variables from groups with in utero infection to 
those without infection may provide valuable information.  Despite these limitations, useful 
descriptive data was obtained, and the acquisition of fetal fluids for measurement of soluble 







THE POTENTIAL ROLE OF CYTOKINES IN AN EXPERIMENTAL 
MODEL OF INFECTIVE PRE-TERM DELIVERY IN THE MARE 
 
4.1 Introduction 
 Intrauterine infection resulting from ascension of bacteria through the cervix with 
invasion of the chorioamnion and deciduas (maternal endometrium at the site of placental 
attachment) is a significant cause of pre-term delivery (PTD) in women [221] as it is in the mare. 
A wide variety of animal models have been described to investigate the mechanisms of PTDs 
[251]; but direct comparisons between models are hampered by differences in species used, 
agent used to initiate PTD, and route of inoculation/administration. In most species studied, an 
increase in pro-inflammatory cytokines has been detected in fetal fluids in response to 
inflammation or infection [223-229]. Non-infectious models for preterm delivery typically use 
lipopolysaccharide (LPS) administered into the maternal circulation [230], the maternal 
peritoneal space [231,232], or the uterus [233] to cause pregnancy loss. Intraamniotic, but not 
maternal, administration of LPS to sheep at approximately 80% gestation resulted in increases in 
amniotic and fetal IL-6 concentrations but no premature labor despite increased uterine activity, 
though there was a considerable degree of variability and the sample sizes were small [228]. 
Intraamniotic inoculation of group B streptococci in instrumented (fetal artery and vein, amniotic 
pressure catheter, myometrial EMG electrodes, maternal artery and vein) rhesus macques at 77% 
gestation produced increases in the amniotic concentrations of TNF-α, IL-1β, and IL-6 as early 
as 9 h following inoculation. PGE2 and PGF2α concentrations paralleled the increases in 




 While intraamniotic inoculation may provide a greater uniformity of response due to 
precise deposition of the inflammatory agent, it does not reproduce what happens during the 
course of natural infection, namely ascension through the cervical canal. Other models have 
attempted to mimic natural infection by intracervical inoculation.  Intracervical inoculation of 
rabbit does at 70% gestation with E. coli also produced increased concentrations of TNF-α, IL-β, 
and IL-6, and PGE2 and PGF2α in amniotic fluid as early as four  h after inoculation [223]. 
Similarly, intracervical deposition of either LPS or E. coli in wild-type or IL-1β -/- mice 
produced increases in amniotic TNF-α, IL-β, and IL-6 and premature delivery in 92% (E. coli) to 
100% (LPS) of mice. Although decreased cytokine was observed in IL-1β -/- mice, pregnancy 
loss was the same [226]. 
 One of the proposed mechanisms of infection-induced PTD is that pro-inflammatory 
cytokines (IL-1, IL-6, TNF-α) from the deciduas and cortisol from the mother cause activation of 
the fetal hypothalamic-pituitary-adrenal axis, causing an increase of fetal cortisol [48]. Increased 
fetal cortisol, either at term or in response to pro-inflammatory cytokines, decreases 
concentrations of PGDH, an enzyme responsible for inactivation of PGE2 and PGF2 , leading to 
increased PGE2 and PGF2  and subsequent myometrial contractions. Pro-inflammatory cytokines 
also increase the activity of another key enzyme, prostaglandin H2 synthase (PGHS-2 or COX-
2), which increases prostaglandin synthesis. The decrease in PGDH and increase in PGHS-2 
leads to increased PGE2 and PGF2  synthesis, myometrial contractions and premature labor 
[227,234,235,252]. 
 One model examining the relationship between inflammatory cytokines and ascending 





 CFU of S. zooepidemicus in mares between 283 and 291 d of gestation. 
98 
 
No differences were detected in the activities of TNF-α, IL-1, and IL-6 between groups over 
time. Placental IL-6 and IL-8 mRNA were higher at the cervical star and IL-6 mRNA was higher 
in the placental body of inoculated mares compared to term-delivery control mares. Based on the 
expression data it was hypothesized that bacterial infection causes increased expression of pro-
inflammatory cytokines leading to the release of PGE2 and PGF2α into the allantoic fluid 
resulting in premature labor.  
 The failure to demonstrate an increase in the concentrations of pro-inflammatory 
cytokines in equine fetal fluids following bacterial infection differs from results from rabbits, 
monkeys, women, sheep, and mice [223-226,228]. Variability in response to inoculation 
[168,227], histologic characterization of placentitis, dose of inoculum, and site of inoculation 
may have contributed to the failure to detect increased concentrations of pro-inflammatory 
cytokines in fetal fluids. Failure to detect soluble cytokines in the allantoic fluid may have also 
been due to sampling intervals that were too infrequent to detect changes in cytokine 
concentrations. Amniotic concentrations of TNF-α, IL-1α, and IL-1β were elevated within four h 
of transcervical inoculation of pregnant rabbits with E. coli [223]. In pregnant ewes, the 
concentration of IL-6 in amniotic fluid peaked between four to six h following administration of 
LPS and had begun to decrease by 24 h [228], making it conceivable that changes in cytokine 
levels were missed in the equine study [237]. Other potential sources of variability were the 
presence of allantoic catheters in some, but not all, of the mares; and repeated ultrasound-guided 
allantocentesis to obtain fluid from mares without catheters or those with non-patent catheters. 
Biochemical characterization for creatinine, chloride, sodium, and calcium of fetal fluids to 
determine its origin [239,240] was not performed; therefore, the nature of fetal fluid may have 
affected differences between groups.   
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 The temporal relationship between increases in allantoic cytokines and prostaglandins is 
quite important. If the synthesis of PGF2α and PGE2 is driven by cytokines in concert with fetal 
cortisol, as has been suggested in a model of ascending placentitis [48], then a therapeutic regime 
that is unsuccessful in interrupting the signaling of cytokines and prostaglandins will fail to 
prevent the onset of labor. The hypothesis was that the concentration of soluble TNF-α in fetal 
fluids and the expression of pro-inflammatory cytokines in chorioallantoic tissue would be 
increased in mares with in utero infection or spontaneous abortion.  
4.2 Material and Methods 
4.2.1 Experimental Animals, Instrumentation, and Inoculation 
 Animal care, instrumentation, and inoculation were as previously described (Chapter 3). 
Briefly, indwelling allantoic catheters were placed laparoscopically in 13 adult pony mares 
between 260 and 285 d of gestation.  All procedures were in accordance with Louisiana State 
University’s Institutional Animal Care and Use Committee’s guidelines for the humane 
treatment of research animals. Mares received either 1 x 10
7
 CFU live S. zooepidemicus (n=3), 
5.1 x 10
8
 CFU live S. zooepidemicus (n=1), 1 x 10
7
 heat-killed S. zooepidemicus (n=3), 1 mL 
sterile PBS (n=3).  Sham conrol mares did not receive a transcervical inoculation (n=3). One 
mare received 5.1 x 10
8
 CFU live S. zooepidemicus but was not instrumented with an allantoic 
catheter. Two sham control mares, one PBS control mare, one killed-Strep mare and one low-
dose Strep mare were induced to deliver fetuses as previously described (Chapter 3) to provide 
gestational age-matched placental and fetal tissue, and control for the variability from 
inoculation to delivery. Preparation of the inocula, transcervical inoculations, patient monitoring, 
and sample collection were performed as previously described (Chapter 3).  Five mL of fetal 
fluid was collected at 0, 4, 8, 12, 16, 20, 24, 32, 40, 48, h and then daily until spontaneous 
delivery or induction of parturition. Fetal fluid samples were collected and immediately placed 
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on ice for transport to the laboratory, centrifuged at 2,000 x g for 15 minutes at 4
○
C, and the 
supernatant separated into 1-mL aliquots and stored at -70
○
C for future analysis. At delivery of 
the fetus, the chorioallantois was cleaned of debris with sterile saline, placed within a sterilized 
bag, and transported on ice to the laboratory for processing. Three 0.2-g pieces of tissue were 
collected from the region of the cervical star, any grossly abnormal area, the catheter site if 
identifiable, and from one normal area at least 10 cm from any grossly abnormal site, placed in 2 
mL (wt/vol ratio of 10%) of RNA stabilization reagent (RNAlater, Qiagen Inc., Valencia, CA), 
and stored at -20
○
C for later analysis of cytokine expression. 
4.2.2 TNF-α Enzyme-Linked ImmunoSorbant Assay 
 Concentrations of soluble TNF-α protein (TNFp) were determined using a commercially 
available equine-specific screening kit (Equine TNF-α Screening Set, Endogen®, Pierce 
Biotechnology, Rockford, IL) according to manufacturer’s instructions except for the following 
modifications. This assay has been validated for equine serum samples [253]. Preliminary data 
showed a reduction in the optical density by the presence of allantoic fluid, so a standard diluent 
with allantoic fluid from a sample collected at surgery (T-4SD) was prepared at a 1:100 dilution 
(vol/vol). The high standard (10,000 pg/mL) was diluted in T-4SD at a 1:40 dilution to provide 
the top standard in the assay at 250 pg/mL. Serial dilutions (1:2; vol/vol) were prepared so that 
the lowest value was 1.95 pg/mL. The same allantoic sample (T-4) was used to prepare T-4SD 
for all assays. Samples were diluted 1:100 in reagent diluents, and 100 µL of each sample was 
added to individual wells. Blocking and coating of 96-well plates was as directed by the 
manufacturer. Plates were incubated for 1 hr at room temperature, and all remaining steps were 
as directed by the manufacturer. Absorbance was read at A450 on a microplate spectrophotometer 
(Benchmark Plus, Bio-Rad Laboratories, Hercules, CA) and associated software (Microplate 
Manager 5.2, Bio-Rad Laboratories, Hercules, CA). For any samples with detectable values, 
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samples were re-evaluated at either a 1:2 or 1:10 dilution and serially diluted within the plate, 
with the upper and lower standards of the assay at 1000 and 7.8125 pg/mL, respectively. In order 
to efficiently delineate a potential relationship between time of infection and detection of TNFp, 
samples from two mares with, and two mares without, in utero infection were analyzed at the 
following time points: 0, 4, 8, 12, 16, 20, 48, 72, 96, and 120h, and 6, 7, and 8 d relative to 
inoculation. Based on these findings, samples from the remainder of mares were analyzed at the 
last four samples available prior to spontaneous abortion or induced delivery. 
4.2.3 Expression of Cytokines 
4.2.3.1 RNA Extraction 
RNeasy
®
 System – Approximately one-half of the tissue from a site was placed in 600 µL of RLT 
with β-mercaptoethanol (Qiagen, Inc., Valencia, CA), minced with a sterile blade, and placed in 
a snap-cap vial. The tissue was homogenized with a rotor-stator homogenizer (Power Gen 125, 
fisher Scientific, Hampton, NH) and a sterile generator probe (Power Gen disposable 7 x 
110mm, Fisher Scientific, Hampton, NH) while remaining in RLT buffer. The lysate was 
pipetted into a microcentrifuge shredder spin-column (QIAshredder, Qiagen, Valencia, CA), 
placed inside a 2-mL collection tube and centrifuged for 2 minutes at 8,000 x g. The spin-column 
was removed, the lysate centrifuged a second time for 3 minutes, and the resultant supernatant 
transferred to a new microcentrifuge tube. An equal volume of 70% ethanol was added to the 
lysate, mixed, and transferred to a spin-column (RNeasy spin-column, Qiagen Inc., Valencia, 
CA) in a 2-mL collection tube. Following centrifugation at 8,000 x g, the spin-column was 
removed and the flow-through discarded. The spin-column was washed three times by the 
addition of 500 µL of Buffer RPE (Qiagen, Valencia, CA) and centrifugation at 8000 x g for 2 
minutes removed any residual ethanol. The spin-column was placed in a new 2-mL collection 
tube and centrifuged at 8,000 x g for one minute. Finally, the spin-column was transferred to a 
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new 1.5-mL collection tube, and RNA eluted twice by the addition of 30 to 50 µL of RNase-free 
H2O, centrifuged at 8,000 x g, and stored at -80
○
C until needed for further assay. 
RNA-STAT Method – Approximately one-half of the tissue from a site was placed in 1000 µL of 
RNA stabilization reagent (RNA-STAT, Fisher Scientific, Hampton, NH), minced with a sterile 
blade, and placed in a 5-mL snap-cap vial. The tissue was homogenized with a rotor-stator 
homogenizer (Power Gen 125, Fisher Scientific, Hampton, NH) and a sterile generator probe 
(Power Gen disposable 7 x 110mm, Fisher Scientific, Hampton, NH) while remaining in 
stabilization reagent. After vortexing to further homogenize the sample, 200 µL of chloroform 
was added and mixed vigorously for 15-20 seconds. Samples were allowed to stand for 3 
minutes. Following centrifugation at 12,000 x g for 15 minutes at 4
○
C, the upper 400 µL of the 
aqueous layer was transferred to a new 1.5-mL centrifuge tube and 320 µL of isopropyl alcohol 
was added and pulse-vortexed. Samples were incubated at 20
○
C for a minimum of 30 minutes. 
Following centrifugation at 20,000 x g for 10 minutes at 4
○
C, the supernatant was decanted, the 
rim of the tube blotted, and 800 µL of 75% ethanol added to the pellet. Following vortexing, 
samples were centrifuged at 14,000 x g for 5 minutes at 4
○
C. The supernatant was carefully 
removed and discarded, and the tubes placed on their side to allow the pellets to dry while under 
the path of an air-flow hood for four to five minutes. A 60-µL volume of RNase-free water was 
added and the samples placed in a 60
○
C water bath for 10 minutes, pulse-vortexed, and stored at 
-80
○
C until needed for further assay. 
4.2.3.2 Reverse Transcription Reaction 
 The concentration of RNA was determined by measuring the absorbance at 260 nm, 
and the volume of sample containing a maximum of 1 µg of RNA was calculated. RNase-free 
water was added to each PCR sample to give a final volume of 41.5 µL. The Master Mix is 
provided in Table 4.1. To each PCR tube, 35.8 µL of Master Mix was added, pipetted repeatedly 
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to completely mix, and placed in a themocycler (Bio-Rad Laboratories, Hercules, CA) with 
reaction settings at 42
○
C for 15 minutes, 95
○
C for 5 minutes, and a 4
○
C holding time. Samples 




Table 4.1 Master Mix reaction components for reverse transcription reaction. 
Master Mix Each reaction Promega, Madison, WI 
AMV buffer (5X) 16 µL Supplied with PR-M9004 
MgCl2 (25 mM) 16 µL PR-A3511 
dNTP 4 µL PR-U1515 
RNAsin (40 U/µL) 1 µL PR-N2615 
AMV Rtase 0.5 µL PR-M9004 
Oligo dT15 primer (500 µg/mL 1 µL PR-C1101 
Total volume Master Mix per 
reaction 
38.5 µl  
 
4.2.3.3 Quantitative Real-Time PCR (qRT-PCR) 
 Quantitative RT-PCR was performed using a fast real-time detection system (7900HT 
Fast Real-Time PCR System, Applied Biosystems, Foster City, CA). Primer probe sets (Table 
4.2) for the detection of equine-specific IL-1β, IL-6, IL-8, IL-10, IL-15, IL-18, iNOS, MCP-1, 
TNF-α, TGF-β, and β-GUS were designed using a commercially available service (Assays-By-
Design, Applied Biosystems, Foster City, CA). The reaction in each well consisted of 5 µL of 
Taq (TaqNab Gene Expression Master Mix, Applied Biosystems, Foster City, CA), 0.5 µL of 
primer probe (20X), and 4.5µL of cDNA template. PCR conditions were 50
○
C for 2 minutes, 
95
○
C for 10 minutes, 95
○
C for 15 seconds (45 cycles), and 60
○
C for 1 minute. Equine β-
glucuronidase (β-BUS) was chosen for the housekeeping gene because of its low variability and 
lack of pseudogenes [254,255]. The individual amplification efficiency for each PCR  in each  
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well was subjected to a linear regression analysis [256,257] prior to calculation of the ΔΔCT 
[258], where  
 ΔΔCT = [gene of interest CT – β-GUS CT]sample – [gene of interest CT – β-GUS CT]calibrator 
and 
 CT = the amplification cycle at which the gene reaches a threshold level of fluorescence 
and the relative quantification, or fold change in gene expression is 
 RQ = 2
- ΔΔCT
. 
Three different calibrators were used: 
 No inflammation = average of ΔΔCT for all normal sites for all mares 
 No inflammation/No infection = average of ΔΔCT for normal sites of uninfected mares 
 Individual = normal site for that mare 
4.2.4 Statistical Analysis 
 Because of the small samples sizes within treatment groups, analysis of effect of 
treatment group on cytokine expression was not possible. Mares were categorized according to 
infection and type of delivery. Using the three different calibrators, the difference in relative 
quantification within each site between infected and uninfected mares, or aborting and induced-
delivery mares was compared by a student’s t test, using a statistical analysis software program 
(SAS 9.1, Cary, NC) with significance set at p<0.10, including Satterthwaite’s  and Cochran’s 
methods for sample populations with unequal variances.  
4.3 Results 
4.3.1 Soluble TNF-α in Fetal Fluid 
 In only three samples of all mares at all time-points assayed was TNFp detectable (Table 
4.3). One PBS control mare, one SHAM control mare, and one mare receiving 1 x 10
7
 CFU/mL 
of S. zooepidemicus had detectable concentrations of TNFp; all three mares experienced in utero  
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Table 4.3 Soluble TNF-α protein (TNFp) in fetal fluid from mares with experimental in utero 
infection. The allantoic space was catheterized laparoscopically between 265-280 d gestation: 
SHAM mares (n=3) received no transcervical procedure; PBS Control mares (PBS; n=3) 
received 1 mL sterile PBS transcervically; KILLED STREP (KS; n=3) received 10
7
 heat-killed 
Streptococcus zooepidemicus transcervically; low STREP mares (LS; n=3) received 10
7
 S. 
zooepidemicus transcervically; and high STREP mares (HS; n=1) received 5.1 x 10
8
 S. 





delivery Sample TNFp (pg/mL) 
Infected mares         
20 LS >120h 11d 0h BD
1
 
    
4h BD 
    
8h BD 
    
12h BD 
    
16h BD 
    
20h BD 
    
48h BD 
    
72h BD 
    
96h BD 
    
120h 24.5 
    
>120 h no sample available
2
 
23 HS 11d 11d 0h BD 
    
4h BD 
    
8h BD 
    
12h BD 
    
16h BD 
    
20h BD 
    
40h BD 
    
48h BD 
    
72h BD 
    
96h BD 
    
120h BD 
    
6d BD 
    
7d BD 
682 KS 10d 11d 6d BD 
    
7d BD 
    
8d BD 
    
9d BD 
    
 
  
                                                          
1
 Value below detection limit of assay. 
2
 Sampling after 120h was not possible due to catheter system failure. 
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delivery Sample TNFp (pg/mL) 
781 PBS 72h 4d 32h BD 
    
40h BD 
    
48h BD 
        72h 10,304 
12 LS 17d 18d 11d BD 
    
12d BD 
    
13d BD 
    
17d BD 
847 SHAM 96h 13d 32h 12,129 
    
48h BD 
    
72h BD 
    
8d BD 
790 PBS ?? 7d 32h BD 
    
40h BD 
    
48h BD 
        72h BD 
Uninfected mares         
762 SHAM — 8d 0h BD 
    
4h BD 
    
8h BD 
    
12h BD 
    
16h BD 
    
20h BD 
    
48h BD 
    
72h BD 
    
96h BD 
    
120h BD 
    
6d BD 
    
7d BD 
    
8d BD 
22SG PBS — 8d 0h BD 
    
4h BD 
    
8h BD 
    
12h BD 
    
16h BD 
    
20h BD 




Table 4.2 continued 
 
Uninfected mares         
22SG PBS — 
 
72h BD 
    
96h BD 
    
120h BD 
    
6d BD 
    
7d BD 
    
8d BD 
416 KS — 6d 48h BD 
    
72h BD 
    
96h BD 
        120h BD 
24SG LS — 8d 120h BD 
    
6d BD 
    
7d BD 
    
8d BD 
12SG KS — 8d 120h BD 
    
6d BD 
    
7d BD 
    
8d BD 
25 SHAM — 19d 96h BD 
    
120h BD 
    
8d BD 
        19d BD 
 
infection. Tumor necrosis factor-α protein was detectable prior to a positive culture of the fetal 
fluids twice (64 h once and interval unknown once), and in one instance the detection of TNFp 
and bacterial isolation from fetal fluids were at the same time point. In all other time points 
sampled, TNFp was below the detection limit of the assay. The mares and time points with 
detectable TNFp were: one mare from the PBS control group (#781; 10,304 pg/mL), one mare 
from the SHAM control group (#847; 12,129 pg/mL), and one mare in the low-dose STREP 





4.3.2 Expression of Cytokines in Chorioallantoic Tissues 
 Of the eleven equine-specific cytokines evaluated at four sites (normal, abnormal, 
catheter site, cervical star) from the chorioallantois of thirteen mares, significant differences in 
relative quantitative expression (RQ) for IL-1β, IL-18, IL-15, iNOS, MCP-1, and IFN-γ, were 
found, while that of  IL-8 approached significance.  
4.3.2.1 Change in Expression of Cytokines with Intrauterine Infection 
At normal sites of the chorioallantois, the mean RQ of IL-1β (Table 4.4, p=0.069) and IL-
18 (Table 4.9, p=0.052) were greater in infected mares than in uninfected mares. At abnormal 
sites of the chorioallantois, the mean RQ of IL-15 (Table 4.8, p=0.067) was greater in infected 
mares than uninfected mares; and the mean RQ of IL-1β (Table 4.4, p=0.033), IL-6 (Table 4.5, 
p=0.13), IL-8 (Table 4.6, p=0.11), and TNF-α (Table 4.14, p=0.14) tended to be greater in 
infected mares than in uninfected mares. At the cervical star, the mean RQ of IFN-γ (Table 4.10, 
p=0.13) tended to be greater in infected mares than in uninfected mares, while the RQ of MCP-1 
(Table 4.12, p=0.04) was greater in uninfected than in infected mares. 
4.3.2.2 Change in Expression of Cytokines with Spontaneous Abortion 
 At normal sites of the chorioallantois, IL-18 (Table 4.9, p=0.052) and IFN-γ (Table 4.10, 
p=0.092) were greater in aborting mares than in induced-delivery mares. At abnormal sites of the 
chorioallantois, IL-1β (Table 4.4, p=0.045) and IL-18 (Table 4.9, p=0.052) were greater in 
aborting mares than in induced-delivery mares, while IL-6 (Table 4.5, p=0.11), IL-8 (Table 4.6, 
p=0.11), and TNF-α (Table 4.14, p=0.13) tended to be greater in aborting mares than in induced-
delivery mares. At the cervical star, iNOS (Table 4.11, p=0.049) was greater in aborting mares 
than in induced-delivery mares, while MCP-1 (Table 4.12, p=0.049) was greater in induced-
delivery mares than in aborting mares.
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Table 4.4 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for interleukin-1 
(IL-1) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of infective preterm delivery in the 
mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites from mares without 
infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  no inflamm 2.4. + 0.82 (8) 0.61 + 0.20 (4) 0.069 Satterthwaite 
 no infect/no inflamm 5.40 + 1.85 (8) 1.376 + 0.45 (4) 0.069 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal  no inflamm 74.45 + 37.87 (5) 0.41 + 0.021 (3) 0.12 Satterthwaite 
 no infect/no inflamm 167.54 + 85.22 (5) 0.9182 + 0.05 (3) 0.12 Satterthwaite 
 Individual 22.93 + 6.83 (5) 1.114 + 0.28 (3) 0.033 Satterthwaite 
Cath site No inflamm 6.418 + 2.48 (4) 0.30 (1)   ·   · 
 No infect/no inflamm 14.44 + 5.57 (4) 0.67 (1)   ·   · 
 Individual 16.44 + 11.65 (4) 0.9406 (1)   ·   · 
Cervical star No inflamm 70.44 + 57.3 (8) 2.065 + 0.87 (4) 0.27 Satterthwaite 
 No infect/no inflamm 158.50 + 128.90 (8) 4.65 + 2.0 (4) 0.27 Satterthwaite 
 Individual 18.58 + 10.84 (8) 4.32 + 2.26 (4) 0.24 Pooled 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 2.218 + 0.7d ( 9) 0.56 + 0.27 (3) 0.25 Pooled 
 No infect/no inflamm 4.99 + 1.68 (9) 1.254 + 0.62 (3) 0.25 Pooled 
 Individual 1.00 + 0 (9) 1.00 + 0 (3)   ·   · 
Abnormal no inflamm 62.12 + 33.29 (6) 0.39 + 0.01 (2) 0.12 Satterthwaite 
 no infect/no inflamm 139.80 + 74.91 (6) 0.871 + 0.01 (2) 0.12  Satterthwaite 
 Individual 19.21 + 6.71 (6) 1.38 + 0.14 (2) 0.045 Satterthwaite 
Cath site No inflamm 6.42 + 2.48 (4) 0.30  (1)   ·   · 
 No infect/no inflamm 14.44 + 5.57 (4)  0.67 (1)   ·   · 
 Individual 16.44 + 11.65 (4) 0.94 (1)   ·   · 
Cervical star no inflamm 62.70 + 51.12 (9) 2.47 + 1.088 (3) 0.27 Satterthwaite 
 No infect/no inflamm 141.10 + 115.00 (9) 5.55 + 2.24 (3)  0.27 Satterthwaite 
 individual 16.64 + 9.76 (9) 5.39 + 2.82 (3) 0.53 Pooled 
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Table 4.5 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for interleukin-6 
(IL-6) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of infective preterm delivery in the 
mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites from mares without 
infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  No inflamm 3.12 + 1.61 (8) 1.61 + 0.91 (4) 0.56 Pooled 
 No infect/no inflamm 8.73 + 4.64 (8) 4.50 + 2.53 (4) 0.56  Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal  No inflamm 11.20 + 5.61 (5) 0.60 + 0.31 (3) 0.13 Satterthwaite 
 No infect/no inflamm 31.32 + 15.69 (5) 1.69 + 0.88 (3) 0.13 Satterthwaite 
 Individual 3.38 + 1.15 (5) 1.65 + 1.03 (3) 0.35 Pooled 
Cath site No inflamm 2.28 + 0.86 (4) 0.31 (1)   ·   · 
 No infect/no inflamm 6.36 + 2.40 (4) 0.86 (1)   ·   · 
 Individual 5.81 + 2.69 (4) 0.85 (1)   ·   · 
Cervical star No inflamm 13.97 + 10.32 (8) 4.59 + 1.86 (4) 0.40 Satterthwaite 
 No infect/no inflamm 39.03 + 28.85 (8)  12.82 + 5.20 (4) 0.40 Satterthwaite 
 Individual 2.87 + 0.96 (8) 13.90 + 9.05  (4) 0.31 Satterthwaite 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 3.22 + 1.47 (9) 0.81 + 0.61 (3) 0.38 Pooled 
 No infect/no inflamm 9.00 + 4.10 (9) 2.27 + 1.69 (3) 0.38 Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal No inflamm 9.54 + 4.88 (6) 0.291 + 0.06 (2) 0.12 Satterthwaite 
 No infect/no inflamm 26.67 + 13.63 (6) 0.87 + 0.02 (2) 0.11 Satterthwaite 
 Individual 2.87 + 1.07 (6)  2.326 + 1.36 (2) 0.80 Pooled 
Cath site No inflamm 2.28 + 0.86 (4) 0.31 (1)   ·   · 
 No infect/no inflamm 6.361 + 2.402 (4)  0.87 (1)   ·   · 
 Individual 5.81 + 2.69 (4) 0.85 (1)   ·   · 
Cervical star No inflamm 12.66 + 9.20 (9) 5.37 + 2.39 (3) 0.46 Satterthwaite 
 No infect/no inflamm 35.39 + 25.70 (9) 15.02 + 6.67 (3) 0.46 Satterthwaite 
 Individual 2.61 + 0.889 (9) 18.35 + 11.15 (3)  0.29 Pooled 
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Table 4.6 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for interleukin-8 
(IL-8) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of infective preterm delivery in the 
mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites from mares without 
infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  No inflamm 10.64 + 8.68 (8) 0.146 + 0.06 (3) 0.27 Satterthwaite 
 No infect/no inflamm 97.81 + 79.84 (8) 1.34 + 0.53 (3) 0.27  Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal  No inflamm 121.50 + 59.59 (5) 1.73 + 1.68 (3) 0.11 Satterthwaite 
 No infect/no inflamm 1117.00 + 547.90  (5) 15.96 + 15.48 (3) 0.11 Satterthwaite 
 Individual 82.80 + 43.72 (5)  0.56 + 0.17 (2) 0.13 Satterthwaite 
Cath site No inflamm 9.71 + 3.87 (4) 0.023(1)   ·   · 
 No infect/no inflamm 89.25 + 35.60 (4) 0.24 (1)   ·   · 
 Individual 15.59 + 12.50 (4) 0.12 (1)   ·   · 
Cervical star No inflamm 101.20 + 76.87 (8) 3.74 + 2.62 (4) 0.25 Satterthwaite 
 No infect/no inflamm 930.50 + 706.80 (8) 34.42 + 24.10 (4) 0.25 Satterthwaite 
 Individual 45.67 + 28.46 (8) 7.90 + 3.20 (3) 0.23 Satterthwaite 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 10.64 + 8.68 (8) 0.146 + 0.06 (3) 0.27 Satterthwaite 
 No infect/no inflamm 97.81 + 79.84 (8) 1.34 + 0.53 (3)  0.27 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal No inflamm 102.10 + 52.38 (6) 0.05 + 0.03 (2) 0.11 Satterthwaite 
 No infect/no inflamm 939.00 + 481.6 0(6) 0.48 + 0.27 (2) 0.11 Satterthwaite 
 Individual 82.80 + 43.72 (5) 0.56 + 0.175(2) 0.13 Satterthwaite 
Cath site No inflamm 9.71 + 3.87 (4) 0.03 (1)   ·   · 
 No infect/no inflamm 89.25 + 35.60 (4) 0.24 (1)   ·   · 
 Individual 15.59 + 12.50 (4) 0.12 (1)   ·   · 
Cervical star No inflamm 91.23 + 68.52 (9) 1.18 + 0.76 (3) 0.23 Satterthwaite 
 No infect/no inflamm 838.80 + 630.00 (9) 10.83 + 6.99 (3) 0.23  Satterthwaite 
 Individual 45.67 + 28.46 (8) 7.90 + 3.20 (3) 0.23 Satterthwaite 
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Table 4.7 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for interleukin-
10 (IL-10) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of infective preterm delivery in 
the mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites from mares without 
infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  No inflamm 1.27 + 0.46 (8) 5.39 + 3.22 (3) 0.33 Satterthwaite 
 No infect/no inflamm 0.34 + 0.12 (8) 1.45 + 0.87 (3) 0.33 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal  No inflamm 22.12 + 17.77 (5) 0.73 + 0.36 (3) 0.30 Satterthwaite 
 No infect/no inflamm 5.95 + 4.78 (5) 0.20 + 0.10 (3) 0.30 Satterthwaite 
 Individual 51.81 + 38.93 (5) 0.46 + 0.03 (2) 0.26 Satterthwaite 
Cath site No inflamm 6.85 + 3.64 (4) 0.65 (1)   ·   · 
 No infect/no inflamm 1.84 + 0.98 (4) 0.18 (1)   ·   · 
 Individual 8.14 + 1.54 (4) 0.23 (1)   ·   · 
Cervical star No inflamm 26.53 + 22.19 (8) 3.89 + 1.32 (3) 0.34 Satterthwaite 
 No infect/no inflamm 7.13 + 5.97 (8)  1.05 + 0.36 (3) 0.34 Satterthwaite 
 Individual 55.70 + 49.48 (8) 2.16 + 1.67 (2) 0.32 Pooled 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 1.27 + 0.46 (8) 5.39 + 3.22 (3) 0.33 Satterthwaite 
 No infect/no inflamm 0.34 + 0.12 (8) 1.45 + 0.87 (3) 0.33 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal No inflamm 18.45 + 14.96 (6) 1.02 + 0.369 (2) 0.3 Satterthwaite 
 No infect/no inflamm 4.96 + 4.02 (6) 0.27 + 0.10 (2) 0.3 Satterthwaite 
 Individual 51.81 + 38.93 (5) 0.46 + 0.03 (2) 0.26 Satterthwaite 
Cath site No inflamm 6.85 + 3.64 (4) 0.65 (1)   ·   · 
 No infect/no inflamm 1.84 + 0.978 (4) 0.18 (1)   ·   · 
 Individual 8.14 + 1.54 (4) 0.23 (1)   ·   · 
Cervical star No inflamm 24.07 + 19.72 (9) 3.62 + 2.24 (2) 0.65 Pooled 
 No infect/no inflamm 6.47 + 5.30 (9) 0.97 + 0.60 (2) 0.65 Pooled 
 Individual 55.70 + 49.48 (8) 2.16 + 1.67 (2) 0.32 Satterthwaite 
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Table 4.8 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for interleukin-
15 (IL-15) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of infective preterm delivery in 
the mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites from mares without 
infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  No inflamm 1.33 + 0.34 ( 8)  1.01 + 0.19 (4) 0.54 Pooled 
 No infect/no inflamm 1.14 + 0.29 (8) 0.87 + 0.16 (4) 0.54 Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal  No inflamm 3.12 + 0.99 (5) 0.67 + 0.20 (3) 0.067 Satterthwaite 
 No infect/no inflamm 2.67 + 0.84 (5) 0.5704 + 0.17 (3) 0.067 Satterthwaite 
 Individual 5.71 + 2.90 (5) 0.71 + 0.16 (3) 0.16 Satterthwaite 
Cath site No inflamm 1.49 + 0.63 (4) 0.36 (1)   ·   · 
 No infect/no inflamm 1.28 + 0.54 (4) 0.30 (1)   ·   · 
 Individual 1.11 + 0.20 (4) 0.34 (1)   ·   · 
Cervical star No inflamm 1.66 + 0.42 (8) 0.99 + 0.28 (4) 0.32 Pooled 
 No infect/no inflamm 1.42 + 0.36 (8) 0.85 + 0.24 (4) 0.32 Pooled 
 Individual 1.47 + 0.25 (8) 1.14 + 0.42 (4) 0.50 Pooled 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n ) Pr > │ │ Method 
Normal No inflamm 1.24 + 0.31 (9) 1.18 + 0.12 (3) 0.91 Pooled 
 No infect/no inflamm 1.06 + 0.27 (9) 1.01 + 0.10 (3) 0.91 Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal No inflamm 2.68 + 0.92 (6) 0.75 + 0.32 (2) 0.29 Pooled 
 No infect/no inflamm 2.30 + 0.79 (6) 0.64 + 0.27 (2) 0.30 Pooled 
 Individual 4.91 + 2.50 (6) 0.58 + 0.17 (2) 0.38 Pooled 
Cath site No inflamm 1.49 + 0.63 (4) 0.36 (1)   ·   · 
 No infect/no inflamm 1.28 + 0.54 (4) 0.30 (1)   ·   · 
 Individual 1.11 + 0.20 (4) 0.34 (1)   ·   · 
Cervical star No inflamm 1.60 + 0.37 (9) 0.95 + 0.39 (3) 0.38 Pooled 
 No infect/no inflamm 1.37 + 0.32 (9) 0.82 + 0.33 (3) 0.38 Pooled 
 Individual 1.54 + 0.24 (9) 0.82 + 0.37 (3) 0.15 Pooled 
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Table 4.9 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for interleukin-
18 (IL-18) with infection or type of delivery at different sites of the chorioallantoic membrane in a  model of infective preterm delivery in 
the mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites from mares without 
infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
 
Infection 
Site Calibrator Infected (mean + SEM) Uninfected (mean + SEM) Pr > │ │ Method 
Normal  No inflamm 1.50 + 0.23 (8) 0.56 + 0.29 (3) 0.052 Satterthwaite 
 No infect/no inflamm 3.45 + 0.53 (8) 1.29 + 0.68 (3) 0.052 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal  No inflamm 5.92 + 2.86 (5) 1.46 + 0.89 (3) 0.29 Pooled 
 No infect/no inflamm 13.64 + 6.59 (5) 3.38 + 2.06 (3) 0.29 Pooled 
 Individual 3.61 + 1.68 (5) 1.24 + 0.65 (2) 0.44 Pooled 
Cath site No inflamm 1.52 + 0.20 (4) 0.58 (1)   ·   · 
 No infect/no inflamm 3.51 + 0.45 (4) 1.35 (1)   ·   · 
 Individual 1.46 + 0.52 (4) 0.00 (1)   ·   · 
Cervical star No inflamm 11.12 + 9.26 (8) 1.01  + 0.56 (4) 0.31 Satterthwaite 
 No infect/no inflamm 25.63 + 21.35 (8) 2.32 + 1.30 (4) 0.31 Satterthwaite 
 Individual 6.40 + 4.98 (8) 1.18 + 0.41 (3) 0.33 Pooled 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) Induction (mean + SEM) Pr > │ │ Method 
Normal No inflamm 1.50 + 0.23 (8) 0.56 + 0.29 (3) 0.052 Pooled 
 No infect/no inflamm 3.45 + 0.53 (8) 1.29 + 0.68 (3) 0.052 Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal No inflamm 5.47 + 2.37 (6) 0.57 + 0.11 (2) 0.094 Satterthwaite 
 No infect/no inflamm 12.62 + 5.48 (6) 1.32 + 0.25 (2) 0.094 Satterthwaite 
 Individual 3.61 + 1.68 (5) 1.24 + 0.65 (2) 0.44 Pooled 
Cath site No inflamm 1.52 + 0.20 (4) 0.58 (1)   ·   · 
 No infect/no inflamm 3.51 + 0.45 (4) 1.35 (1)   ·   · 
 Individual 1.46 + 0.52 (4) 0.00 (1)   ·   · 
Cervical star No inflamm 10.18 + 8.22 (9) 0.46 + 0.07 (3) 0.27 Satterthwaite 
 No infect/no inflamm 23.47 + 18.95 (9) 1.03 + 0.16 (3) 0.27  Satterthwaite 
 Individual 6.40 + 4.981 (8) 1.18 + 0.41 (3) 0.33  Satterthwaite 
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Table 4.10 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for interferon-
γ (IFN-γ) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of infective preterm delivery in 
the mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites from mares without 
infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
 
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  No inflamm 3.11 + 1.15 (8) 0.64 + 0.15 (4) 0.069 Satterthwaite 
 No infect/no inflamm 4.23 + 1.56 (8) 0.87 + 0.20 (4) 0.069 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal  No inflamm 15.31 + 8.22 (5) 0.71 + 0.54 (2) 0.34 Pooled 
 No infect/no inflamm 20.79 + 11.17 (5) 0.96 + 0.73 (2) 0.34 Pooled 
 Individual 5.96 + 2.07 (5) 1.07 + 0.79 (2) 0.22 Pooled 
Cath site No inflamm 0.78 + 0.423 (3) 1.36 (1)   ·   · 
 No infect/no inflamm 1.06 + 0.58 (3) 1.85 (1)   ·   · 
 Individual 1.42 + 0.81 (3) 2.04 (1)   ·   · 
Cervical star No inflamm 5.66 + 2.73 (7) 0.65 + 0.31 (3) 0.12  Satterthwaite 
 No infect/no inflamm 7.69 + 3.72 (7) 0.89 + 0.43 (3) 0.12 Satterthwaite 
 Individual 2.98 + 1.06 (7) 1.20 + 0.38 (3) 0.32 Pooled 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 2.80 + 1.06 (9) 0.75 + 0.12 (3) 0.092 Satterthwaite 
 No infect/no inflamm 3.80 + 1.44 (9) 1.02 + 0.17 (3) 0.09 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal No inflamm 15.31 + 8.22 (5) 0.71 + 0.54 (2) 0.34  Pooled 
 No infect/no inflamm 20.79 + 11.17 (5) 0.96 + 0.73 (2) 0.34 Pooled 
 Individual 5.96 + 2.07 (5) 1.07 + 0.79 (2) 0.22 Pooled 
Cath site No inflamm 0.78 + 0.43 (3) 1.36 (1)   ·   · 
 No infect/no inflamm 1.06 + 0.58 (3) 1.85 (1)   ·   · 
 Individual 1.42 + 0.81 (3) 2.04 (1)   ·   · 
Cervical star No inflamm 4.99 + 2.46 (8) 0.83 + 0.45 (2) 0.44 Pooled 
 No infect/no inflamm 6.78 + 3.34 (8) 1.12 + 0.61 (2) 0.44 Pooled 
 Individual 2.74 + 0.95 (8) 1.27 + 0.64 (2) 0.48 Pooled 
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Table 4.11 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for inducible 
nitric oxide synthase (iNOS) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of infective 
preterm delivery in the mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites 
from mares without infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
 
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  No inflamm 2.30 + 0.70 (8) 1.74 + 0.90 (4) 0.65 Pooled 
 No infect/no inflamm 4.94 + 1.5 (8) 3.74 + 1.93 (4) 0.64 Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal  No inflamm 5.08 + 2.06 (5) 2.29 + 0.60 (3) 0.35 Pooled 
 No infect/no inflamm 10.91 + 4.42 (5) 4.91 + 1.29 (3) 0.35 Pooled 
 Individual 1.28 + 0.37 (5) 3.56 + 2.96 (3) 0.52 Satterthwaite 
Cath site No inflamm 3.63 + 3.38 (4) 1.67 (1)   ·   · 
 No infect/no inflamm 7.79 + 7.26 (4) 3.59 (1)   ·   · 
 Individual 1.38 + 0.68 (4) 5.08 (1)   ·   · 
Cervical star No inflamm 1.24 + 0.60 (8) 0.52 + 0.48 (3) 0.51 Pooled 
 No infect/no inflamm 2.66 + 1.29 (8) 1.11 + 1.04 (3) 0.51 Pooled 
 Individual 0.73 + 0.25 (8) 0.35 + 0.13 (3) 0.39 Pooled 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 2.37 + 0.62 (9) 1.35 + 1.14 (3) 0.44 Pooled 
 No infect/no inflamm 5.09 + 1.34 (9) 2.89 + 2.45 (3)  0.44 Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal no inflamm 4.67 + 1.73 (6) 2.12 + 1.00 (2) 0.45 Pooled 
 no infect/no inflamm 10.03 + 3.72 (6) 4.54 + 2.15 (2) 0.45 Pooled 
 Individual 1.22 + 0.31 (6) 4.89 + 4.59 (2) 0.57 Pooled 
Cath site No inflamm 3.63 + 3.38 (4) 1.67 (1)   ·   · 
 No infect/no inflamm 7.79 + 7.26 (4) 3.59 (1)   ·   · 
 Individual 1.38 + 0.68 (4) 5.08 (1)   ·   · 
Cervical star no inflamm 1.26 + 0.53 (9) 0.04 + 0.00 (2) 0.049 Satterthwaite 
 No infect/no inflamm 2.72 + 1.14 (9) 0.08 + 0.01 (2) 0.049 Satterthwaite 
 individual 0.71  + 0.22 (9) 0.277 + 0.18 (2) 0.40 Pooled 
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Table 4.12 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for monocyte 
chemoattractant protein-1 (MCP-1) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of 
infective preterm delivery in the mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of 
normal sites from mares without infection (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
 
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  no inflamm 1.47 + 0.48 (8) 1.84 + 0.75 (4) 0.68 Pooled 
 no infect/no inflamm 1.75 + 0.56 (8) 2.18 + 0.89 (4) 0.68 Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal  no inflamm 1.79 + 0.623 (5) 1.48 + 0.70 (3) 0.76 Pooled 
 no infect/no inflamm 2.12 + 0.74 (5) 1.75 + 0.83 (3) 0.76 Pooled 
 Individual 1.35 + 0.537 (5) 1.85 + 1.01 (3) 0.64 Pooled 
Cath site No inflamm 2.03 + 0.73 (4) 0.63 (1)   ·   · 
 No infect/no inflamm 2.40 + 0.86 (4) 0.75 (1)   ·   · 
 Individual 1.53 + 0.27 (4) 0.68 (1)   ·   · 
Cervical star No inflamm 1.85 + 0.64 (8) 5.03 + 1.50 (3) 0.044 Pooled 
 No infect/no inflamm 2.19 + 0.76 (8) 5.96 + 1.78 (3) 0.044 Pooled 
 Individual 1.88 + 0.50 (8) 2.46 + 0.70 (3) 0.54 Pooled 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 1.67 + 0.46 (9) 1.38 + 0.83 (3) 0.77 Pooled 
 No infect/no inflamm 1.98 + 0.55 (9) 1.64 + 0.99 (3) 0.77 Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal no inflamm 1.97 + 0.54 (6) 0.78 + 0.05 (2) 0.27 Pooled 
 no infect/no inflamm 2.33 + 0.64 (6) 0.93 + 0.05 (2) 0.27 Pooled 
 Individual 1.27 + 0.44 (6) 2.33 + 1.54 (2) 0.37 Pooled 
Cath site No inflamm 2.03 + 0.73 (4) 0.64 (1)   ·   · 
 No infect/no inflamm 2.40 + 0.86 (4) 0.75 (1)   ·   · 
 Individual 1.53 + 0.27 (4) 0.68 (1)   ·   · 
Cervical star no inflamm 2.06 + 0.60 (9) 5.67 + 2.35 (2) 0.049 Pooled 
 No infect/no inflamm 2.44 + 0.71 (9) 6.72 + 2.79 (2) 0.049 Pooled 
 individual 1.80 + 0.45 (9) 3.11 + 0.44 (2) 0.23 Pooled 
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Table 4.13 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for 
transforming growth factor-β (TGF-β) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of 
infective preterm delivery in the mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of 
normal sites from mares without infection or inflammation (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
 
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  no inflamm 1.58 + 0.75 (8) 1.06 + 0.19 (3) 0.52 Satterthwaite 
 no infect/no inflamm 1.54 + 0.73 (8) 1.03 + 0.19 (3) 0.52 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal  no inflamm 4.03 + 1.28 (5) 2.52 + 1.10 (3) 0.45 Pooled 
 no infect/no inflamm 3.91 + 1.24 (5) 2.44 + 1.07 (3) 0.45 Pooled 
 Individual 5.81 + 1.54 (5) 1.97 + 1.19 (2) 0.21 Pooled 
Cath site No inflamm 0.82 + 0.31 (4) 2.93 (1)   ·   · 
 No infect/no inflamm 0.80 + 0.31 (4) 2.84 (1)   ·   · 
 Individual 1.59 + 1.04 (4) 2.04 (1)   ·   · 
Cervical star No inflamm 2.91 + 0.73 (8) 2.59 + 0.76 (4) 0.80 Pooled 
 No infect/no inflamm 2.82 + 0.71 (8) 2.52 + 0.74 (4) 0.80 Pooled 
 Individual 2.51 + 0.49 (8) 1.93 + 0.47 (3) 0.53 Pooled 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 1.58 + 0.75 (8) 1.06 + 0.19 (3) 0.52 Satterthwaite 
 No infect/no inflamm 1.54 + 0.73 (8) 1.03 + 0.19 (3) 0.52 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal no inflamm 3.74 + 1.09 (6) 2.64 + 1.89 (2) 0.63 Pooled 
 no infect/no inflamm 3.63 + 1.06 ( 6) 2.57 + 1.83 (2) 0.63 Pooled 
 Individual 5.81 + 1.54 (5) 1.97 + 1.19 (2) 0.21 Pooled 
Cath site No inflamm 0.82 + 0.31 (4) 2.93 (1)   ·   · 
 No infect/no inflamm 0.80 + 0.31 (4) 2.84 (1)   ·   · 
 Individual 1.59 + 1.04 (4) 2.04 (1)   ·   · 
Cervical star no inflamm 3.00 + 0.65 (9) 2.20 + 0.92 (3) 0.54 Pooled 
 No infect/no inflamm 2.91 + 0.64 (9) 2.14 + 0.89 (3) 0.54 Pooled 
 individual 2.51 + 0.49 (8) 1.93 + 0.47 (3) 0.53 Pooled 
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Table 4.14 Mean relative quantitative expression, standard error of the mean, and the probabilities that means are different for tumor 
necrosis factor-α (TNF-α) with infection or type of delivery at different sites of the chorioallantoic membrane in a model of infective 
preterm delivery in the mare (n=13). Calibrator was either a pool of normal sites from all mares (―no inflamm‖), a pool of normal sites 
from mares without infection or inflammation (―no infect/no inflamm‖), or that individual’s normal site (―individual‖).  
 
Infection 
Site Calibrator Infected (mean + SEM) (n) Uninfected (mean + SEM) (n) Pr > │ │ Method 
Normal  no inflamm 2.30 + 1.10 (8) 0.98 + 0.34 (4) 0.29 Satterthwaite 
 no infect/no inflamm 2.64 + 1.27 (8) 1.13 + 0.39 (4) 0.29 Satterthwaite 
 Individual 1.00 1.00   ·   · 
Abnormal  no inflamm 36.70 + 19.37 (5) 0.78+ 0.37 (3) 0.14 Satterthwaite 
 no infect/no inflamm 42.19 + 22.28 (5) 0.90 + 0.43 (3) 0.14 Satterthwaite 
 Individual 33.17 + 21.76 (5) 1.12 + 0.422(3) 0.21 Satterthwaite 
Cath site No inflamm 2.64 + 0.94 (4) 0.33 (1)   ·   · 
 No infect/no inflamm 3.03 + 1.08 (4) 0.38 (1)   ·   · 
 Individual 5.22 + 2.10 (4) 0.49 (1)   ·   · 
Cervical star No inflamm 20.87 + 14.59 (8) 1.83 + 0.452 (4) 0.23 Satterthwaite 
 No infect/no inflamm 23.99 + 16.78 (8) 2.11 + 0.52 (4) 0.23 Satterthwaite 
 Individual 6.71 + 4.85 (8) 2.65 + 1.10 (4) 0.44 Satterthwaite 
Type of Delivery 
Site Calibrator Abortion (mean + SEM) (n) Induction (mean + SEM) (n) Pr > │ │ Method 
Normal No inflamm 2.13 + 0.99 (9) 1.05 + 0.47 (3) 0.56 Pooled 
 No infect/no inflamm 2.45 + 1.14 (9) 1.21 + 0.54 (3) 0.56  Pooled 
 Individual 1.00 1.00   ·   · 
Abnormal no inflamm 30.83 + 16.87 (6) 0.41 + 0.074 (2) 0.13 Satterthwaite 
 no infect/no inflamm 35.45 + 19.40 (6) 0.4682 + 0.08 (2) 0.13 Satterthwaite 
 Individual 27.97 + 18.51 (6) 0.70 + 0.00 (2) 0.20 Satterthwaite 
Cath site No inflamm 2.64 + 0.94 (4) 0.33 (1)   ·   · 
 No infect/no inflamm 3.04 + 1.08 (4) 0.38 (1)   ·   · 
 Individual 5.22 + 2.10 (4) 0.48 (1)   ·   · 
Cervical star no inflamm 18.83 + 13.03 (9) 1.60 + 0.55 (3) 0.22 Satterthwaite 
 No infect/no inflamm 21.65 + 14.98 (9) 1.84 + 0.63 (3) 0.22 Satterthwaite 




 This data describes the change in expression pattern of equine-specific cytokines in 
chorioallantoic tissue from mares with experimental in utero infection and spontaneous abortion. 
Experimentally-induced infection increased the expression of IL-1β, IL-18, IL-15, IFN-γ, and 
possibly IL-8, in a site-dependant manner.  Mares spontaneously aborting also had increased 
expression of IL-1β, IL-18, IFN-γ, and iNOS in a site dependant manner. Expression of MCP-1 
at the cervical star was reduced with spontaneous abortion. This expression pattern of pro-
inflammatory cytokines in response to infection of equine placental tissue is slightly different 
from a previous report [237], where IL-6 and IL-8 were increased at the cervical star and IL-6 
was increased at the uterine body. Two possible reasons for this difference are the housekeeping 
genes used, and lack of gestational age-matched tissue. The previous study [237] used GAPDH 
as the housekeeping gene, which has since been shown to have a high degree of variability 
[254,255]. For this reason, β-GUS was chosen for this study. In this study presented here, 
induced delivery provided gestational age-matched tissue for comparison. The expression of 
various enzymes and cytokines can vary greatly with gestation [48]; therefore, the appropriate 
controls for experimentally infected fetal membranes are those of the same gestational age. The 
transient presence of soluble TNF-α was detected in a limited number of fetal fluids. Although 
this was somewhat surprising, TNF-α may only be present for a brief period of time in response 
to infection of fetal fluids [228]; therefore, sampling time in relation to an inflammatory insult is 
crucial. The experimental design attempted to account for this by frequent sampling within the 
first 24 h; however, the lag phase from inoculation to inflammation of the chorioallantois was 
much longer than expected. 
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 IL-1β is a pro-inflammatory cytokine belonging to the IL-1 superfamily, which includes 
IL-1α, IL-18, and IL-1 receptor antagonist (IL-1Ra), among others (review, [259]). It is secreted 
by a variety of cell types, such as monocytes, macrophages, endothelial cells, and epithelial cells 
to produce pro-inflammatory responses such as increased vascular permeability, increased 
adhesion molecules on endothelial cells, chemokine induction (IL-8), induction of IL-6, 
activation of T and B cells, synthesis of acute phase proteins in the liver, proliferation of platelets 
and fibroblasts, and fever. The production of fever is linked to its induction of  COX-2 (PGHS-2) 
and PGE2 synthesis [260-262]. Il-1β has been shown in a variety of species and models to play a 
pivotal role in infective pre-term delivery [76,223,224,263,264]. Following binding to the type 1 
IL-1 receptor (IL-1R1), signaling pathways that lead to target cell effector functions involve 
adaptor molecules (myeloid differentiation primary response gene (88); MyD88) and IL-1R 
associated kinases (IRAK), and ultimately activate nuclear factor (NF)-ĸB through the 
degradation of inhibitor of NF-ĸB (IĸB) [265].   
 IL-18, also known as IFN-γ inducing factor, signals through a receptor in the IL-1 
receptor family that is distinct from IL-R1[266]. Following binding of IL-18 to IL-18R, signaling 
also involves MyD88 and IRAK; however, further signaling through NF-ĸB does not occur with 
IL-18, but rather is primarily through the p38-mitogen-activated protein kinase (MAPK) / 
activator protein 1 (AP-1) pathway and does not lead to COX-2 upregulation in epithelial cells 
[267]. IL-2,  IL-12 and IL-15 are considered co-stimulants for IL-18, and are thought to be 
required for IL-18-induced IFN-γ production [268]. Both IL-1β and IL-18 can induce IL-1α, IL-
6, and IL-8 secretion from epithelial cells; the ability of IL-18 to do so is independent of IL-1β 
[267].  Increased IL-18 in amniotic fluid [269,270]  and cervical mucus [270] is seen with intra-
amniotic infection in women. Interestingly, either IL-18 gene disruption or IL-18 neutralization 
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led to an increased susceptibility to fetal loss secondary to LPS-induced intrauterine 
inflammation [271], highlighting the complex interaction of cytokines and pre-term delivery due 
to inflammation. 
 Following stimulation with IL-12 or IL-18, IFN-γ is secreted by TH1 cells (CD4+), CD8+ 
cells, natural killer (NK) cells, B cells, NKT cells and professional antigen-presenting cells to 
cause macrophage activation and increased expression of class I and II MHC molecules, thereby 
increasing antigen presentation [272]. The role of INF-γ in pre-term delivery has been 
infrequently described, but increased expression of INF-γ was found in the placentas of women 
in pre-term labor compared to normal delivery at term [273].  Increased expression of INF-γ was 
only observed at sites were IL-18 was increased. An increase in IL-15 (co-stimulant for IL-18) 
was observed in abnormal sites from infected mares where IL-18 and INF-γ were also increased. 
 Nitric oxide (NO) is an important mediator of inflammation [274], as well as a wide 
variety of reproductive processes [275]. Inducible nitric oxide synthase (iNOS) is one of three 
synthases that produces NO [276], and is upregulated in human cervical tissue at term [277,278], 
human fetal trophoblast cells at term [279], and murine placenta subsequent to LPS-induced pre-
term delivery [280]. IFN-γ stimulation of macrophages causes upregulation  of iNOS [281]. 
Similarly, increased expression of iNOS was observed in tissue from the cervical star region of 
the chorioallantois in spontaneously aborting mares.  
 Monocyte chemoattractant protein-1 (MCP-1; CCL2) is a chemokine secreted by 
endothelial cells and cells of the monocyte-macrophage cell linage in response to inflammatory 
stimuli, such as IL-1, TNF-α, and LPS. Its action is to attract monocytes, basophils, T cells, and 
NK cells to the site of inflammation [282,283]. Monocyte chemoattractant protein-1 was 
increased in amniotic fluid of women with pre-term labor with or without intra-amniotic 
124 
 
infection [284] and expression of MCP-1 was increased in cervical biopsies from women  in 
term labor without infection [285].  Both MCP-1 expression and protein production were 
increased in a murine model of intrauterine LPS-induced pre-term delivery [286]. Increased 
expression of MCP-1 was observed at the cervical star in mares without infection or in those 
induced to deliver. The reason for this discrepancy is unknown. Collection of term-in-labor 
samples from mares without infection would be useful to defining the role of MCP-1 in term 
delivery and that complicated by in utero infection. 
 In summary, infection or spontaneous abortion is associated with increased expression of 
IL-1β, IL-18, IL-15, IFN-γ, and iNOS in both abnormal and normal equine placenta. Although 
extremely transient, there is evidence to suggest that soluble TNF-α is secreted into the allantoic 
fluid. These findings are in agreement with those of previously published experimental models 
and clinical findings from women with intra-amniotic infection and pre-term delivery [76,223-
228,263,270,273,280]. The potential consequence of increased IL-1β in infected chorioallantois 





THE ROLE OF THE PROSTAGLANDINS PGE2 AND PGF2α IN AN 
EXPERIMENTAL MODEL OF INFECTIVE PRE-TERM DELIVERY IN 
THE MARE  
 
5.1 Introduction 
 One of the proposed mechanisms of infection-induced pre-term delivery is that pro-
inflammatory cytokines (IL-1, IL-6, TNF-α) from the deciduas and cortisol from the mother 
cause activation of the fetal hypothalamic-pituitary-adrenal axis, causing elevation of fetal 
cortisol [48]. Increased fetal cortisol, either at term or in response to pro-inflammatory cytokines, 
decreases concentrations of PGDH, an enzyme responsible for inactivation of PGE2 and PGF2 , 
leading to increased PGE2 and PGF2  and subsequent myometrial contractions. Pro-inflammatory 
cytokines also increase the activity of another key enzyme, prostaglandin H2 synthase (PGHS-2), 
which increases prostaglandin synthesis. The decrease in PGDH and increase in PGHS-2 lead to 
increased PGE2 and PGF2  synthesis, myometrial contractions and premature labor 
[227,234,235,252]. 
 One model examining the relationship between inflammatory cytokines and 
prostaglandin concentration in fetal fluids during ascending placentitis in pregnant mares has 
been reported [237]. Placentitis was induced by intracervical inoculation of S. zooepidemicus in 
mares between 283 and 291 d of gestation. Allantoic fluid samples were obtained from an 
allantoic catheter or by allantocentesis from inoculated and control mares at several-day intervals 
until abortion or term delivery. Concentrations of PGE2 (competitive binding RIA) in allantoic 
fluid rose from pre-inoculation values of 108 + 29 pg/mL to 13,972 + 6255 pg/mL within 48 h of 
delivery, while those in control mares ranged from 25 to 432 pg/mL.  Concentrations of PGF2α 
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rose from pre-inoculation values of 295.7 + 50 pg/mL to 3241 + 1487 pg/mL within 48 h of 
delivery, while control mares ranged from 105 to 432 pg/mL. Allantoic fluid samples were 
obtained from control mares on a 7 to 10 d interval until spontaneous parturition, therefore a 
sample within 48 h of delivery was likely not available from the majority of mares within this 
group. Based on the increased expression of placental IL-6 and IL-8 at the cervical star and IL-6 
at the uterine body, it was hypothesized that bacterial infection causes increased expression of 
pro-inflammatory cytokines leading to the release of PGE2 and PGF2α into the allantoic fluid 
resulting in premature labor [237]. 
 The temporal relationship between increases in allantoic cytokines and prostaglandins is 
quite important. If the synthesis of PGF2α and PGE2 is driven by cytokines in concert with fetal 
cortisol, as has been suggested in a model of ascending placentitis [48], then a therapeutic regime 
that is unsuccessful in interrupting the signaling of cytokines and abrogating the production of 
prostaglandins will fail to prevent the onset of labor. We hypothesized that the concentrations of 
PGE2 and PGF2α would be increased in mares with spontaneous abortion or intrauterine 
infection. 
5.2 Material and Methods 
5.2.1 Experimental Animals, Instrumentation, and Inoculation 
 Thirteen adult pony mares mare of various ages were used in this study over a 2-year 
period (2005 to 2006). Mares were maintained on pasture and supplemented with hay and a 
pelleted ration during the winter to maintain good body condition. All procedures were in 
accordance with Louisiana State University’s Institutional Animal Care and Use Committee’s 
guidelines for the humane treatment of research animals. Allantoic catheters were placed in 
sedated standing animals under local anesthesia using laparoscopic visualization as previously 
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described (Chapter 2). Pony mares were assigned to receive one of four transcervical 
inoculations: low STREP (1 x 10
7
 CFU S. zooepidemicus; n=3), high STREP (5.1 x 10
8
 CFU S. 
zooepidemicus; n=1), KILLED STREP (1 x 10
7
 heat-killed S. zooepidemicus’ n=3), PBS 
CONTROL (1 mL sterile PBS; n=3), and SHAM CONTROL groups (n=3). Procedures were 
performed between 260 and 285 d of gestation. Two SHAM CONTROL mares, one PBS 
CONTROL mare, one KILLED STREP mare, and one low STREP mare were induced to deliver 
fetuses as previously described (Chapter 3), to provide gestational age-matched placental and 
fetal tissue, and control for the variability from inoculation to delivery. Preparation of the 
inocula, transcervical inoculations, patient monitoring, and sample collection were performed as 
previously described (Chapter 3).  Briefly, 12 mL of fetal fluid was collected at 24 h intervals, 
and immediately placed on ice for transport to the laboratory. Samples were centrifuged at 2,000 
x g for 15 min at 4ºC, and the supernatant separated into one 5-mL aliquot and four 1-mL 
aliquots and stored at -70ºC for future analysis.  
5.2.2 Determination of PGE2 Concentration in Fetal Fluids 
 The concentration of PGE2 in fetal fluid was assessed using a commercially available 
competitive-binding immunoassay (Prostaglandin E2 Parameter™ Assay, R&D Systems, 
Minneapolis, MN) according to manufacturer’s directions. The assay was validated for use with 
fetal fluid by demonstrating parallelism of the serially diluted allantoic fluid curve and the kit 
curve (slopes 4.148 and 3.258 respectively), and linearity of serially diluted allantoic fluid (R
2
 = 
0.9923). The mean percent recovery was 90.3%. The sample volume per well was 2.5 μL; 
samples were assayed in duplicate. Plates were read at 450 and 540 nm on a microplate 
spectrophotometer (Synergy™ HT, Bio-Tek, Winooski, VT) with associated software (KC4, 
Bio-Tek, Winooski, VT). The standard curve ranged from 0 to 2500 pg/mL, and the intra- and 
interassay coefficients of variation were 12% and 20% µg/dL respectively.  
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5.2.3 Determination of PGF2α Concentration in Fetal Fluids 
 The concentration of PGF2α in fetal fluid was assessed using a commercially available 
competitive-binding enzyme immunoassay (Prostaglandin F2α EIA kit, Cayman Chemical, Ann 
Arbor, MI) according to manufacturer’s directions. The assay was validated for use with fetal 
fluid by demonstrating parallelism of the serially diluted allantoic fluid curve and the kit curve 
(slopes 3.0728 and 3.3457 respectively), and linearity of the serially diluted allantoic fluid (R
2
 = 
0.9973). The mean percent recovery was 90.8%. The sample volume per well was 10 μL, and 
samples were assayed in duplicate.  Plates were read at 405 nm on a microplate 
spectrophotometer (Synergy™ HT, Bio-Tek, Winooski, VT) with associated software (KC4, 
Bio-Tek, Winooski, VT). The standard curve ranged from 3.9 to 500 pg/mL, and the intra- and 
inter-assay coefficients of variation were 7.3% and 21%, respectively. 
5.2.4 Statistical Analysis 
 Because of the small samples sizes within treatment group, effect of treatment group on 
the concentration of PGE2 or PGF2α in fetal fluid was not possible. The effect of type of delivery 
(spontaneous abortion or induced delivery) on the difference in PGE2 or PGF2α concentration 
between the sample immediately prior to delivery (TEND) and that at the time of inoculation (T0) 
was compared by a Student’s t test, using a statistical analysis software program (SAS 9.1, Cary, 
NC) with significance set at p<0.05, including Satterthwaite’s method for sample populations 
with unequal variances. Examination of the daily pattern of PGE2 concentration data revealed 
that PGE2 concentrations rose transiently from T0 for the following 1 to 2 days following 
laparoscopy, and then declined. Consequently, a separate calculation of TEND – TLOW was made, 






Data from two mares were removed; one because the fluid was determined to be of 
peritoneal origin (PBS control mare), and one because sample viscosity interfered with assay 
performance (SHAM control mare). The individual fetal fluid concentrations of PGE2 for the 
remaining eleven mares are shown in Table 5.1 and Figure 5.1. The difference in TEND – T0 was 
not statistically significant (p=0.1021) between spontaneously aborting mares and induced-
delivery mares; even after removal of mares in which a sample within 24 h of delivery was 
unavailable for analysis (p=0.0807; Table 5.3). The difference in TEND – TLOW for all mares was 
not statistically significant (p=0.0950) between spontaneously aborting mares and induced-
delivery mares; however, the difference in TEND – TLOW for all spontaneously aborting mares in 
which a sample within 24 h of delivery was available for analysis was statistically significant 
from induced-delivery mares (p=0.0455; Table 5.3) The individual fetal fluid concentrations of 
PGF2α for eleven mares are shown in Table 5.2 and Figure 5.2. There was a significant difference 
in TEND – T0 between all spontaneously aborting mares and induced-delivery mares (p=0.0312); 
there was also a significant difference in TEND – T0 between all spontaneously aborting mares 
and induced-delivery mares in which a sample within 24 h of delivery was available for analysis 
(p<0.0001; Table 5.3).  
There was no significant effect of the presence of infection on the difference (TEND – T0) 
in PGE2 concentration for mares (p=0.3166); however, after removal of mares in which a sample 
with 24 h of delivery was not available for analysis TEND – T0 was statistically different 
(p=0.0306). There was no significant effect of the presence of infection on the difference (TEND – 
T0) in PGF2α concentration for all mares (p=0.1518; Table 5.3); however, after removal of mares 
in which a sample with 24 h of delivery was unavailable for analysis TEND – T0 was statistically 
different (p=0.0324; Table 5.3).  
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Table 5.1 Daily PGE2 concentrations and differences in concentrations in fetal fluids from mares 
in an experimental model of ascending placentitis. The allantoic space was catheterized 
laparoscopically between 265-280 d gestation: SHAM mares (n=3) received no transcervical 
procedure; PBS Control mares (n=3) received 1 mL sterile PBS transcervically; KILLED STREP 
(n=3) received 1 x 10
7
 heat-killed Streptococcus zooepidemicus transcervically; low STREP 
mares (n=3) received 1 x 10
7
 Streptococcus zooepidemicus transcervically; and high STREP 
mares (n=1) received 5.1 x 10
8
 Streptococcus zooepidemicus transcervically. 
Pony 
Treatment 











781 PBS 0 5598.8 
   
  
781  1 4806.6 
   
  
781  3 17107.6 11508.8 12301.0 abortion infected 4 
416 KILLED 0 6561.8 
   
  
416  1 5213.2 
   
  
416  2 1752.8 
   
  
416  3 2640.2 
   
  
416  4 8123 
   
  
416  6 14204.6 7642.8 12451.8 abort uninfected 6 
762 SHAM 0 4405.8 
   
  
762  1 3767.3 
   
  
762  2 3063.1 
   
  
762  3 3658.5 
   
  
762  4 4104.7 
   
  
762  5 4156.9 
   
  
762  6 4475.8 
   
  
762  7 4639.4 
   
  
762  8 5058.2 652.4 1995.1 induct uninfected 8 
20 low STREP 0 4881.5 
   
  
20  1 3063.1 
   
  
20  2 3658.5 
   
  
20  3 4104.7 
   
  
20  4 4156.9 
   
  
20  5 4475.8 -405.7 1412.7 abort infected 11 
12 low STREP 1 1335.7 
   
  
12  3 2112.8 
   
  
12  4 1958.1 
   
  
12  6 1295.9 
   
  
12  7 1475.2 
   
  
12  8 714.32 
   
  
12  9 986.8 
   
  
12  11 1230.6 
   
  




Table 5.1 continued 
Pony 
Treatment 













682 KILLED 0 1327.6 
   
  
682  1 474.9 
   
  
682  2 843.3 
   
  
682  3 1165.9 
   
  
682  4 3383.7 
   
  
682  5 815.9 
   
  
682  6 1656.8 
   
  
682  7 1624.8 
   
  
682  8 23314.8 21987.2 22471.5 abort infected 11 
22 PBS 0 1913.1 
   
  
22  1 2669.9 
   
  
22  2 2085.9 
   
  
22  3 2345.3 
   
  
22  4 1208.3 
   
  
22  5 1105.3 
   
  
22  6 1539.2 
   
  
22  8 2318.8 405.7 1110.5 induct uninfected 8 
12SG KILLED 0 2207.0 
   
  
12SG  1 1980.6 
   
  
12SG  2 2145.2 
   
  
12SG  3 2674.7 
   
  
12SG  4 1372.7 
   
  
12SG  6 1155.8 
   
  
12SG  7 875.2 
   
  
12SG  8 737.9 -1469.1 -137.4 induct uninfected 8 
24 low STREP 0 2492.1 
   
  
24  1 3001.8 
   
  
24  2 3096.6 
   
  
24  3 3533.7 
   
  
24  4 2080.7 
   
  
24  5 1734.3 
   
  
24  6 1169.5 
   
  
24  7 1259.1 
   
  




Table 5.1 continued 
Pony 
Treatment 













23 high STREP 0 1635.8 
   
  
23  1 1542.7 
   
  
23  2 1639.9 
   
  
23  3 573.3 
   
  
23  4 90.9 
   
  
23  5 22.8 
   
  
23  6 619.8 -1016.0 529.0 abort infected 11 
25 SHAM 0 3676.52 
   
  
25  1 563.5 
   
  
25  2 0 
   
  
25  3 281.5 
   
  
25  4 1853.7 
   
  
25  5 1680.3 -1996.2 1398.8 induct uninfected 19 
 
1
TEND-T0 is the difference in concentration from the last sample obtained and T0. 
 
2
TEND-TLOW is the difference in concentration from the last sample obtained and the lowest value 




Figure 5.1 Daily PGE2 concentrations in fetal fluids from mares in an experimental model of 
ascending placentitis with type of delivery. The allantoic space was catheterized laparoscopically 
between 265-280 d gestation: SHAM mares (n=3) received no transcervical procedure; PBS 
Control mares (n=3) received 1 mL sterile PBS transcervically; KILLED STREP (KS, n=3) 
received 1 x 10
7
 heat-killed Streptococcus zooepidemicus transcervically; low STREP mares 
(LS, n=3) received 1 x 10
7
 Streptococcus zooepidemicus transcervically; and high STREP mares 
(HS, n=1) received 5.1 x 10
8
 Streptococcus zooepidemicus transcervically. 
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Table 5.2 Daily PGF2α concentrations and differences in concentrations in fetal fluids from 
mares in an experimental model of ascending placentitis. The allantoic space was catheterized 
laparoscopically between 265-280 d gestation: SHAM mares (n=3) received no transcervical 
procedure; PBS Control mares (n=3) received 1 mL sterile PBS transcervically; KILLED STREP 
(n=3) received 10
7
 heat-killed Streptococcus zooepidemicus transcervically; low STREP mares 
(n=3) received 10
7
 Streptococcus zooepidemicus transcervically; and high STREP mares (n=1) 
received 5.1 x 10
8
 Streptococcus zooepidemicus transcervically. 
Pony 
Treatment 







781 PBS 0 122.0 
  
  
781  2 106.9 
  
  
781  2 176.4 
  
  
781  3 2624.0 2502.0 abort infected 4 
416 KILLED 0 518.3 
  
  
416  1 964.2 
  
  
416  2 207.6 
  
  
416  3 759.0 
  
  
416  4 2624.0 
  
  
416  5 2624.0 2105.8 abort unifected 6 
762 SHAM 0 149.0 
  
  
762  1 152.0 
  
  
762  2 161.3 
  
  
762  3 185.2 
  
  
762  4 161.7 
  
  
762  5 165.6 
  
  
762  6 166.1 
  
  
762  7 185.1 
  
  
762  8 253.1 104.1 induct uninfected 8 
20 low STREP 0 370.2 
  
  
20  1 268.2 
  
  
20  2 2624.0 
  
  
20  3 990.4 
  
  
20  4 2624.0 
  
  
20  5 2624.0 2253.8 abort infected 11 
12 low STREP 0 102.1 
  
  
12  3 75.7 
  
  
12  4 70.1 
  
  
12  6 73.5 
  
  
12  7 77.2 
  
  
12  8 69.7 
  
  
12  9 68.8 
  
  
12  11 74.3 
  
  















682 KILLED 0 100.2 
  
  
682  24 96.9 
  
  
682  48 64.5 
  
  
682  72 48.9 
  
  
682  0 61.0 
  
  
682  1 62.0 
  
  
682  2 65.6 
  
  
682  3 76.6 
  
  
682  4 68.4 
  
  
682  5 65.6 
  
  
682  6 68.0 
  
  
682  7 67.8 
  
  
682  8 2624.0 2563.1 abort infected 11 
22 PBS 0 244.9 
  
  
22  1 194.6 
  
  
22  2 168.2 
  
  
22  3 143.9 
  
  
22  4 136.6 
  
  
22  5 135.9 
  
  
22  6 116.2 
  
  
22  8 113.3 -131.6 induct uninfected 8 
12SG KILLED 0 322.4 
  
  
12SG  1 186.0 
  
  
12SG  2 93.9 
  
  
12SG  3 72.0 
  
  
12SG  4 64.8 
  
  
12SG  6 49.8 
  
  
12SG  7 68.6 
  
  
12SG  8 59.3 -263.1 induct uninfected 8 
24 low STREP 0 254.2 
  
  
24  1 125.3 
  
  
24  2 72.4 
  
  
24  3 68.0 
  
  
24  4 65.2 
  
  
24  5 63.7 
  
  
24  6 59.2 
  
  
24  7 114.5 
  
  




Table 5.2 continued 
Pony 
Treatment 







23 high STREP 0 484.1 
  
  
23  1 107.4 
  
  
23  2 59.4 
  
  
23  3 50.8 
  
  
23  4 47.6 
  
  
23  5 42.4 
  
  
23  6 117.8 -366.3 abort infected 11 
25 SHAM 0 132.0 
  
  
25  1 127.5 
  
  
25  2 154.3 
  
  
25  3 111.1 
  
  
25  4 100.1 
  
  
25  5 99.7 -32.3 induct uninfected 19 
 
1





Figure 5.1 Daily PGF2α concentrations in fetal fluids from mares in an experimental model of 
ascending placentitis with type of delivery. The allantoic space was catheterized laparoscopically 
between 265-280 d gestation: SHAM mares (n=3) received no transcervical procedure; PBS 
Control mares (n=3) received 1 mL sterile PBS transcervically; KILLED STREP (KS, n=3) 
received 1 x 10
7
 heat-killed Streptococcus zooepidemicus transcervically; low STREP mares 
(LS, n=3) received 1 x 10
7
 Streptococcus zooepidemicus transcervically; and high STREP mares 
(HS, n=1) received 5.1 x 10
8
 Streptococcus zooepidemicus transcervically. 
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Table 5.3 Analysis of the difference in PGE2 or PGF2α concentration between pre-inoculation 










Abortion 6737.3 3668.1 
0.10 Satterthwaite 




Abortion 13713 4285 
0.081 Satterthwaite 
Induced -257.9 488.8 
PGE2 TEND-TLOW 
Abortion 8415.6 3607.6 
0.095 Satterthwaite 




Abortion 15741.0 3365.3 
0.045 Satterthwaite 











Abortion 1506.4 543.5 
0.031 Satterthwaite 




Abortion 2390.3 143.3 
<0.0001 Pooled 











infected 7608.4 4306.3 
0.3166 Pooled 




infected 17386.0 5085.3 
0.0306 Pooled 











infected 1386.5 649.3 
0.1518 Pooled 




infected 2532.5 30.5 
0.0324 Pooled 
uninfected 325.3 449.3 
 
1
Where variances were found to be unequal (F΄ statistic; folded), Satterthwaite’s method for 
calculation of degrees of freedom associated with the approximate t is used, and the approximate 
t΄ statistic is computed Where variances were found to not be significantly different, the t statistic 
uses a pooled variance.   
 
2





 Significant increases in the concentrations of PGE2 and PGF2α in fetal fluids were 
observed when a sample was obtained within 24 h of delivery in mares with spontaneous 
abortion or intrauterine infection in an experimental model of ascending placentitis. Previously 
published mean concentrations of PGE2 and PGF2α in allantoic fluid from chronically 
catheterized mares during a similar stage of gestation were 3000 pg/mL and 2000 ng/mL, 
respectively [287], which are comparable to the values observed in this study.  The daily pattern 
from a single mare from catheterization to abortion (17 d post-operatively) was also similar to 
the daily pattern of most mares from our study. A mild increase in both PGE2 and PGF2α 
concentration was observed for the first several days following surgery (an increase of 1500 
pg/mL and 1000 pg/mL for PGE2 and PGF2α, respectively), followed by either an eight-day 
plateau (PGF2α) or a decline (PGE2), followed by a large increase (10,000 pg/mL and 5,000 
pg/mL for PGE2 and PGF2α, respectively) just prior to abortion [287]. Similarly a more 
consistent increase in PGE2 concentration than in PGF2α concentration was observed following 
surgery; therefore, the calculated rise in PGE2 from the peak prior to delivery in relationship to 
the lowest value for that individual mare (TEND – TLOW) was used for statistical analysis. The 
absolute values of PGE2 concentration were lower than those in a previously published model of 
placentitis [237], although in both study populations, variances were high and the 
instrumentation of the sample populations were different. All mares in the study described herein 
were instrumented with allantoic catheters, while in the previous study [237] some mares were 
catheterized and some were sampled by repeated allantocentesis. Despite these differences, both 
studies documented significant increases in concentrations of PGE2 and PGF2α in fetal fluids in 
response to an ascending placentitis.  
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 Prostaglandins are produced from both fetal membranes and from maternal uterine 
tissues. PGHS-1 and PGHS-2 expression was localized to human amniotic epithelium and 
mesoderm [66,67,288] , while the chorion laeve was found to either express both PGHS-1 and 
PGHS-2 [67,68], PGHS-1 [66], or PGSH2 [288]. In most studies, the expression  of PGHS-2 has 
been shown to increase with labor [66,69,288] and the activity of PGHS-2 (measured as the 
ability of the microsomal fraction of chorionic tissue to convert arachidonate to PGE2) was 
significantly greater in chorion from term spontaneous labor patients compared to chorion from 
term prior to labor patients [69]. Similar to human fetal membranes, PGHS-1 and PGHS-2 
mRNA were expressed in cotyledonary tissues from ewes at 40 d to term; and while no change 
in the relative abundance of PGHS-1 was observed during this period, the relative abundance of 
PGHS-2 mRNA increased sevenfold between 40 to 85 d and 140 to 145 d. No significant change 
in PGHS-2 was observed between ewes not in labor at 140 to 145 d and ewes in labor [70]. No 
change in PGE2 or PGF2α receptor subtype with respect to onset of spontaneous labor has been  
identified [71].With experimental Group B streptococcal infection in rhesus monkeys, 
extravillous trophoblast cell necrosis was associated with loss of immunoreactive PGDH staining 
and relative sparing of ir-PGHS-2 in amniotic epithelial cells, thereby leading to a net increased 
production of prostaglandins. Comparable studies have not been carried out with tissues from 
equine pregnancies.  
 The source of PGE2 and PGF2α in fetal fluids, although not specifically defined in the 
literature, is presumably through a paracrine route (i.e., secretion from fetal membranes into the 
allantoic or amniotic compartment), with potential contribution through endocrine pathways. The 
major consequence of fetal membrane and intrauterine production of PGE2 and PGF2α is 
myometrial contraction, by either paracrine or endocrine signaling. Secretion of PGE2 in the fetal 
fluids could have a secondary end result of paracrine action on fetal membranes with further 
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upregulation and release of interleukin-8 (IL-8) contributing to cervical relaxation (ripening) 
[289]. 
 The effect of cytokines on prostaglandin production is well documented in a variety of 
tissues. Interleukin-1β (IL-1β) and tumor necrosis factor alpha (TNF-α) have been shown to 
increase prostaglandin production by cultured human amnion cells [92,93], human chorion laeve 
cells [290] and myometrial cells [94], through increased expression of PGHS-2 [291], and while 
the administration of an IL-1β receptor antagonist prevented IL-β-induced labor in mice [95] it 
was unable to prevent delivery in endotoxin-induced pre-term labor [96]. The observed response 
to direct stimulation with IL-6 has been less consistent, varying from causing an increase in 
cPLA2 expression by myometrial cells [75], to having no significant effect on PGE2 production 
by human myocytes [94]. 
Several studies would advance the knowledge of signaling pathways involved in the pro-
inflammatory cytokine-induced production of PGE2 and PGF2α in equine uterine and placental 
tissues. Measurement of a simultaneous increase in the expression of PGHS-2 (COX-2), along 
with IL-β, and IL-18 (as was seen in Chapter 4), would confirm the relationship between 
upregulation of pro-inflammatory cytokines and PGHS-2 in response to infection. 
Immunohistochemical staining for PGHS-2 in both the chorioallantois and endometrium of 
mares following experimental induction of ascending placentitis would provide further 
corroborating evidence. Both techniques have been previously validated for equine tissues 
[292,293].  Additional recommended studies would include in vitro production of PGE2 and 
PGF2α from chorioallantoic and endometrial cell lines in response to IL-1β and IL-6.  
 One area of research in therapeutic regimes for equine placentitis that has not been 
adequately addressed is the use of selective, rather than  non-selective, cyclooxygenase inhibitors 
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to reduce the production of PGE2 and PGF2α. Conventional therapy currently involves non-
selective agents such as flunixin meglumine or phenylbutazone [244,294]. Results from a sheep 
model of preterm delivery documenting the effectiveness of meloxicam, a selective PGHS-2 
(COX-2) inhibitor, decreased PGHS-2 expression in endometrium, myometrium, and amnion 
[295], and attenuated amplitude and frequency of contractions, increased contraction duration, 
and delayed labor, without altering either fetal renal or cotyledonary blood flow [296].   These 
findings warrant investigation of its use as a tocolytic in the mare. 
 In summary, increased concentrations of PGE2 and PGF2α in fetal fluids were observed 
within 24 h of spontaneous abortion or in utero infection in an experimental model of infective 
pre-term delivery in the mare. Further research is needed to define more the localization and 
regulation of PGHS-2 in equine placental and maternal tissues, and to assess the effectiveness of 








EVIDENCE OF FETAL HYPOTHALAMIC-PITUITARY-ADRENAL AXIS 
ACTIVATION IN AN EXPERIMENTAL MODEL OF INFECTIVE PRE-
TERM DELIVERY IN THE MARE  
 
6.1 Introduction 
In most species, activation of the hypothalamic-pituitary-adrenal axis (HPAA) is a key 
event in the control of labor at term. In sheep the increase in fetal cortisol concentration during 
the last 2 weeks of gestation causes a decline in the placental production of progesterone and an 
increase in estrogen production [137,138]. Parturition can either be delayed by hypophysectomy 
[139] or adrenalectomy [140], or accelerated by fetal ACTH administration [141]. The fetal pig 
also has a gradual increase in cortisol concentrations during the last 2 weeks, but the final surge 
is of a shorter duration than that of the fetal lamb [142,143]. In contrast, cortisol concentration in 
the fetal horse only rises just before birth [142,144]. Activation of the HPAA in primates is 
characterized by increased fetal cortisol, dehydroepiandrosterone sulfate, estrone, and 
progesterone concentrations only a few days prior to term vaginal delivery [116]. Similar to 
sheep, administration of glucocorticoids promotes fetal maturation, and is commonly given to 
affect pulmonary surfactant secretion [145,146] . The HPAA activation has also been shown to 
be a key event in preterm delivery due to intrauterine infection in women. Patients with 
intrauterine infection and preterm delivery, as defined by recovery of a microbial pathogen from 
amniotic fluid or an amniotic IL-6 concentration > 2 ng/ml, had significantly higher amniotic 
fluid concentrations of cortisol (5.28 + 1.0 µg/dL) and dehydroepiandrosterone (539 + 79 
pg/mL) than patients with preterm delivery without intrauterine infection (1.61 + 1.05 µg/dL and 
273 + 82 pg/mL respectively) [147].  
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Increased concentrations of equine fetal plasma cortisol were seen during the final 4 to 5 
[148] or the final 9 d [144] of gestation. Cortisol concentrations rose from 3.1 + 1.0 to 13.4 + 3.7 
ng/mL, while significant increases in ACTH concentrations were not seen until the last 2 d of 
gestation (159 + 21 to 246 + 42 pg/mL) [144]. Fetuses less than 295 d of gestation failed to 
release cortisol in response to administration of  intravenous ACTH1-24, those greater than 304 d 
showed small but significant releases in cortisol, while those greater than 313 d of gestation 
showed the greatest release of cortisol, demonstrating that the equine fetal adrenal 
responsiveness to exogenous ACTH does not develop until extremely late in gestation [148]. 
Based on the observed adrenal response in fetuses greater than 304 d, the investigators then 
compared the effects of intramuscular intrafetal ACTH1-24 (n=16) administration daily for three 
days with saline administration (n=7), and whether induction of parturition 2 to 4 days after 
ACTH1-24 administration was associated with a positive neonatal outcome (n=4) compared to 
spontaneous delivery. Five mares aborted immediately following the last ACTH1-24 injection. 
Administration of ACTH1-24 did shorten gestation significantly in mares delivering 
spontaneously (312 to 314 vs. 327 to 333) and postnatal adaptive and endocrine patterns were 
normal; however, in pregnancies induced to deliver (306 to 308 days) one fetus died, and five of 
the remaining six foals required supportive care, and had lower plasma cortisol and increased, 
progestagen concentrations which failed to decline within the first 24 h of life [149] . Given the 
number of abortions and postnatal complications associated with intrafetal injections, the effect 
of maternally administered depot ACTH1-24 (1 mg vs. 4 to 5 mg) on days 300, 301, and 302 on 
fetal maturation was examined. Earlier parturition was significantly correlated with high dose 
ACTH given to mares mated late in the season (after July 1), compared to those mated early, 
although the strength of the correlation, as measured by the coefficient of determination, was not 
strong (r
2
=0.5). Maternal plasma cortisol and progestagen concentrations were increased 
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following ACTH1-24 administration, and this effect was greater and of a longer duration with 
high dose ACTH1-24 [297].  Investigations on maternally-administered dexamethazone on 
delivery and precocious fetal development have yielded conflicting results. Administration of 
100 mg/d, for three days beginning at either 321 or 315 d of gestation has been shown to induce 
parturition with no dystocia and good eventual neonatal outcome [298,299] while administration 
beginning on 331-347 d resulted in dystocia and fetal death in two of three mares [300].  
Betamethazone administration on 305, 306 , and 307 d advanced spontaneous delivery by 7 to 14 
d, but did not improve outcome if delivery was induced on day 320 [301]. One study evaluating 
the effect of maternally administered dexamethazone in combination with antibiotics to mares 
with experimentally induced streptococcal placentitis, failed to demonstrate that dexamethazone 
improved neonatal viability or postnatal outcome [302]. 
It is apparent from these studies that not only does maturation of the equine HPAA occur 
only at the end of gestation in normal pregnancies, but that manipulations in an attempt to 
accelerate fetal maturation precociously are frequently complicated with a negative neonatal 
outcome. Effective interventional strategies to advance fetal maturation would be of great benefit 
in many instances of both reproductive and non-reproductive high risk pregnancy. Changes in 
fetal plasma cortisol concentration in response to in utero infection have not previously been 
reported, nor have concentrations of cortisol in fetal fluid. The objective of this study was to 
measure cortisol concentrations in fetal fluid from mares in an experimental model of infective 
pre-term delivery. We hypothesized that cortisol concentrations in equine fetal fluids would 






6.2 Material and Methods 
6.2.1 Experimental Animals, Instrumentation, and Inoculation 
 Thirteen adult pony mares of various ages were used in this study over a 2 year period 
(2005-2006). Mares were maintained on pasture and supplemented with hay and a pelleted ration 
during the winter to maintain good body condition. All procedures were in accordance with 
Louisiana State University’s Institutional Animal Care and Use Committee’s guidelines for the 
humane treatment of research animals. Allantoic catheters were placed in sedated standing 
animals under local anesthesia using laparoscopic visualization as previously described (Chapter 
2). Pony mares were assigned to receive one of five transcervical inoculations: low STREP (1 x 
10
7
 CFU S. zooepidemicus; n=3), high STREP (5.1 x 10
8
 CFU S. zooepidemicus; n=1), KILLED 
STREP (1 x 10
7
 heat-killed S. zooepidemicus’ n=3), PBS CONTROL (1 mL sterile PBS; n=3), 
and SHAM CONTROL groups (n=3). Procedures were performed between 260 and 285 d of 
gestation. Two SHAM CONTROL mares, one PBS CONTROL mare, one KILLED STREP 
mare and one low STREP mare were induced to deliver fetuses as previously described (Chapter 
3), to provide gestational age-matched placental and fetal tissue, and control for the variability 
from inoculation to delivery. Preparation of the inocula, transcervical inoculations, patient 
monitoring, and sample collection were performed as previously described (Chapter 3).  Briefly, 
12 mL of fetal fluid was collected at twenty-four hour intervals, and immediately placed on ice 
for transport to the laboratory. Samples were centrifuged at 2,000 x g for 15 min at 4ºC, and the 
supernatant separated into one 5-mL aliquot and four 1-mL aliquots and stored at -70ºC for 
future analysis.  
6.2.2 Determination of Cortisol Concentration in Fetal Fluid 
 The concentration of cortisol in fetal fluid was assessed using commercially available 
radioimmunoassay reagents (Cortisol RIA, Diagnostic Systems Laboratories, Inc., Webster, TX) 
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and methods as previously described [303], and validated for equine samples [304]. Samples 
were assayed in duplicates. The intra- and interassay coefficients of variation and assay 
sensitivity were 6%, 8%, and 0.11 µg/dL, respectively.  
6.2.3 Statistical Analysis 
 Because of the small sample sizes within treatment group, effect of treatment group on 
the cortisol concentration in fetal fluid was not possible. The presence of infection (positive 
allantoic fluid culture), type of fetal fluid (allantoic or admixture), type of delivery (spontaneous 
abortion or induced delivery), and presence of histologic inflammation on cortisol concentrations 
was compared by a Student’s t test, using a statistical analysis software program (SAS 9.1, Cary, 
NC) with significance set at p<0.05, including Satterthwaite’s method for sample populations 
with unequal variances. Cortisol to creatinine ratios (CCR) were calculated and also compared 
by the Student’s t test to assess the potential influence of the relative dilutional effect of amniotic 
fluid on cortisol concentrations.  
6.3 Results 
 Two mares were excluded from the analysis – one PBS CONTROL mare due to peracute 
abortion (less than 96 h following laparoscopy), and one PBS CONTROL mare because the 
catheter pulled out of the uterus within 24 h following laparoscopy. The individual daily fetal 
fluid cortisol concentrations, creatinine concentrations, and CCRs for the eleven mares are found 
in Table 6.1.  Significant increases in cortisol concentration were found in fetal fluids from three 
mares (one KILLED STREP, one SHAM CONTROL, and one low STREP mare), and were 
observed prior to spontaneous abortion. Because there were different number of days from 
laparoscopy to delivery for each mare, the difference between the final (TEND) and initial (T0) 
cortisol concentration and CCR (Cortdiff, CCRdiff; Table 6.2) were used for statistical analysis. A 
summary of the means, standard error of the mean, and probabilities that Cortdiff and CCRdiff are 
148 
 
Table 6.1 Individual daily fetal fluid cortisol and creatine concentration and cortisol to creatinine ratios (CCR) in an experimental 
model of placentitis. 



















































inf admix induced inflamm 
25 
 
8 0.74 0.38 20.8 0.0356 0.02653 inf admix induced inflamm 







































inf allantoic abortion inflamm 
847 
 
8 1.7 1.3 141 0.0121 0.00797 inf allantoic abortion inflamm 





















































uninf allantoic induced none 




Table 6.1 continued 
































































uninf allantoic induced none 
22sg 
 
8 0.35 -0.13 54 0.0065 -0.00297 uninf allantoic induced none 












































101 0.0033   inf allantoic abortion inflamm 
682 
 
8 0.28 -0.04 82 0.0034 -0.00049 inf allantoic abortion inflamm 
































uninf admix abortion inflamm 
416 
 
5 3.12 2.66 16 0.1950 0.18063 uninf admix abortion inflamm 




uninf admix induced none 






uninf admix induced none 






uninf admix induced none 
12 SG    3 0.28   29 0.0097   uninf admix induced none 
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Table 6.1 continued 















uninf admix induced none 






uninf admix induced none 
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uninf admix induced none 
12 SG  
 
8 0.27 -0.23 25 0.0108 -0.0027 uninf admix induced none 
































































    




    




    
inf allantoic abortion inflamm 
12 
 
17 0.49 0.11 79 0.0062 -0.00046 inf allantoic abortion inflamm 














































uninf admix induced none 




Table 6.1 continued 





























inf admix abortion inflamm 
20 
 
4 1.49 1.26 11.9 0.1252 0.11426 inf admix abortion inflamm 














































inf allantoic abortion inflamm 




Table 6.2 Differences in resting and final cortisol concentrations and cortisol to creatinine ratios (CCR) in an experimental model of 
placentitis (n=11). 









diff CCR diff 
     ID   µg/dL µg/dL infection category delivery histopath   
25 SHAM 8 19 0.38 0.02653 inf admix induced inflamm 
 847 SHAM 8 8 1.3 0.00797 inf allantoic abortion inflamm 
 762 SHAM 8 8 0.06 -0.00040 uninf allantoic induced none 
 781 PBS 2 4 -0.05 -0.00987 inf allantoic abortion inflamm 
 22SG PBS 8 8 -0.13 -0.00297 uninf allantoic induced none 
 682 KILLED 10 10 -0.04 -0.00049 inf allantoic abortion inflamm 
 416 KILLED 5 6 2.66 0.18063 uninf admix abortion inflamm 




















Table 6.3 Means, standard error of the means, and the probabilities that means are different for cortisol concentrations (Cort diff) and 
cortisol to creatinine ratios (CCR diff) between pre-inoculation and prior to delivery in a model of placentitis.  
 





Admixed (n=5) 0.796 0.534 
0.30 Pooled 
Allantoic (n=6) 0.202 0.223 
CCR diff 
Admixed (n=5) 63.9 x 10
-3




Allantoic (n=6) 0.153 x 10
-3




Infection (n=6) 0.487 0.260 
0.96 Pooled 




Infection (n=6) 0.487 0.26 
0.075 Satterthwaite 
No infection (n=4) -0.098 0.060 
CCR diff 
Infection (n=6) 24.2 x 10
-3




No infection (n=5) 35.1 x 10
-3






Infection (n=6) 24.2 x 10
-3




No infection (n=4) 1 x 10
-3




Abortion (n=6) 0.867 0.442 
0.11 Satterthwaite 
Induced (n=5) -0.00200 0.106 
CCR diff 
Abortion (n=6) 49.9 x 10
-3




Induced (n=5) 4.24 x 10
-3




Inflammation (n=6) 0.487 0.260 
0.96 Pooled 




Inflammation (n=6) 0.462 0.246 
0.072 Satterthwaite 
No inflammation (n=4) -0.0975 00.0602 
CCR diff 
Inflammation (n=6) 24.2 x 10
-3




No inflammation (n=5) 35.1 x 10
-3






Inflammation (n=6) 24.2 x 10
-3




No inflammation (n=4) 1.33 x 10
-3




Where variances were found to be unequal (F΄ statistic; folded), Satterthwaite’s method for calculation of degrees of freedom 
associated with the approximate t is used, and the approximate t΄ statistic is computed Where variances were found to not be 
significantly different, the t statistic uses a pooled variance.   
 
2
Mare #416 removed from analysis 
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significantly different are provided in Table 6.3. There was no significant difference in Cortdiff 
(p=0.30) or CCRdiff (p=0.15) between admixed fetal fluid and allantoic fluid. There was no 
significant difference in Cortdiff (p=0.96) between mares with infected fetal fluids (Figure 6.1) 
compared to those with uninfected fetal fluids. However, only a single mare in the uninfected 
group (KILLED STREP mare; #416) had a substantial increase in cortisol concentration. This 
mare did not have histologic evidence of inflammation of the chorioallantois, and removal of her 
data from the analysis led to the effect of infection on cortisol concentration approaching 
significance (p=0.075).  There was no difference in CCRdiff (p=0.79) between mares with 
infected fetal fluids compared to those with uninfected fetal fluids; no change in significance 
(p=0.23) was seen when #416 was removed from analysis. All three mares with elevated cortisol 
spontaneously aborted (Fig. 6.2); however, the Cortdiff (p=0.11) and CCRdiff (p=0.22) were not 
significant between spontaneously aborting mares and those induced to deliver. There was no 
difference in Cortdiff between mares with histologic inflammation of the chorioallantois and those 
without inflammation (p=0.96); removal of mare #416 from the analysis led to the effect of 
infection on cortisol concentration approaching significance (p=0.072). There was no significant 
difference in CCRdiff between mares with or without histologic inflammation (p=0.79); no 
change in significance was seen with removal of mare #416 from the analysis (p=0.22) 
6.4 Discussion 
 These results suggest that increased cortisol concentration in fetal fluid may be seen with 
infection or histologic inflammation of the chorioallantois at 80% gestation. None of the fetal 
fluids from mares induced to deliver, or without inflammation of the chorioallantois, had 
increased cortisol concentrations. Failure of intra-fetal administration of ACTH at a similar stage 
of gestation to cause fetal cortisol release has led to the conclusion that the HPAA was immature 






Figure 6.1 Cortisol concentrations (µg/dL) in fetal fluids from mares uninfected (n=6) and 






Figure 6.2 Cortisol concentrations (µg/dL) in fetal fluids from mares where fetal delivery was 







Figure 6.3 Cortisol concentrations (µg/dL) in fetal fluids from mares with (n=5) or without 
(n=4) histologic evidence of inflammation in an experimental model of placentitis. 
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and that the equine fetal adrenal less than 295 d may be capable of response to stimuli. 
Unfortunately the sample sizes are small, and evaluation of additional animals would be useful. 
The highest cortisol concentrations were seen in one of the KILLED STREP mares (#416) which 
is difficult to explain. From instrumentation until abortion, this fetus was extremely active, 
precluding measurement of fetal heart rate. No infection was detected in either fetal fluids or 
fetal samples at delivery, and minimal inflammation was found in the chorioallantois. This mare 
spontaneously aborted and had a significant increase in CTUP (Table 3.1) and edema at the 
cervical star (Table 3.3), both of which are characteristic of changes at term in normal 
pregnancies [248].   At necropsy the fetus had a fibrinous pneumonia but no bacteria were 
present, either from culture or histologic specimens. It would appear that this fetus was 
experiencing in utero stress, although the source of the trigger is unknown. While it is tempting 
to speculate that this was secondary to the effects of a non-infectious inflammation produced by 
inoculation with heat-killed S. zooepidemicus, this is unlikely. This mare was inoculated in 2005, 
when difficulties were encountered with the type of pipette used for inoculation (Chapter 3).  It 
was suspected that either all or part of the inoculum was not deposited at the surface of the 
chorioallantois, leading to a failure to produce inflammation or infection.  
 The signaling pathways responsible for release of cortisol from the equine fetal adrenal 
gland subsequent to intrauterine infection are unknown, but data from other species would 
suggest that pro-inflammatory cytokines is one likely mechanism resulting in fetal HPAA 
activation.  Administration of  full length IL-1 stimulates preterm delivery in mice [264] and 
guinea pigs [305], and increased fetal cortisol concentration [305] and pulmonary lung function 
[305,306] in guinea pigs.  We have previously shown (Chapter 4) that expression of IL-1, IL-18 
and IFN-γ in the equine chorioallantois increased with infection and spontaneous abortion. All 
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three of the mares with increased fetal fluid cortisol concentrations had greater than a 25-fold 
expression change in IL-1β at the cervical star, and normal and abnormal areas of the 
chorioallantois. Further investigations, such as in vitro fetal adrenal cell responsiveness to IL-1 
and ACTH at various stages of gestation may provide insights into the signaling pathways 
leading to cortisol secretion subsequent to IL-1 treatment exposure.  
 Several studies suggest another potential signaling pathway leading to increased fetal 
cortisol output is by prostaglandin E2 (PGE2) stimulation. Administration of PGE2 to chronically 
catheterized fetal sheep resulted in premature labor [307], and produced significant increases of 
fetal immunoreactive ACTH and cortisol within 30 min of  infusion compared to control fetuses  
from gestational age 119 d to term, with the greatest response see with fetuses between 119 to 
125 d [308]. Meloxicam (a specific PGHS-2 inhibitor) significantly decreased fetal plasma 
concentrations of  PGE2, ACTH, and cortisol in a competitive progesterone receptor antagonist 
(RU486, mifepristone)-induced model of pre-term delivery in the ewe [309]. Prostaglandin E2 
enhanced the ability of arginine vasopressin to stimulate ACTH secretion by cultured pituitary 
cells [310]. These results have led to the conclusion that PGE2 plays a role in activation of the 
HPAA at term; however, this hypothesis is questioned by the failure of nimesulide, a selective 
PGHS-2 inhibitor, to reduce fetal ACTH or cortisol concentration in the late gestation ewe 
despite significantly decreasing fetal PGE2 concentrations [311]. There is insufficient data 
available on fetal fluid PGE2 concentrations from the three mares with increased fetal fluid 
cortisol concentrations in the study presented here to draw conclusions on PGE2 signaling equine 
fetal cortisol secretion.  
 It is unlikely that the elevated cortisol concentrations in fetal fluid described here are due 
to elevated maternal cortisol. Placental 11β-hydroxysteroid dehydrogenase type 2 enzyme (11β-
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HSD2) converts cortisol to cortisone, protecting the fetus from excessive exposure to maternal 
cortisol [312-314].  The equine endometrium has been shown to express 11β-HSD2 [315], and 
presumably the equine chorioallantois would as well. It would be useful to confirm the presence 
and activity of 11β-HSD2 in the equine chorion during gestation, and whether its activity is 
altered with infection, inflammation, or stage of gestation. In the future, documenting no increase 
in maternal cortisol concentration in samples contemporaneous with fetal fluid samples would 
provide evidence that an increase in fetal fluid cortisol concentration is solely of fetal origin. 
 In summary, these data provide preliminary evidence that the equine adrenal gland may 
be capable of cortisol secretion in response to stimuli prior to 295 d. Precocious fetal maturation 
is observed with some cases of naturally occurring equine placentitis, and neonatal survivability 
is most probably due to accelerated activation of the HPAA. If IL-1β is indeed the signal for 
HPAA activation, then perhaps intra-allantoic or intra-amniotic treatment with either full length 
IL-1β [305] or a non-inflammatory IL-1β-fragment [306] might provide a means of accelerating 





SUMMARY AND CONCLUSIONS 
 
 Ascending placentitis is a significant cause of abortions, stillbirths, and perinatal loss in 
horses. Empirical treatment for placentitis includes progestins to maintain uterine quiescence, 
broad-spectrum antibiotics to eliminate bacterial infection, and anti-inflammatory agents to 
prevent prostaglandin synthesis. Although these agents should address the basic problems of 
infection-induced prostaglandin synthesis that leads to uterine contractions and fetal expulsion, 
the efficacy of these regimes is often poor [316]. Recent investigations suggest that if therapy is 
instituted early in the course of infection, a favorable outcome is more likely [244,294]. 
Unfortunately, the diagnosis in clinical cases often lags the initiation of infection. There are two 
major areas where the basic knowledge of the pathophysiology of equine placentitis is lacking: 
(1) the endocrinological events associated with loss of myometrial quiescence and (2) the 
temporal relationship between the inflammatory cascade, increases in prostaglandin synthesis 
and release, and activation of the fetal hypothalamic-pituitary-adrenal axis.  
 In the first study (Chapter 2), we developed a technique for laparoscopic-guided 
catheterization of the allantoic space. The goal was to define a minimally invasive technique that 
would allow reliable allantoic fluid sample acquisition, and would allow for repeated animal use 
during subsequent pregnancies. Many technical hurdles, such as portal placement, catheter 
design, repeated use in subsequent years, and bacterial tracking were resolved. Laparoscopic 
ultrasound proved extremely useful in identifying a suitable pocket of allantoic fluid for catheter 
placement; however, a high percentage of attempts where fetal positioning precluded catheter 
insertion were still encountered. Attempts to rectify this problem by laparoscopic retractors and 
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pharmacologic intervention (propantheline as a myometrial relaxant) were unsuccessful in 
creating a deeper pocket of allantoic fluid. Despite these limitations, this technique holds 
promise in future investigations. It is likely that instrumentation earlier in gestation, when the 
relative ratio of allantoic to amniotic fluid volume is greater [317], would simplify placement of 
a catheter.  
 In the second study (Chapter 3), we described an experimental model of streptococcal 
infective pre-term delivery using mares instrumented with allantoic fluid catheters. Bacterial 
tracking confounded the data, and in only one-half of mares inoculated with live S. 
zooepidemicus was placentitis established. Clearly this study was hampered by small samples 
sizes and bacterial contamination due to tracking along the catheter system. Our original study 
design included sample sizes of six in each treatment group; however, we were forced to 
conclude the study with only three animals per treatment group. Despite these limitations, useful 
descriptive data was obtained, and fetal fluids were acquired for future measurement of soluble 
TNF-α, prostaglandin, cortisol, and progestagen concentrations, and chorioallantoic tissue was 
obtained for analysis of gene expression patterns. Of particular interest were the histologic 
changes in the fetal lung in response to infection. Fetal pneumonia in response to the presence of 
bacteria within the lung was inconsistent. The interpretation of the post-mortem bacterial 
contamination; however, this was not the case. In all of these instances, fetal fluids were culture 
positive prior to abortion, and identical isolates were recovered from fetal fluid and fetal lung. 
Whether this finding represents a peracute fetal infection and death prior to the initiation of an 
inflammatory response, or the failure of the fetus to mount an immunologic response to infection 
is unknown. In two of the fetuses with bacteria and no pneumonia, there was no increase in fetal 
fluid cortisol (Chapter 6), so an incompetent immunologic response is possible. 
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 In the third study (Chapter 4), we described the change in expression pattern of equine-
specific cytokines in chorioallantoic tissue from mares with experimental in utero infection and 
spontaneous abortion. Experimentally-induced infection increased the expression of IL-1β, IL-
18, IL-15, and IFN-γ in a site-dependant manner.  Spontaneous abortion also increased the 
expression of IL-1β, IL-18, IFN-γ, and iNOS in a site dependant manner. This expression pattern 
of pro-inflammatory cytokines in response to infection of equine placental tissue is different 
from a previous report [237], where IL-6 and IL-8 were increased at the cervical star and IL-6 
was increased at the uterine body. The findings presented here are in agreement with those of 
previously published experimental animal models and clinical findings from women with intra-
amniotic infection and pre-term delivery [76,224-228,243,263,270,273,280]. The consequence of 
increased IL-1β is the induction of COX-2 and PGE2 production leading to labor. We were also 
able to detect the transient presence of soluble TNF-α in a limited number of fetal fluids. 
Although this was somewhat surprising, TNF-α may only be present for a brief period of time in 
fetal fluids [228], therefore sampling time in relation to an inflammatory insult is crucial.  
 In the fourth study (Chapter 5), we described the changes in concentrations of PGE2 and 
PGF2α in fetal fluids from mares in an experimental model of ascending placentitis. The 
concentrations of PGE2 and PGF2α in fetal fluids were increased within 24 h of delivery in mares 
with spontaneous abortion or intrauterine infection. Similar to a previously reported catheterized 
model [287] , we observed a fairly consistent modest increase in PGE2 concentrations following 
surgery, followed by a decline. The absolute values of PGE2 concentration immediately prior to 
delivery we observed were lower than those in a previously published model of placentitis [237], 
although in both study populations, variances were high and the instrumentation of the sample 
populations were different. IL-1β has been shown to upregulate PGHS-2 [267]; similar studies 
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with equine cell lines are recommended. Conventional therapy for equine placentitis currently 
involves non-selective agents such as flunixin meglumine or phenylbutazone [244,294]; 
however, meloxicam, a selective cyclooxygenase inhibitor, has been shown to effectively 
prevent pre-term labor in sheep [295,296], warranting investigation of  its use as a tocolytic in 
the mare.  
 In the final study (Chapter 6), we observed increased cortisol concentrations in fetal fluid 
in some mares with infection or histologic inflammation of the chorioallantois. None of the fetal 
fluids from mares induced to deliver or without inflammation of the chorioallantois had 
increased cortisol concentrations. Previous research has led to the conclusion that the 
hypothalamic-pituitary-adrenal axis (HPAA) in fetuses less than 295 d are immature [149]; 
however, the data presented here suggest that this may not be the case, and that the equine fetal 
adrenal gland less than 295 d is capable of responding to stimuli. The signaling pathways 
responsible for release of cortisol from the equine fetal adrenal gland subsequent to intrauterine 
infection are unknown, but data from other species suggest that IL-1 stimulation is the likely 
mechanism producing fetal HPAA activation [264,305,306].  The in vitro response of equine 
adrenal cells throughout gestation to IL-1β would significantly add to the knowledge of what 
occurs during the course of in utero infection, and possibly delineate potential novel therapeutics 
in cases of high risk pregnancy. Precocious fetal maturation is observed with some cases of 
naturally occurring equine placentitis, and neonatal survivability is most probably due to 
accelerated activation of the HPAA. If IL-1β is indeed the signal for HPAA activation in equids, 
then perhaps intra-allantoic or intra-amniotic treatment with either full length IL-1β [305] or a 
non-inflammatory IL-1β-fragment [306] might provide a means of accelerating HPAA activation 
and enhancing neonatal outcome in high risk pregnancies. Other conditions associated with high 
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risk pregnancy in the mare, such as endotoxemia, are areas where further knowledge is needed of 
the signaling events leading to pre-term delivery. Although amniocentesis is commonly used by 
physicians to diagnose chorioamnionitis in women and assess fetal maturity, allantocentesis is 
rarely used in cases of suspected placentitis in the mare to either document infection of the fetal 
fluid compartments or to ascertain readiness for birth. The risk of allantocentesis causing fetal 
infection is considered by some high [318]. Increased cortisol concentration in fetal fluid appears 
to provide evidence of fetal HPAA activation. Continued research is needed to determine 
whether cortisol concentration determination in allantoic fluid can be used as an indicator of 
equine fetal maturity. Until reliable markers for fetal maturity and for infection are identified, the 
use of allantocentesis in the diagnosis and management of placentitis should be undertaken with 
caution.  
 In summary, we have developed a novel method of catheterization of the allantoic space 
in the mare, and have applied this method of instrumentation to a model of streptococcal 
placentitis. Based on our observations, we propose the following sequence of events leading 
from intrauterine infection to infective pre-term delivery. Following infection of the 
chorioallantois, IL-1β, IL-18, IL-15, and IFN-γ are upregulated in a site-dependant manner. IL-
1β causes increased PGHS-2 (COX-2) expression, resulting in increased PGE2 and PGF2α 
production, and ultimately labor.  IL-1β also accelerates fetal HPAA activation, thereby 
promoting precocious in utero fetal maturation. The eventual outcome of pre-term labor, i.e., 
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Mild diffuse placental degeneration with loss of 
villous tips (though  labeled normal, there are 











    1+     1+   1+   2+ Mild 
squamous 
metaplasia 
Mild subacute vasculitis; mild placentitis 







              1+ 1+     Marked cystic allantoic dysplasia, 
microcotyledonary atrophy 
D lung Acute fetal 
pneumonia 
  None seen 
on H+E 










  2+     2+     1+   Mild 
squamous 
metaplasia 
Marked cystic allantoic dysplasia, ulceration of 
allantois with intense focal placentitis - mixed 
inflammatory infiltrate admixed with keratin 
(apparent breechment of amnion - these are fetal 
cutaneous squames; microcotyledonary atrophy 







3+   3+ 3+       2+ 3+     Severe necrotizing funicitis, limited to superficial 
1/3 of tissue below ulcerated amnion; embedded 
kerating within a granulomatous inflammatory 
cirumferential band. 
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847 / 
SHAM 
                            
    A                             













          Severe bronchopneumonia. There is marked 
mononuclear cell exudate accumulated within the 
larger airways and alveolar lumen. This is an 
unusual inflammatory cell infiltrate as there are 
relatively few neutrophils. 





1+ 2+ 2+ 1+         1+   Trophoblast 
cell 
phagocytosi
s of large 
cocci 
(Staph?) 
Marked focal bacterial placentitis 
    C Cervical Star Necrosis of 
cotyledonar





2+                   Trophoblast 
necrosis 
Locally extensive placental degeneration and 
villous necrosis 






                    Autolytic 
sloughing 





    E amnion Fibrin 
adhere to 
surface 






2+ 1+ (large 
cocci) 
2+     2+           Subacute necrotizing funicitis with vascular 
thrombosis, scattered cocci on surface of cord 




























          PMNs Lymphs Mixed Edema           
    A Liv - Lung Aerated 
lung! 
                      The foal breathed 











            3+         Moderate diffuse placenta edema and 
degeneration 





            2+           
    D UC - amn                 1+       Mild edema of amnion, no UC changes 







            3+ 1+       The dramatic vacuolization of trophoblast 
cytoplasm is unusal:interpreted as a degenerative 
change (perhaps in response to experimental 
exposure to ??) 
    F UC - all Cord 
hematoma 
              3+         











                      Chronic focal reactive placental changes. No 






















          PMNs Lymphs Mixed Edema           















Subacute placentits with mild to moderate 
allantoic stromal infiltration by macrophages 
and neutrophils; focal stromal mineralization 
    B Cervical Star edematous 
with mild 
placentitis 
          1+ 2+           







3+ 3+ 1+                Vascular thrombi, transmural infarction; 
coccoid bacteria in great abundance 
    D liver Congestion 
and 
hemorrhae 
              2+         




      Diffuse bronchopneumonia, many alveolar 
macrophages contain bacteria 















1+     1+       1+   Non-suppurative placentitis with locally 
extensive chorionic villous atrophy and 
necrosis. 
    F UC Funicitis; 
Amnionic 
segment 
  2+ 2+     2+   3+     
  Moderate hemorrhagic necrotizing funicitis 
    G allantoic UC                       
  





















781/PBS           PMNs Lymphs Mixed Edema           






















1+ 1+       1+     1+     Subacute placentitis with coccal bacteria on the 
chorionic surface 





 2+           2+         




                      Mild fibrino-hemorrhagic funicitis 




  2+                     
    Mild cord 
hemorrhag
e 
              2+         





              2+         






  3+                   Despite the presence of large numbers of 
bacteria within the lung, there is only mild 

























          PMNs Lymphs Mixed Edema           
    A Amn                           





            2+ 1+         
    C liver                        




            1+           
    D Chorio-all: 
norm 




                            
    A Chorio-all: 
norm 
                          
    B Liver Mild 
hepatic 
congestion 
            1+           
    C allantoic 
membrane 
 1+     1+                 






1+   1+                 Mild fibrino-suppurative funicitis; fibrin 
within coelomic space 
    D Cervical 
Star 
     1+                   
    E amnion   1+             1+         





1+   2+ 1+       1+       Fibrino-suppurative funicitis 
    F Chorio-all 






























416/KS           PMNs Lymphs Mixed Edema           




                        
  allantoic UD                           





                        










          2+     2+     Placental mineralization and villous necrosis 






            2+         Minimal placentitis 
    E UC - amn minimal 
funicitis 
                        
    F liver Diffuse 
hepatic 
congestion 
                        


























12SG/ KS           PMNs Lymphs Mixed Edema           
    A amniotic 
UC 
                          









  Colonies of 
cocci 
                  Although there are cocci on the chorionic 
surface and a mixed bacterial   population 
within the allantois stroma, there is no 
significant placentitis present- this raised the 
possibility that the bacteria are postmortem 
overgrowth 
    C* liver               




            1+ 1+       Fetal distress - inhaled squames 
    D UC - all               
    E Chorio-
all: norm 
              1+           
















Locallly extensive placental degeneration; (but 





















20/LS           PMNs Lymphs Mixed Edema           


















3+ 3+ 2+     2+     2+     Chronic necrotizing placentitis with vascular 
thrombosis and intralesional colonies of coccal 
bacteria 
    C Chorio-all 





3+   2+     2+     2+   Diffuse 
squamous 
metaplasia 
Severe diffuse placental necrosis with marked 
squamous metaplasia of trophoblast cells; Diffuse 
allantoic fibrosis; ulceration of allantoic surface; 
allantoic vascular thrombosis 
    D* liver               






    3+ 3+               Severe neutrophilic and giant cell pneumonia; 
many sqames and some meconium are present in 
the deep airways. 
    E allantois Allantoic 
epithelial 
hyperplasia 
                      Mild hemorrhagic funicitis 





          1+   2+         
    F* amnoin Necrotizing 
amnionitis 
2+   2+     2+           Severe necrotizing amnionitis with vascular 
thrombosis 
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    A* Chorio-all 













Marked focal necrosis, villous atroph, cystic 
allantoic dysplasia, allantoic fibrosis, vascular 
infarction, mild stromal mineralization 
    B allantoic             No change in allantoic epithelium 







                        
    C* amnion               







          1+ 1+         The focal granulomatous inflammation in the cord 
may have been secondary to mechanical trauma as 
keratin flakes were embedded a short distance into 
the stroma 








              1+       Moderate hepatic congestion and sub-capsular 
hemorrage 





      Subacute fetal pneumonia with intralesional 
phagocytized bacteria, fetal distress as indicated by 
inhaled keratin squames embedded deep in the 
airways 
    E Cervical 
Star 
       1+ 1+ 1+     







              3+ 1+     No inflammatory infiltrate 
    G Chorio-
all: norm 





















24SG/LS           PMNs Lymphs Mixed Edema           
    A Chorio-
all: norm 






                        
    B amnon               
  amniotic 
UC 
                          
    C Chorio-all 











                2+ 2+   The CA has a focal area of fibrosis and granulation 
tissue; no significant inflammation.There is mild 
cystic allantoic dysplasia and adhesion of 
hippomane type debris on the allantoic surface. 
    D liver               





                        




            2+ 1+ 1+       
    G Chorio-
all:abn 
              1+   1+     Mild myxomatous change in stroma surrounding 
intermediate sized arteries, No placentitis is 
present. 





































          PMNs Lymphs Mixed Edema           
A cath site                           
B cerv star necrotizing 
placentitis 
2+ 3+ cocci 2+     2+     2+ 2+   necrotizing placentitis 
C allant UC necrotizing 
placentitis 
2+ 3+ 2+     2+     2+     necrotizing placentitis 
D amnio mild 
fibrinous 
funicitis 
    1+     1+           mild fibrinous funicitis 
E abn CA allantoic 
hyperplasia 
              2+       allantoic hyperplasia 
F lung necrotizing 
placentitis 
2+   1+                 necrotizing placentitis 
G normal CA bacterial 
colonies 
  3+                   autolysis; bacterial overgrowth 





      2+               neutrophilic funicitis 
42 / 
HS 
                            





              2+ 2+ 3+ mineralizati
on 
placental fibrosis; degeneration 
C all UC                     1+     
D amnion reactive                       reactive amnion epithelium, amnion nodosum 
E abn CA necrotizing 
placentitis 
  2+ 2+ 2+         1+ 2+ atrophy necrotizing placentitis 
F lung bacterial 
overgrowth 
  2+                   Pulmonary hemorrhage, postmortem bacterial 
proliferation. Fetal inhalation of keratinaceous 
debris (fetal in utero stress). Pulmonary 
hemorrhage, postmortem bacterial proliferation  
 Fetal inhalation of keratinaceous debris (fetal in 
utero stress) 
G normal CA reactive 
allantoic 
epith 
                    1+   
H liver                         autolysis 
I amn UC focal 
hemorrhage 
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